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Abstract
When engineers control gene expression, cells can be re-programmed to create living
therapeutics or materials by initiating expression of biosynthetic pathways in response to specific
signals. In this thesis, two new genetic tools were developed to aid the construction of genetic
circuits and facilitate their delivery to bacteria isolated from diverse environments. First,
antisense transcription was explored as a new tool for tuning gene expression in Escherichia coli.
Antisense transcription was found to reliably repress gene expression and was applied tune
simple genetic circuits. Second, an integrative conjugative element from Bacillus subtilis,
ICEBsJ, was engineered to deliver exogenous DNA to diverse strains of undomesticated Gram-
positive bacteria. Engineered ICEBsI conjugation was demonstrated in twenty different bacterial
strains, spanning sixteen species and five genera. To demonstrate ICE's utility in creating new
probiotics, the element was used to deliver functional nitrogen fixation pathways (rnf clusters) to
bacteria isolated from agricultural soils. Collectively, the tools presented here in provide a
platform for programing bacteria from diverse environments for advanced applications.
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Chapter 1: Introduction
1-1: THE HISTORY OF INTERACTIONS BETWEEN HUMANS AND BACTERIA
Humans and bacteria have a complicated relationship. For the bulk of human history,
bacteria were credited almost exclusively with causing disease. Plagues and pandemics caused
by bacteria, such as the 5th Plague of Egypt (1250 B.C.E.)', the Plague of Athens (430 B.C.E.) 2 ,
the Black Death (1346 to 1361 C.E.)3 , and the Paris Whooping Cough Epidemic (1578 C.E.)4 ,
wiped out significant portions of human populations in the past and often lead to a weakening of
society in cities and nations (Fig 1-1). At first, doctors believed that these diseases were spread
by miasma, a noxious form of "bad air" emanating from rotting organic matter. In the miasma
theory of disease, illnesses were caused by environmental factors (miasma) present at specific
locations and not by transmission between individuals5 . However in the 19th century, humans
began to realize that bacteria were responsible for causing some diseases. European physicians
developed the germ theory of disease, which stated that microorganisms cause diseases when
they grow and reproduce within a human host6 .Acceptance of the germ theory of disease led to
an increase in sanitation practices and a decline in devastating human pandemics. Since the mid-
1 9 th century researchers have identified several of the pathogenic bacteria that caused the major
pandemics, e.g Bacillus anthracis (5th Plague of Egypt)', Salmonella enterica serovar typhi
(Plague of Anthens) 2, Yersinia pestis (Black Death) 3, and Bordetella pertussis (Whooping
cough) 4, using DNA recovered from teeth in mass graves and historical descriptions of illness.
Although the germ theory of disease correctly identified pathogenic bacteria as causative agents
of illness, it missed the beneficial effects of other bacteria. In the late 1 9 th century, researchers
began to identify bacteria capable of positively influencing their hosts. One of the first symbiotic
relationships between bacteria and a eukaryotic host was reported in 1889 by a Dutch
microbiologist and botonist named Martinus Willem Beijerinck (1851-1931)7. Beijerinck
demonstrated that legume roots contained bacteria that turned atmospheric nitrogen (N2) into
ammonium (NH3)8 . He named the bacteria Rhizobia and demonstrated that they provide the
nitrogen needed for legume plants to grow. Around the same time, another bacterium Bacillus
thuringiensis was isolated from silkworms by a Japanese biologist named Ishiwata Shigetane9 .
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Strains of this bacterium kill insects and can protect plants from predators by living on its
surfaces. More recently, researchers have identified beneficial bacteria in humans. Human
symbiotic bacteria are typically studied en masse as a microbiota, i.e. a community of
microorganisms living in a specific environment. Research into the human gut microbiota has
demonstrated the importance of bacteria in defining human susceptibility to disease, nutrient
absorption, immune function, and neural function'0 . In fact, the human gut microbiotia is often
characterized as a "forgotten organ" because it plays so many important roles in human health".
Studies of the human skin", vaginal", and mouth 4 microbiota have revealed other important
roles for bacteria in maintaining human health.
First deliberate use Treaty signed to5"h Plague of of bacterial warfare prohibit biologicalEgypt (B. (B. antracis) warfare
anth acls) First bacterial Discovery of SyntheticPlague of Athens pesticide penicillin Insulin (E. coll)(S. enterica) discovered
(B. thunr nsis)
First written First Isolation of First microbial
record of nitrifying bacteria community study
B yurt
1500 1000 500 0 500 1000 1500 1600 1700 1800 1850 1900 1950 2000
First Boubonic S. aureus DNA structure MRSA
Plague (Y pestis) discovery solved emergence
Black Death First synthetic Human
Second Boubonic genetic circuit Microblome
Plague (V. POOtl) (E. Coil) Project
Paris Wooping First Cholera Bacteria Identified
Cough Pandemic as natto fermenter Synthetic
Epidemic (V. cholerae) (B. subtils) Artemisinin
(B. Petj~rg 0 ~. Precursor(B er9ubonic (.c/Plague (Y
pestis)
Wt Disease C Beneficial o- Research Development *. War *. Synthetic Biology
Figure 1-1: Timeline of human/bacteria interactions.
Although pathogenic and beneficial interactions between humans and bacteria typically
arise without conscious human action, humans can deliberately use bacteria to produce goods.
Bacterially fermented foods, such as yogurt (fermented milk), beer (fermented grain), and natto
(fermented soy bean), have been produced by humans using bacteria since at least the 1 8 th
century B.C.E.". Production of these goods relies on naturally occurring bacteria to ferment
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milk, grain, and beans. However relying on naturally occurring bacteria limits the types of
products that can be made using microorganisms. Fortunately, researchers developed cloning
techniques that allow biologists to engineer bacteria and alter their behavior. Since the late
1970s, bacterial engineering has enabled fermentation-based production of drugs to treat diabetes
(insulin)16 , malaria (artemisinin) 7 , and cancer (taxol)'8 . Bacteria have also been engineered to
detect toxins (arsenic)19 and human pathogens (Pseudomonas aeruginosa)o to prevent illness.
Though naturally occurring bacteria can positively impact our world, engineering opens up new
ways for bacteria and humans to interact and may create new solutions to today's problems.
1-2: THE PROCESS OF ENGINEERING BACTERIA
The process of engineering bacteria can be crudely broken down into three steps (Fig 1-
2). First, a researcher must select a strain of bacteria to modify. There is no shortage of bacteria
with unique capabilities that can be used as starting strains for engineering projects. There are
approximately 5x103 0 bacteria on earth2 1 , many of which have interesting innate abilities, such as
tolerance of extreme environments, utilization of unusual carbon sources, sensing/production of
interesting molecules, etc. Ideally a researcher would engineer bacteria with the most
advantageous characteristics for their purpose. These characteristics may include the ability to
withstand a specific harsh condition, thrive in a competitive environment, secrete a massive
amount of protein, or interact with other cell types. When selecting strains, researchers must also
consider a bacterium's capacity to uptake and express genes from foreign DNA. Since most
genetic engineering techniques/tools, e.g., transformation methods, DNA vectors, antibiotic
resistance cassettes, were developed for laboratory strains of model microorganisms, e.g.,
Escherichia coli K12, Saccharomyces cereviseae, these strains are often used by engineers to
create complex genetic programs, e.g., multi-input logic gates 22, synthetic oscillators23
Unfortunately, genetic engineering techniques/tools can be difficult to use with non-model
organisms. Thus, although unique strains of bacteria may be more desirable for specific
applications, they may not be selected for engineering projects because they can be difficult to
work with. The pros and cons of working with well-characterized model organisms need to be
weighed when selecting strains to engineer.
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The second step in engineering bacteria is to design and build DNA that alters the
bacteria's behavior. Genes that produce the desired effect can be sourced from any organism. For
example, if researchers want to produce the neuroactive compound phenylethylamine (PEA), an
aromatic amino acid decarboxylase can be used to convert phenylalanine to the desired product.
This decarboxylase can be sourced from any organism, including complex eukaryotes, as long as
it can catalyze the desired reaction. DNA sequences that encode the enzyme just need to be
introduced to the bacteria with the correct control elements, i.e., promoters, ribosome binding
sites (RBSs), terminators, etc. These parts control the amount of gene expression, i.e., mRNA
levels and protein concentration, and are usually carefully selected to express the correct amount
of mRNA and protein in the target bacteria. Over expression of the target molecules can
overburden cells and slow growth', however under expression can result in weak phenotypes or
poor yields of the desired product. Several large promoter, RBS, and terminator libraries have
been built and tested in model organisms to facilitate the design of DNA that expresses the right
amount of mRNA and protein26 7 . These parts can be used with additional biochemical tuning
knobs (discussed in Chapter 2) to achieve the desired expression levels.
1. Select bacteria 2. Design DNA to 3. Introduce DNA to
with desirable change the bacteria the bacteria
traits Which genes? Which method?
How much expression?
0.&
Figure 1-2: Steps to engineer bacteria.
Once the DNA is designed and built, the last step in engineering is to introduce it to
bacteria. There are four commonly used strategies for introducing exogenous DNA to bacteria
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(Fig 1-2). The first is to use a bacteria's natural ability to uptake extracellular DNA from their
environment. This is a genetically encoded ability that few bacteria possess 2 . Bacteria that are
not capable of natural competence can be made artificially competent with chemical or electrical
shocks. Chemical and electrical shocks make bacterial membranes transiently permeable to
DNA. Unfortunately, these methods can also kill cells and are not suitable for all cell types29 0 . A
third strategy is to use engineered bacteriophages to deliver DNA3 1 . Delivering DNA with phage
engineering requires isolating phage that can infect the target bacteria without causing lysis.
Phage genomes can be modified to include exogenous segments of DNA. Unfortunately, the
amount of DNA that can be delivered using engineered phage is limited by the phage capsid,
which must package the DNA for delivery into target bacteria32 . Finally, conjugation can be used
to transfer genetic material between cells. Conjugation is a form of horizontal gene transfer that
occurs frequently in nature. Using conjugation to engineer bacteria in the lab requires two
steps. First the foreign DNA must be introduced to a genetically tractable donor strain, then it
can be conjugated into the bacteria of interest. Fortunately, it is easy to introduce foreign DNA to
lab strains of E. coli and B. subtilis, which can be used as donors for conjugation.
After the new DNA is introduced to the bacteria of interest, the strain can be tested for
the desired phenotype. If the phenotype is suboptimal, the second two steps can be iteratively
repeated to create a design, build, test cycle that ultimately leads to the desired engineered
bacteria product.
1-3: TECHNIQUES TO IMPROVE BACTERIAL ENGINEERING
This thesis is devoted to developing tools that can be used to engineer environmental
isolates of non-model bacteria. The desire to engineer these organisms was inspired by bacteria
that form symbiotic relationships with humans, plants, and animals. Symbiotic bacteria
positively impact the health of their hosts through several mechanisms, such as protecting hosts
from pathogens 12 ,13 ,34 , providing nutrients 35 , or influencing host behavior36- 3 . However, these
bacteria could be engineered further improve our world by performing new functions. Some
examples of new advantageous functions include: producing therapeutic drugs in specific
locations in the human body to fight cancer and providing nutrients to specific food crops to
reduce fertilizer input and weed growth. Engineered symbiotic bacteria can be thought of as
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smart probiotics, which are expected to perform a beneficial function after being delivered to a
target environment. One key challenge in developing smart probiotics is ensuring survival of the
engineered bacterium in the target environment. The most well studied strains of bacteria, e.g.,
Escherichia coli K-12, are poorly adapted for survival outside lab conditions. Therefore, smart
probiotics would ideally be engineered using bacteria that have evolved to survive in the target
environment. The tools developed herein can be used to deliver DNA to environmental isolates
of bacteria and tune expression of the delivered genes. In addition to creating smart probiotics,
the tools can be applied to engineer bacteria that possess unique properties for other purposes,
such as solvent tolerant bacteria for the industrial production of enzymes or chemicals.
The first chapter of this thesis is a distillation of what is currently known about how to
construct complex genetic programs in Escherichia coli. The chapter is intended to serve as a
benchmark for current state of the art of constructing genetic circuits in model organisms. There
is an emphasis on the tools that are available for constructing genetic circuits and methods that
can be used to tune gene expression. Studies that characterize gene expression control elements,
e.g., sRNAs, ribosome binding sites (RBSs), UP-elements, for the specific purpose of using them
as 'parts' to tune gene expression in synthetic circuits are summarized using mathematical
models that demonstrate the impact of modifying/including these 'parts' in synthetic circuits.
Commonly encountered failure modes, and techniques to circumvent them, are also described to
emphasize the practical challenges associated with constructing complex genetic programs in
bacteria.
After surveying the tools available for constructing genetic circuits in E. coli, we decided
to characterize a method for tuning gene expression with potentially broad applicability across
organisms. In the second chapter of this thesis, antisense transcription is rigorously characterized
using a fluorescent reporter system and mathematical modeling. Antisense transcription is a
pervasive biological phenomenon that has been detected in all three domains on the tree of life.
We sought to rigorously quantify its impact on gene expression so that it could be used as
another tool for precisely controlling gene expression. We envision engineers using antisense
transcription as a secondary tool that can be layered on top of other methods of regulation to
make small adjustments in expression. Since convergent promoters on the same segment of DNA
generate antisense transcription, operon arrangement can now be used as a tuning knob. Using
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the results of our study, engineers can quantitatively predict the change in gene expression
produced by designing convergent transcriptional units in synthetic gene clusters.
Two aspects of the antisense transcription project are especially important. First,
antisense transcription may be a method of repressing gene expression that is applicable across
all cell types. Although we characterize the phenomena in E. coli, the basic tenants of antisense
transcription should hold true in other organisms, including eukaryotes. The qualitative effect
that antisense transcription has on gene expression (repression) should be universal, even if the
quantitative predictions made by our model are not. Second, this project is an example of a
synthetic biology study that makes mechanistic predictions about a biological process.
Specifically, the mathematical model of RNA polymerase collision that we built and
parameterized using experimental data predicts that RNA polymerase collision rarely results in
the release of the polymerase(s) from the DNA (5 50%). We believe that mechanistic insight
into biological processes could be obtained by analyzing more data from synthetic biology
studies, especially because synthetic biology projects often produce large datasets that could be
mined for more information.
The last chapter of this thesis is aimed at generating a tool for delivering DNA to
undomesticated bacterial species. We recognize that DNA delivery is the first challenge, after
isolation and culturing, associated with engineering new bacterial species. In order to begin
building sophisticated genetic programs in new strains/isolates of bacteria, we must first be able
to reliably introduce foreign DNA to the organism. We adapt an integrative conjugative element
from the soil bacterium Bacillus subtilis as a tool for introducing DNA to undomesticated
isolates of Gram-positive bacteria. This chapter fits into the broader goal of being able to
engineer the best bacteria for a specific application by developing a tool that can be used to
naively engineer new bacterial isolates.
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Chapter 2: Practical applications of genetic circuits
This chapter is an introduction to genetic circuit design. It is focused on the tools that are
currently available for constructing genetic circuits and the potential applications of genetic
circuits in medicine, industrial chemical production, and agriculture. First, the parts that are
currently available for constructing genetic circuits are presented and ordinary differential
equation models are used to show how regulator choices and "tuning knobs" can influence
circuit dynamics. Next, commonly encountered failure modes and the constraints that arise from
operating within a living cell are discussed. Ultimately, this introduction attempts to demonstrate
that better tools, well-characterized parts, and a comprehensive understanding of how to
compose circuits are leading to a breakthrough in the ability to program living cells for advanced
applications.
2-1. INTRODUCTION
The ability to perform computation in a living cell will revolutionize biotechnology by
improving existing products and enabling new applications. In the short term, genetic circuits
could be used to improve bio-based chemical production by inducing gene expression at
different stages of fermentation or limiting expression of an enzyme to specific conditions (e.g.,
low oxygen)39-44. As circuits become more advanced, entire algorithms from control theory could
be applied to further improve biochemical production (Fig 2-Ia) 4 - 4 . Synthetic regulation could
also be used to discover new natural products, including pharmaceuticals and insecticides, by
stimulating expression of biosynthetic gene clusters that are not expressed in laboratory
conditions 5 -6 0 . Outside the fermenter, living cells could be programmed to serve as therapeutic
agents that correct genetic disease (Fig 2-1b) or colonize niches in the human microbiome to
perform a therapeutic function (Fig 2- c) 6 1-73 . Longer-term capabilities include "smart plants"
that sense and adapt to environmental challenges (Fig 2-1d) and bacteria that organize to weave
functional materials with nanoscale features74-84.
Despite its potential, genetic circuit design remains one of the most challenging aspects
of genetic engineering 1 . The earlier fields of protein and metabolic engineering have yielded
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tools to optimize enzymes and flux through a metabolic network. These tools include
computational methods that can predict the impact of an amino acid substitution on protein
thermostability"2 or the distribution of flux through modified metabolic networks8. Biotech
companies often have research groups dedicated to protein and metabolic engineering that have
specialized training in these tools. However, industrial groups dedicated to building synthetic
regulation are rare and even simple tasks, like building a switch or inducible system, tend to be
one-off projects performed by a non-specialist.
A
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Figure 2-1: Potential uses of synthetic genetic circuits.
(a) In industrial applications, most synthetic metabolic pathways are overexpressed at all times or are under
simple inducible control. This could be improved by incorporating timing, feedback of metabolic
intermediates, or dynamic control. Here, we show a circuit that is controlling the production of a diesel
fuel alternative (bisobolane84) by regulating the accumulation of a toxic intermediate (HMG-CoA) by
sensing sugar, which induces oscillations in the production of HMGR. This type of oscillatory control
occurs in natural metabolic networks". (b) Gene therapy circuits could be built based on CRISPRi
technology by detecting SNPs and integrating this information with tissue-specific sensors. As a
hypothetical example, we show a circuit that could detect two SNPs associated with colon cancer
susceptibility (rs4444235 and rs9929218)' and this is integrated with a promoter that is specific to colon
cells (pAMUC2) to control the expression of misregulated genes (DLGAP5, N03, and DDX28). (c)
Bacteria could be programmed to colonize human gut and implement a therapeutic response. An example is
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envisioned where a commensal bacterium is used to stabilize pH and treat gastoesophageal acid reflux
(GERD). A bacterium that naturally resides in the stomach could be programmed to maintain a specific pH
using a set point control circuit"' whose output is a proton pump inhibitor (PPI). The imagined circuit
would restrict acid regulation to the stomach by terminating the bacterium via an irreversible switch if it
leaves this organ". (d) Genetic circuits could also be used to build "smart plants" that are able to sense
environmental stimuli and implement a response. Currently, traits are produced all the time whether or not
they are needed by the plant. Here, we envision a circuit that would operate in the chloroplast integrate
sensors for drought (pSpark), temperature (pCBF), and plant maturity (pSAG12) to control multiple traits.
This could reduce the amount of recombinant protein that is produced and enters the food supply without
reducing the effectiveness of the trait.
Several features of genetic circuits make them challenging to work with. First, circuits
require the precise balancing of their component regulators to generate the proper response"".
Computational tools and part libraries that enable the tuning of expression levels have only been
developed recently91-94. Before this, only course-grained control was achievable with small sets
of parts89 ' 90 95 . Second, many circuits are difficult to screen in directed evolution experiments.
Digital logic has clear on and off states that can form the basis for a screen50 ,96-1o 2 . However,
screening for functional dynamic circuits, such as oscillators, is significantly more complex 0 3
and it is hard to imagine how screens would be established for more sophisticated functions, like
a PID controller with proscribed response properties. Third, there are few tools to measure circuit
performance. Typically, a fluorescent reporter is used to measure the output, but fluorescence
detection requires artificially high expression levels and fluorescent protein degradation rates can
limit the ability to measure dynamics. Fourth, synthetic circuits are very sensitive to
environment, growth conditions, and genetic context in ways that are poorly understood% .
Finally, the process of building a large genetic circuit requires the assembly of many DNA parts
and this process has been both technically challenging (until recently) and fraught with its own
sources of errors101 '105" 0 .
This chapter can serve as a guide for designing prokaryotic transcriptional circuits, where
both the inputs and outputs are promoters6 9',111-114. Transcriptional circuits maintain a common
signal carrier, which simplifies the connection of circuits to build up sophisticated operations" .
Post-transcriptional circuits, including those based on protein and RNA interactions, are covered
in excellent reviews' 1-118. Although the majority of this guide is dedicated to bacterial circuits,
many of the principles, albeit not the details, are relevant for eukaryotes, including human cells
and plants1 9' 120
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2-2. GENETIC CIRCUIT DESIGN BASED ON DIFFERENT REGULATOR CLASSES
Transcriptional circuits operate by affecting the flow of RNA polymerase (RNAP) on
DNA. There are a number of molecules that impact transcription that have been used as the basis
for building synthetic circuits (Fig 2-2). For example, DNA-binding proteins can recruit or block
RNAP to increase or decrease the flux, respectively. Analogously, the new CRISPRi system can
use the Cas9 protein to bind DNA and alter transcription121122. RNAP flux can also be altered
with invertases that change the orientation of promoters, terminators, or gene sequences. Finally,
RNA translational repressors, such as RNA-IN/OUT, can be converted to transcriptional
regulators to control RNAP flux 2 3", 2 4. In this section, we describe recent advances in these
methods and analyze the impact that each regulator has on circuit response.
2-2-1. DNA-binding Proteins
Many families of proteins can bind to specific DNA sequences (operators). The simplest
way to use these proteins as regulators is to use them as repressors, which block the binding of
RNAP to promoters or inhibit elongation. Repressors have been built out of zinc finger proteins
(ZFPs)"2 , transcription activator-like effectors (TALEs) 26" 2 7, TetR homologues" 4 , phage
repressors 12,129 , and LacI homologues 30 . A core set of -3 repressors were re-used in many of the
first synthetic circuits (CI, TetR, LacI) 9096,13 1-134 . However, recently there have been efforts to
expand the number of DNA-binding proteins that are available for circuit design97, 3 s'4 2
Expanding protein libraries can be challenging because each repressor has to be orthogonal; i.e.,
only interact with their operator and not the others in the set. Because of their simple function,
repressors are relatively easy to move between species, including to eukaryotes 3-14. DNA-
binding proteins can also function as activators that increase the flux of RNAP on DNA.
Activators either recruit host RNAP to a promoter or are alternative RNAPs that transcribe genes
directly. Recent efforts have increased the number of such proteins that are available for
constructing circuits 97'141-143
Many logic gates have been constructed with DNA binding proteins that recruit or block
RNAP" 4 44"5 2 . For example, NOT and NOR gates have been built with inducible promoters that
drive expression of repressors (Fig 2-2a)" 4 53 90,13 1. Additional transcriptional logic has been
achieved with regulators that bind directly to the proteins to either inhibit or enhance their
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function. For example, AND gates have been built with activators that require chaperones (Fig 2-
2b)98'"4 4 and with artificially split proteins4. Similarly, NAND gates can be built with proteins
that block the activity of an activator, such as anti-o factors, which inhibit 5 factors' 43. Of the
regulators described in this review, DNA-binding proteins are the only class (so far) that has
been used to build dynamic circuits. This includes pulse generators1 55, bistable switches'9",
counters" 2 , feedback loops, and oscillators that have different periods and amplitudes' 3 ,3 1 ,i 7'5 s
Analog computing modules have also been built with DNA binding proteins, which highlights
the diverse signal processing capabilities of these regulators,4,144,146,3
2-2-2. Invertases
Invertases are site-specific recombinase proteins that facilitate the inversion of DNA
segments between binding sites"o. All invertases mediate "cut-and-paste" recombination, during
which DNA is looped, cleaved and re-ligated1 61. Two types of invertases have been used to build
genetic circuits. The first are tyrosine recombinases, such as Cre, Flp, and FimBE, which require
host-specific factors112,162-164. These recombinases can be reversible and flip the DNA in both
directions, or irreversible and only flip DNA in a single direction. The second class of invertases
is serine integrases, which catalyze unidirectional reactions that rely on double stranded breaks to
invert DNA. Serine integrases typically do not require host factors and often have cognate
excisionases that can be expressed independently to return the DNA to its original orientation.
163164 12Invertases have been used to build switches6 2 , memory circuits '3, , counters' , and
logic gates 165, . These proteins are ideal for memory storage, because they flip DNA
permanently and do not require the continuous input of materials or energy to maintain their new
orientation. In invertase logic gates, discrete physical states of the DNA can correspond to on
and off states (0 and 1). However, using invertases can be challenging because their reactions are
slow (requiring 2-6 hours) and can generate mixed populations when targeting a multicopy
plasmid 64 . Reversible invertases can also generate mixed populations, however this limitation
was overcome recently by using a serine integrase to flip DNA in one direction and an
integrase/exisionase pair to return it to the original state167.
All two-input gates, including AND and NOR logic, have been constructed using
orthogonal serine integrases (Fig 2-2cd)1 65'". The gates are organized such that two input
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promoters express a pair of orthogonal recombinases, which change RNAP flux by inverting
unidirectional terminators, promoters, or entire genes. These gates are based on unidirectional
serine integrases without excisionases, therefore they operate as memory circuits that remember
exposure to two input signals. Once flipped, the circuits cannot be returned to their original state,
therefore the gates do not distinguish the order they were exposed to the inputs or even if they
occurred at the same time.
2-2-3. CRISPR
CRISPR (Clustered Regularly Spaced Short Palindromic Repeat) arrays function as a
bacterial "immune system" that targets specific DNA sequence motifs for degradation".
CRISPR systems utilize a Cas nuclease and guide RNA to introduce double strand breaks to
specific DNA sequences1 69. Mutant Cas proteins (dCas9122 , Cas9N 170) that do not have nuclease
activity have been developed and used as transcription factors that knock down gene expression
by forming a DNA bubble that interferes with RNAP activity'. CRISPR machinery can also
be used to activate transcription by fusing an RNAP recruiting domain to catalytically inactive
Cas92  -"4 . Considering the needs of synthetic circuits, a significant advantage of CRISPR is
the ability to design guide RNAs to target specific DNA sequences. A large set of orthogonal
guide sequences that target different promoters would enable the construction of large genetic
circuits.
CRISPRi is still relatively new and NOT gates are the most complex circuits built to
date 22 . The NOT gates induce sgRNA and dCas9 expression simultaneously to repress
transcription at an output promoter. In theory, a NOR gate could be created by introducing a
second sgRNA that targets the same output promoter (Fig 2-2e). In general, CRISPRi circuits
will probably resemble DNA binding protein circuits. However, unlike the repressor based NOR
gate (Fig 2-2a), the CRISPRi NOR gate will need to have the sgRNAs expressed from separate
input promoters because 5' RNA extensions can reduce or eliminate activity (Fig 2-2e)" .
Circuits based on CRISPRi are expected to operate on similar timescales to protein-based
circuits because of the stability of the regulatory dCas9/sgRNA/DNA duplex1 22 .
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Figure 2-2: Logic gates built based on different regulator types.
All of the gates are transcriptional, where there are two input promoters (PIN, and PIN2) and one output
promoter (Pour). Two-input transcriptional logic gates have not yet been built for CRISPRi and RNA-
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IN/OUT so we hypothesize how these biochemistries could be used. The graphs at the right show how the
gates will respond to inputs introduced at the same time (graphs at left) or sequentially (right). In all panels,
the on state is assumed to generate ten fold higher than the off state. (a) A NOR gate is shown based on a
repressor that binds DNA 53. The lines are based on measured induction ( 1 1 2 ~36 min) and relaxation (-U,1 2
~35 min) half-lives176. (b) An AND gate based on an activator that binds DNA that requires a second
protein to be active.9 8 The lines are based on a measured induction (T1 1 2 -36 min)' and approximate
relaxation ( 1 ,2 ~35 min) half-life. (c) A NOR gate based on integrases that flip two terminators to turn off
the output16516 . We assume a small readthrough probability, which leads to a change in the rate when only
one terminator is flipped. Conceptually, a NOR gate could also be constructed by having two input
promoters in series drive the expression of a single integrase. The lines are based on an on-rate of 1.8 hours
162,164,165. (d) An AND gate based on integrases 165. The same on- and off- rates are used as in part c. (e) A
NOR gate could be built based on CRISPRi by setting a constitutive level of Cas9 expression and then
having the two input promoters drive the expression of two guide RNAs. The lines are based on measured
induction (TV 2 = 35 min) and relaxation (T,,2 = 47 min) half-lives. (f) A NOR gate could be built based on
the RNA-IN/RNA-OUT system developed by Arkin and co-workers1 2 1. RNA-OUT represses translation of
tnaC, which allows Rho to bind the mRNA and repress transcription of the output. The CRISPR machinery
needed to process RNA-IN mRNA for this circuit is not shown. The lines are based on theoretical induction
(T 1 2 ~30 min) and relaxation (T1 ,2 -35 min) half-lives176'177
A current challenge in implementing CRISPRi circuits is toxicity, which is difficult to
control. Toxicity is most likely the result of Cas9 binding to the host genome at PAM sequences
(NGG) and forming bubbles that deleteriously impact host gene expression7 8"1 79. Another
consideration for building CRISPRi circuits is retroactivity '8, which could arise from using Cas9
as a shared resource (Section III). One way to circumvent retroactivity would be to express
multiple orthogonal Cas9 homologues 8 1 "8 2 . Finally, each guide RNA will need to be
experimentally screened because predicting guide RNA orthogonality is complicated 5 "8 ' ,183,184
2-2-4. Adapted RNA-IN / RNA-OUT
The RNA-IN/OUT system from E. coli represses translation of a target protein when a
short noncoding RNA (RNA-OUT) is expressed. In the natural system, RNA-OUT binds to a
specific sequence at the 5'end of an mRNA (RNA-IN) to occlude ribosome binding and increase
mRNA degradation18-187. Arkin and co-workers retooled this system to repress transcription,
instead of translation, using a transcriptional adaptor from the tna operon". The tna regulatory
element is composed of a ribosome binding site (RBS), the coding sequence for a short peptide
called tnaC, a Rho binding site and an RNAP pause site that facilitates Rho-mediated
transcription termination. Translation of tnaC causes ribosomal stalling, which blocks Rho-factor
binding and allows RNAP to transcribe genes downstream of tnaC. However, when translation
of tnaC is prohibited, Rho binds the growing mRNA and knocks off RNAP thereby inhibiting
15
transcription elongation. RNA-IN/OUT RNAs regulate transcription elongation by altering
translation of tnaC. Like CRISPRi, the adapted RNA-IN/OUT system could be used to generate
a large set of orthogonal regulators because it is based on designable RNA-RNA interactions. To
date, more than 150 different families of at least seven orthogonal RNA-IN/OUT mutants have
been designed using an RNA-IN/OUT model and all of the mutants tested experimentally have
been functional and orthogonal"'.
Adapted RNA-IN/OUT has been used to build two-, three-, and four-input NOR gates
(Fig 2-2f)123 . In these systems, orthogonal RNA-IN variants were connected such that expression
of any cognate RNA-OUT represses transcription of the output gene. Additional layers of
regulation could be engineered into the adapted RNA-IN/OUT system with ligand-responsive
aptamers that regulate RNA-OUT activity'8 or tRNAs that control ribosomal pausing in tnaC89 .
A challenge in building larger RNA-IN/OUT circuits is that each transcriptional regulator
requires the same tna regulatory element (-290bp). The re-use of this part in multiple circuits
could lead to homologous recombination (Section III). Engineering TnaC to reduce the length of
the repeated sequence 2 or using homologs from other organisms and alternative Rho binding
sites could potentially attenuate recombination.
2-3. SELECTING PARTS TO TUNE THE CIRCUIT RESPONSE
Genetic circuits need to be tuned to meet the specifications required for a particular
application. For example, a large dynamic range may be required to strongly activate a pathway.
Similarly, low off states are desirable when expressing toxic proteins'9. When the first synthetic
circuits were built, there were few options available for tuning circuits and only course-grained
changes were possible8 9'90. New libraries of well-characterized parts and computational tools
have made it easier to design and tune genetic circuits. Moreover, new classes of insulators
improve the reliability of these parts when they are placed in the local genetic context of a
circuit. Additional biochemical interactions, such as small RNA (sRNA), have been incorporated
into circuits in order to provide additional tuning knobs. In a review, graduate students from the
Voigt lab detailed advances in part design and tools to obtain reliable expression levels' 91 . Here,
we show how the selection or modification of different parts impacts the response of a circuit.
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Two circuits are used as model systems to demonstrate the effects of various tuning
knobs. The first, a NOT gate, represents a simple logic operation (Fig 2-3a)"9'6. Logic gates are
often characterized by their response function, which captures how the steady-state output
changes as a function of input. The shape of this function is defined by: 1. the ON and OFF
states, which define the circuit's dynamic range, 2. the amount of input required to reach the
half-maximum output (also referred to as the threshold), and 3. cooperativity of the switch 92 ,193.
An oscillator was selected as an example of a dynamic circuit (Fig 2-4a). These types of circuits
can be very difficult to tune because they need to be balanced in a narrow region of parameter
space in order to function properly33 94 195 . For an oscillator, tuning will affect the period,
amplitude, and shape of the oscillations. Tuning can also force the system out of the oscillating
parameter space and cause the circuit to fai'1 33 .
Two ordinary differential equation (ODE) models were used to show how the selection or
modification of different parts impacts the performance of the logic gate and dynamic circuit.
The following equations, 2-1 - 2-9, comprise the NOT gate ODE model, with the base
parameters in Table 2-1.
dL -0 (2-1)dt
dPT - pT+L 6 L - PTLaL + PT+LYT+L (2-2)
dPt+
dt = PTLaL - PT+L 6 L - T+LYT+L (2-3)
dmR = PT7T - mRYmR (2-4)
dt
d - mRCR - RYR - RPRcaR + PR+R 6 5R (2-5)
dPR = pR+R OR- RPRaR + PR+RYR+R (2-6)dt
dPRR = RPR cR - R+R 6 R - PR+RYR+R (2-7)
dmy = PRlR - mYMY (2-8)dt
dY = myTy - YyY (2-9)
Here PT and PR are the input and output promoters, mR and my are the mRNA species for the
repressor and output reporter protein (YFP), L, R and Y are Lac, the repressor protein, and YFP
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and PT+L and R+R are the input promoter bound to Lac and the output promoter bound to the
repressor, respectively. The model assumes that the Lac repressor concentration changes only as
a function of added inducer. The concentration of Lac was determined using the following
model:
[LacI] - (1-IPTG 2 )0.01(IPTG2 +0.012) (2-10)
Parameter . InitialParameter value Species Species description value
LacI dissociation (AL) 0.1 L Lac repressor (Lac) Eq 1
Lac association (XL) 0.5 P Ptac promoter 25
Lac degradation (YT+L) 0.000005 PT+L Ptac bound by Lac 0
mR transcription (IT) 0.005 mR Repressor mRNA 0
mR degradation (YmR) 0.004 R Repressor 0
R translation (TR) 0.05 PR Repressible promoter 25
R degradation (YR) 0.0008 PR+R PR bound by repressor 0
R dissociation (8R) 0.00036 My YFP mRNA 0
R association (aR) 0.0001 Y YFP protein 0
R degradation on promoter (YR+R) 0.000005 Pc Constitutive promoter 25
mY transcription (rY) 0.01 SR sRNA 0
mY degradation (ymy) 0.004 dSR sRNA mRNA duplex 0
Y translation (TY) 0.03 0 Operator 1000
Y degradation (y,) 0.00028 OR 0 bound by repressor 0
sRNA transcription (k1s) 0.01
sRNA/mRNA hybridization (Y+) 0.001
sRNA/mRNA dissociation (o ) 0.0001
sRNA degradation (Ys) 0.004
RNA duplex degradation (Yd) 0.04
Table 2-1: Base parameters for the NOT gate ODE model.
Parameters were altered to simulate tuning knobs as described in the main text.
The response function of a digital logic gate can be shifted up or down by changing
promoter strengths (Fig 2-3b)", ribosome binding sites (RBS), or the proteins' degradation rates
(Fig 2-3c) 197. Promoter strength can be altered with mutations in the promoter sequence19 8 or by
selecting new promoters from a characterized library92, . Increased degradation can be achieved
with protease tags or N-terminal degrons 97. Circuit components are often distributed between
multiple plasmids at different copy numbers in order to synthesize each component at the
necessary level. However, when entire circuits are expressed on one plasmid, copy number can
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be shifted to simultaneously alter the circuit's dynamic range and threshold (Fig 2-3d). Different
origins of replication can generate complex and poorly understood effects on expression, for
example, by changing localization and supercoiling. This can be minimized by using plasmid
systems where the copy number can be controlled without changing the origin".
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Figure 2-3: Methods of Modifying NOT Gate Behavior.
Every panel displays circuit outputs with original parameter values (black) or tuning knob variations (grey).
Inputs in (a-f) are IPTG. (a) Architecture and ideal response functions for the NOT gate. (b) Promoter
strength is increased (dashed grey line) or decreased (solid grey line) by a factor of two. (c) Enzymatic
degradation of the reporter protein was modeled as a five fold increase in the protein degradation rate". (d)
Gene dosage. The NOT gate is moved between a high copy plasmid (dashed grey line) and the genome
(solid grey line) to tune expression. The high copy plasmid is assumed to be ten times more abundant than
the original circuit. (e) Ribosome binding site strength. Repressor RBSs (RBSI) are increased (dashed grey
line) or decreased (solid grey line) by a factor of five. Altering the reporter RBS would shift the output of
both circuits vertically (not pictured). (f) Small RNA designed to bind repressor mRNA are modeled with
the introduction of a new species that binds repressor mRNA with the same affinity as a ribosome (this
value was chosen arbitrarily and can be modulated to change circuit dynamics). In this model, small RNAs
are produced constitutively and sRNA/mRNA duplexes are degraded faster than either RNA alone. (g)
Decoy operators that bind repressor proteins. Decoy operators were modeled by introducing a new species
that binds repressor protein with the same Kd as the repressible promoter. The model has 25 decoy operator
sites, however circuits can be tuned with more or less as needed.
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The threshold of the gate can be changed via several methods. Selecting a stronger or
weaker RBS, adding multiple operators, or changing operator positions within the repressible
promoter can change the threshold (Fig 2-3e)102 11 4 ,202 ,20 3 . The threshold of a gate becomes steeper
and more switch-like when small changes in the input have a large effect on the output2O4. This
phenomenon, known as ultrasensitivity, can be important for controlling actuators where
intermediate levels of expression are undesirable2 4. It can also make connecting gates easier by
decreasing the range of input needed from an upstream circuit to span the induction threshold.
One way to make a gate ultrasensitive is to change the cooperativity of repressor binding to the
promoter or to introduce DNA looping205 206 . Another approach is to express a sequestering
molecule that binds a circuit component and prevents it from functioning. Sequestration has been
achieved using sRNAs that bind to mRNA 77 2 0 7 (Fig 2-3f), proteins that bind to transcription
factorsi15 2 08 2 09, and decoy DNA operators that titrate the transcription factor away from the
output promoter" (Fig 2-3g).
sRNA-based mRNA sequestration was modeled by adding three equations to the original
NOT gate model (Eq 2-1 - 2-9) and modifying Eq 2-4. These equations (Eq 2-10 - 2-12, with 2-
4M) describe a constitutively expressed sRNA that irreversibly binds mRNA encoding the
repressor, leading to increased degradation (Fig 2-4).
dPC = 0 (2-10)dt
= PC7s - SRMRU+ dRsU- SRS (2-11)dtsmc+ dRx SY
ddRs = sRmRU+ - dRScx- dRSYd (2-12)
dt
dmR= PT7T - mRYmR - SRmR+ + dRSc- -dt
Decoy operator-based sequestration was modeled by adding two equations to the original
NOT gate model (Eqs 2-1 - 2-9) and modifying Eq 2-5. These equations (2-13 - 2-14 with 2-
5M) simulate 1,000 decoy operator sequences that the repressor R binds to with the same affinity
as the promoter PR.
= ORSR - ORaR + 0 R6 R (2-13)
= ORaR - ORSR - ORYR+R (2-14)
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dt =mRTR - RyR - RPRaR + PR+RSR - ORaR + O R 6 R
a bI-
Pc sRNA PIN Repressor PR Output PIN Repressor PR Output
Figure 2-4: Architecture of the NOT gate with sRNA or decoy operator regulation.
Inputs and parameters/initial conditions are the same as in Fig 2-3. (A) NOT gate with sRNA regulation. Pc
is a constitutive promoter driving expression of the sRNA. (B) NOT gate with decoy operators added to
tune the response function.
The next set of equations, 2-15 - 2-31 describe the oscillator model, with parameters in
Table 2-2.
dp - P1RR - PldRR + P1A6 A - PldAaA + P1RYPR + P1AYPAdt
dPlR = P1dRaR 
- P1R(R 
- 1RYPRdt
dPlA = PldA-A 
- AA 
- P1AYPA
dt
dMR = P1 7R P1A71R+ 
- mRYmR
dt
dR_
dt - mR-R RROR++ dRR-+ dRYdR - RyR
(2-15)
(2-16)
(2-17)
(2-18)
(2-19)
ddR = RROR+- dRR-~ dRYdR- PdRR + P1R6 R - P2dRcR + P2R6 R - P3dRaR + P3R6 Rdt
(2-20)
d - P2R6 R - P2dRaR + P2A6 A - P2dAaA + 2RYPR + P2AYPA
dP2R = P 2 dRaR - P2R6 R 
- 2RYPRdt
=P2A = P2dAaA - 2AA 
- 2AYPAdt
dMA = P 2 77A - P2A?7A+ 
- mAYmA
dt
dt = mATA - AAuA++ dAA+ dAYdA - AyA
(2-21)
(2-22)
(2-23)
(2-24)
(2-25)
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(2-5M)
ddA - AAqA+ - dAOA- dAydA - P1dAaA + P1 AA - P 2 dAcA + P2ASA - P3 dgaA + P3A8 Adt
(2-26)
dt= P3R 6 R - P3dRaR + P3A 6 A - P3dACA + P3RYPR + P3AYPA
dP3R - P 3 dRaR - P3RSR 
-3RYPR
dt
dP3A - P 3 dAXA - P3A 6 A 
- P3AYPA
dmy P3 7Y ~ 3A 7Y+ - mYYmY
= mYTy- YyY
Here P 1, P2, and P3 are identical promoters that can be activated or repressed by
(2-27)
(2-28)
(2-29)
(2-30)
(2-31)
dimers of
activator (A) or repressor (R) proteins, respectively. The model assumes monomers of the
activator and repressor cannot bind the DNA and that a single promoter cannot be bound by both
repressors and activators simultaneously. Activator binding to the promoters increases
transcription rate 50-fold.
Parameter vParameter Species Species description Initial
R dissociation w/promoter (6 R)
R association w/promoter (aR)
R degradation on promoter (YPR)
A dissociation w/promoter (8A)
A association w/promoter (aA)
A degradation on promoter (YPA)
mR transcription (qR)
mR transcription + activator (Y]R+)
mR degradation (YmR)
R translation (TR)
R degradation (YR)
mA transcription (fA)
mA transcription + activator (1A+)
mA degradation (YmA)
A translation (TA)
A degradation (YA)
my transcription (ny)
my transcription + activator (rjy,)
my degradation (Ymy)
0.001
5000
0.0005
0.01
0.1
0.0005
0.1
5
0.01
0.15
0.008
0.1
5
0.01
0.05
0.008
0.1
5
0.01
R
dR
mR
P
PIR
PIA
A
dA
MA
P2
P2R
P2A
Y
my
P3
P3R
P3A
PC
Repressor
Repressor dimer
Repressor mRNA
Repressor promoter
P1 bound by repressor
P bound by activator
Activator
Activator dimer
Activator mRNA
Activator promoter
P 2 bound by repressor
P 2 bound by activator
YFP
YFP mRNA
YFP promoter
P 3 bound by repressor
P 3 bound by repressor
sRNA promoter
sRNA
0.804
0
0.31
0
25
0
0.32
0.05
0.021
0.0182
25
0
126
0.2
0.0182
25
0
50
0
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Y translation (Ty)
Y degradation (yy)
R dimerization (OR+)
R dimer dissociation (OR.)
A dimerization (YA+)
A dimer dissociation (CA-)
sRNA transcription (ils)
sRNA/mRNA hybridization (,)
sRNA/mRNA dissociation (a)
sRNA degradation (ys)
RNA duplex degradation (Yd)
2.5
0.008
0.1
0.001
0.01
0.01
0.001
0.02
0.001
0.01
0.05
sRNA mRNA duplex
Operator
O bound by repressor
Table 2-2: Base parameters for the oscillator ODE model.
Parameters were altered to simulate tuning knobs as described in
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Figure 2-5: Methods of Modifying Oscillator Behavior.
Every panel displays circuit outputs with original parameter values (black) or tuning knob variations (grey).
(a) Architecture and ideal response functions for the oscillator. (b) Promoter strength is increased (dashed
grey line) or decreased (solid grey line) by a factor of two. (c) Enzymatic degradation of the reporter
protein was modeled as a five fold increase in the protein degradation rate 201. (d) Gene dosage. The circuit
is moved between a high copy plasmid (dashed grey line) and the genome (solid grey line) to tune
23
0
1000
0
A
Oscillato
B
expression. The high copy plasmid is assumed to be ten times more abundant than the original circuit. (e)
Ribosome binding site strength. Repressor RBSs (RBS1) are increased (dashed grey line) or decreased
(solid grey line) by a factor of five. Altering the reporter RBS would shift the output of the circuit vertically
(not pictured). (f) Small RNA designed to bind repressor mRNA are modeled with the introduction of a
new species that binds repressor mRNA with the same affinity as a ribosome (this value was chosen
arbitrarily and can be modulated to change circuit dynamics). In this model, small RNAs are produced
constitutively and sRNA/mRNA duplexes are degraded faster than either RNA alone. (g) Decoy operators
that bind repressor proteins. Decoy operators were modeled by introducing a new species that binds
repressor protein with the same Kd as the repressible promoter. The model has 25 decoy operator sites,
however circuits can be tuned with more or less as needed.
In an oscillator, parts that impact the rate of gene expression change the amplitude of the
response and can shift the period (Fig 2-5be). Rapid protein degradation is critical for dynamic
circuits to function correctly. If proteins are slow to degrade, then the circuit may slow down or
stop functioning altogether (Fig 2-5c) 211 . Protease tags can be used to decrease the degradation
rate from several hours to -20 minutes, which will increase the rate at which a gate
switches 197113,132,15. Cooperativity is critical for obtaining robust oscillators because it increases
the region of phase space that produces oscillations 205 . Therefore, sequestration approaches (e.g.,
sRNA or dummy operators) are predicted to have a large impact on the period and amplitude of
oscillations (Fig 2-5fg) 2 12.
sRNA-based mRNA sequestration was modeled by adding three equations to the original
oscillator model (Eq 2-15 - 2-31) and modifying Eq 2-18. These equations (Eq 2-32 - 2-34,
with 2-18M) describe a constitutively expressed sRNA that irreversibly binds mRNA encoding
the repressor, leading to increased degradation (Fig 2-6).
dPC = 0 (2-32)
dt
dtR = cOlS - sRmRc~d+ + dRSc- - SdRYS (-3
ddS- SRmRc~d+ -dsd ~~ (2-34)
dt
- 1R ~ PA R+ ~ RYMR - SR nRU+ RS- (2-18M)dt
Decoy operator-based sequestration was modeled by adding two equations to the original
oscillator model (Eq 2-15 - 2-3 1) and modifying Eq 2-20. These equations (2-35 - 2-36 with 2-
20M) simulate 1,000 decoy operator sequences that the repressor dimer dR binds to with the same
affinity as the promoters P 1, P2, and P3 .
= OROR - OdRaR + ORYPR (2-35)dt
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dOR = OdRaR - OR5R - ORYPR (2-36)dt
ddR = RROR+-dRR- dRydR~ 
-PdRaR + P1R(R~ P 2dRaR +P2R(R -P 3dRaR +P3RR~dt
ORaR + ORR (2-20M)
a b
T -O f&TIr f-&T r+ hT
Pc sRNA PA-R1Repressor PA-2 Activator PA-R3 Output PA-RI Repressor PA-R2 Activator PA-R3 Output
Figure 2-6: Architecture of the oscillator with sRNA or decoy operator regulation.
Inputs and parameters/initial conditions are the same as in Fig 2-5. (A) Oscillator with sRNA regulation. Pc
is a constitutive promoter driving expression of the sRNA. (B) Oscillator with decoy operators added to
tune the response function.
2-4. COMMON FAILURE MODES FROM CONNECTING CIRCUITS
Gates can be combined to build larger circuits that implement more sophisticated
computational operations. To connect transcriptional gate, the output promoter of one circuit is
used as the input promoter to the next. This method applies for all transcriptional circuits,
including digital, analog and dynamic circuits or a combination of types. To connect circuits,
they have to broken up into their component parts and then combined in a particular order (Fig 2-
7a). Reorganizing the parts places them in new local contexts that are different from those where
they were characterized. This can be problematic because circuit components can behave
differently in new genetic contexts and small circuits may have identical component parts (e.g.,
terminators) that interfere with each other in the larger circuit. In this section, we discuss failure
modes that can arise when building larger circuits, show the impact that each failure has on
circuit function, and discuss engineering approaches to mitigate these problems.
When connecting circuits, a common problem is that the upstream circuit's output does
not span the dynamic range required to stimulate next circuit in series (Fig 2-7b). In digital
logic, this 'mismatch' manifests as either a decrease in the dynamic range of the complete circuit
or a loss of function. Connectivity mismatches can be corrected by selecting parts that shift the
thresholds of individual gates. For example, RBSs can be mutated to force the threshold of a gate
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to fall within the dynamic range produced from an upstream circuit"' 4 5. 'Mismatches' in an
oscillator can dampen oscillations or force the system outside the functional parameter space
(Fig 2-7b). Mathematical models could be used to streamline circuit design by predicting the
functional parameter space and selecting appropriate RBSs and promoters to achieve the required
expression levels 91"' 203
Genetic parts are often context dependent, meaning their functions change when the
DNA sequences on either side of the part are altered2 3'2 4 . Context dependencies complicate part
substitutions because part characterizations are often carried out in isolation and their activity in
a new context may not match the measured strength. For example, promoters are that are defined
as DNA sequences <50 bp may behave differently in new contexts because the a-domain of E.
coli RNAP can contact the DNA ~100 bp upstream of the transcription start site'98 . In a digital
circuit, reducing promoter efficiency attenuates the response of individual gates and reduces the
output of the complete circuit (Fig 2-7c). Promoter attenuation can increase the amplitude of an
oscillator and elongate the period, by reducing repressor expression. Insulator sequences can
relieve some compositional context effects by standardizing the DNA sequences flanking
promoters21421
Context effects can also occur when promoters are fused to different RBSs. Promoters are
sensitive to the DNA sequences near the transcription start site because that region can alter
promoter melting and polymerase escape frequency1 ". Transcription start sites can also fluctuate
based on the local sequence context216217, which can impact RBS strength by altering the length
of the 5'-UTR and changing mRNA secondary structure. Tandem promoters can generate
especially long 5'-UTRs that exacerbate this effect by base pairing with the RBS or sequences in
the open reading frame2 1 o220 . Circuits can fail completely when mutations in the 5'-UTRs cause
hairpins completely occlude the RBSs and prohibit translation (Fig 2-7d). To solve these
problems, the 5'-UTR can be cleaved with ribozymes or CRISPR processing to standardize RBS
accessibility 215 221. Catalytic insulator elements serve dual functions by standardizing both the 5'
end of mRNA and the promoter region downstream of the transcription start site. RBSs can be
further insulated from the local context using bicistronic designs, which prime the mRNA for
translation with an upstream RBS that keeps the mRNA unfolded92
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Figure 2-7: Common failure modes and their impact on circuit dynamics.
(a) An AND gate 1 4 and oscillator"3 are used as model systems to demonstrate the assembly of parts to
build more complex circuits. Repression is indicated with a blunt ended connector and activation is
indicated with an arrow. For the AND gate, the input promoters are PIN1 and PIN2 and the output promoter is
PR3. Promoters are named by the repressor to which it responds (e.g., PRI is repressed by R1). The steady-
state response to different combinations of inputs is shown as a bar graph, where the OFF states are grey
and the ON state is black. For the oscillator, the promoters PA-R are repressed by R and activated by A. The
impact of various failures (red lines) are shown for the AND gate (left) and oscillator (right) with expected
dynamics shown in black. Models were used to simulate the R2 NOT gate, the AND gate" 4, and oscillator.
Oscillator model equations are identical to those used to create 2-5. Unless indicated otherwise, Input 2 is
the input to the NOT gate transfer function. (b) Mismatched response functions. In the AND gate, R3 was
modeled as a different repressor: Beti (kd = 0.2, n = 2.4, max = 13, min = 0.4) instead of Orf2 (kd = 0.4, n =
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6.1, max = 16, min = 0.2)14. R2 is the input for the R3 transfer function. In the oscillator, the R translation
rate is increased ten-fold. (c) Promoter context. Strength of the indicated promoters is reduced by 50% in
both circuits. (d) RBS context. The translation rates of R2 (AND gate) and R (oscillator) are set to zero.
Input 1 is the input for the R2 transfer function (e) Transcriptional read-through. 30% read-through from
upstream operons through the red terminator is simulated in both circuits. (f) Part-junction interference. A
new constitutive promoter (AND gate) is simulated as approximately 20% of the strength of PIN2- New
terminator (oscillator) decreases transcription 40%. (g) Orthogonality. R3ma, is set as R2min to simulate
repression of PR3 by R2. Additional equations are added to the oscillator model to simulate repressor-
activator complex formation. (h) Recombination. R2 and R were removed from the AND gate and
oscillator models, respectively.
Transcriptional read-through can be a problem in genetic circuits with monocistronic
designs, where every gene has its own promoter and terminator. These designs require strong
terminators to insulate against read-through from neighboring promoters. Failure to fully insulate
each cistron can link the expression of genes that are supposed to be regulated independently
(Fig 2-7e) and can contribute to the leaky expression of uninduced genes. Strong, tandem
terminators can be placed on either side of each gene to ensure isolated expression of individual
operons222 . Large libraries of rho-independent terminators were recently built and characterized
to enable the construction of large circuits that are robust to read-through and homologous
recombination (described below) 93 2 22 .
DNA sequences are information rich, therefore connecting two parts can create a new
functional sequence at the junction 223 . New regulatory elements, such as promoters or
terminators, can be generated at a part junction if the combination creates a sequence of DNA
that resembles a regulatory element. For large circuits, many parts have to be combined in a new
order and unexpected parts that interfere with gene expression can be generated (Fig 2-7f). One
way to scan for unintended functional sequences is to use computer algorithms that search for
various regulatory elements 9' 222 ,2 2 30
Crosstalk, which occurs when regulators interact with each other's targets, can change the
topology of a circuit and can lead to errors in the desired operation98 . For example, crosstalk
between a repressor and non-cognate promoter can inappropriately decrease expression of a gene
and cause a circuit to fail (Fig 2-7g). Avoiding crosstalk requires that parts be screened for
orthogonality via combinatorial experiments that test every combination of promoter and
regulatory ee t14,124,126,141,143,231
Many of the circuits built to date re-use the same regulatory parts, which can lead to
homologous recombination. Homologous recombination deletes DNA between repeated
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sequences and can result in the loss of circuit components and circuit failure (Fig 2-7h) 222 . In
general, the rate of recombination increases with circuit toxicity23 2 and homolgous DNA length,
with the threshold occurring between 20-30bp2 3 . Homologous recombination can be avoided
with large libraries of parts with redundant functions that have enough sequence diversity to
avoid222,234avoid recombination,4
2-5. INTERACTIONS BETWEEN SYNTHETIC CIRCUITS AND THE HOST ORGANISM
Genetic circuits are based on biochemical interactions within living cells. Most circuits
use host resources to function, including transcription/translation machinery (e.g., ribosomes and
RNAP), DNA replication equipment, and metabolites (e.g., amino acids). The availability of
these resources and the details of the intracellular environment change significantly in different
strain backgrounds, environmental conditions, media, growth rate, and cell density. When the
first synthetic circuits were built, they were fragile and it was unclear why they would only work
in specific conditions 20,21. Now, there is a more precise understanding of the ways in which
circuits break due to interactions with the host'04. A better understanding these failure modes are
and the methods natural systems use to overcome them will lead to new design rules for
composing synthetic circuits.
A common observation is that some synthetic regulators can cause growth defects. Yet it
remains unclear why certain regulators can be expressed at high levels with no noticeable impact
whereas others in the same class are very toxic. This was evident in analyzing large libraries of
TetR and s factor homologues sourced from diverse organisms and transferred into E. coli 14.43
Expression of some of regulators slowed E. coli growth, but the origin of this effect is unclear as
it does not correlate with the number of predicted binding sites in the genome or off-target gene
expression measured using RNA-seq. T7 RNAP is another part that can be very toxic when
combined with a strong T7 promoter 45. It is also unclear how this toxicity arises, but it could be
due to the difficulty terminating T7 RNAP, which could cause circular transcription on a plasmid
or expose mRNA by decoupling RNAP and ribosome progression. Circuits based on protein-
protein interactions can also exhibit toxicity when the proteins bind to off-target partners. We
observed this with anti-s factors, which appear to bind and titrate native s factors 43. Small RNA
with RBS-like sequences can also cause toxicity by titrate ribosomes, increasing expression
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variability, and reducing growth (Fig 2-8a)'9. Larger circuits are particularly sensitive to the
toxicity that can arise from individual regulators because their effects are compounded when
they are expressed together"'.
Circuits can also decrease growth rate by monopolizing host resources and slowing
essential protein/RNA production (Fig 2-8a)236. A small reduction in the growth rate can be a
problem when using a circuit for industrial applications that rely on high product yields. A
decrease in growth rate can reduce the dilution rate of circuit components and lead to unintended
build up of proteins or RNA that can cause a circuit to fail. In fact, circuits can appear to function
better when growth is impeded because slow dilution increases the observed concentration of
transcription factors and reporters. Slow growth can also put pressure on the host organism to
evolve away the burdensome circuit, either via homologous recombination, point
mutations/deletions, or copy number reduction.
Circuits can diverge from their expected behavior when they use a limited resource that is
shared with other cellular processes. Overburdening resources causes queuing, which results in a
delay or reduction in circuit activity2 3 7 . For example, when s factors are overexpressed, they can
occupy the entire pool of free core RNAP. When this happens, sigma factors must compete to
bind to the core, which indirectly couples their activity and can disrupt host processes2 8. Native
s factors are able to avoid queuing by pulsing their expression such that they alternate the usage
of core RNAP over time2 39. A similar coupling effect has been observed when the ClpXP
protease is shared by regulators that have been modified to contain C-terminal tags for fast
degradation. If too many proteins are targeted for degradation, the enzymatic machinery can
become overwhelmed and force substrates to wait for processing 211. The rapid degradation of
regulators is important for dynamic circuits, such as oscillators, which will fail if the regulatory
proteins accumulate (Fig 2-8b).
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Figure 2-8: Circuit performance within the context of a living cell.
(a) Recombinant protein expression can cause a growth defect by reducing the availability of host resources
(e.g., RNAP and ribosomes). Here, synthetic sRNAs compete with mRNA for ribosomes to illustrate the
impact of exogenous protein expression on host resource allocation. When sRNAs are produced (left graph,
grey bars), ribosomes are titrated away from fluorescent protein mRNA and observed fluorescence is
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reduced relative to no sRNA (left graph, white bars)5 1 . Center graph, colored circles represent the
overexpression of different proteins in E. coli (blue: Pu promoter b-Galactosidase, red: T7 promoter b-
Galactosidase, black: tac promoter DEF-Tu, green: bla promoter b-Lactamase) 240. Right graph, colored
circles represent growth of different bacterial strains as a function of rRNA supply (blue: E. coli 300C,
green: A. aerogenes 370C, red: C. utilis 250C, orange: C. utilis 300C, black: N. crassa 3 0 1C) 2 41. (b) Queuing
as a result of overloading the ClpXP protease machinery with proteins from a synthetic oscillator. The
graph shows the difference between expected (black) and measured (red) dynamics for an oscillator
affected by queuing 211 . (c) An additional output (PR2) on a high copy plasmid is added to the NOT gate.
This causes retroactivity, which alters the activation dynamics of the original output (PRI) (black line:
original dynamic response, orange line: retroactive effect)2 4 1. (d) One plasmid with two reporter proteins is
transformed into different E. coli strains. The ratio of expression varies in some strains (left graph: wild
type E. coli strains, right graph: KEIO collection knockouts) 2 4 2 . (e) Different media impact the performance
of an AND gate based on T7 RNAP4"' 45. Data are shown for the circuit in the absence (white) and presence
(black) of both inputs in different medias (LB: luria broth, Min: minimal media, #T and/or #L: minimal
media supplemented with tryptone (#T = #g/L) or yeast extract (#Y = #g/L).
Retroactivity can also interfere with circuit activity. Retroactivity is defined as the
influence that a downstream genetic element can have on an upstream one and it describes the
changes in circuit behavior that result from connecting new downstream modules to a circuit"O.
Downstream modules may affect the performance of upstream circuits by titrating regulators
away from the original circuit. For example, connecting a second output to a NOT gate may
cause retroactivity by titrating the repressor away from the original output promoter (Fig 2-8c).
Retroactivity will impact the NOT gate's dynamics by increasing the time it takes to build up an
adequate amount of protein to repress promoter activity 2 4 1 . Retroactivity that delays a circuit's
response to input stimulation can be alleviated by increasing expression of the problematic
circuit component; however, increasing expression can lead to other trade-offs, including
toxicity.
Strain variation can affect circuit performance in different ways. Differences in growth
rate, ribosome concentration, and induction lag time have been identified as the main
contributors to strain dependent variations in circuit performance24 2 . In recent studies, these
phenotypes have been correlated with specific genes by studying growth and circuit performance
across single gene knockouts (Fig 2-8d) 2422 43 . Media and growth conditions can also impact
circuit performance by altering promoter activity, protein stability, and regulator dilution" 45.
These effects can be so severe that switching from LB to minimal media can cause circuits to fail
(Fig 2-8e)' .
One approach to reduce strain- and media-based variation is to use reference standards to
report circuit performance. To this end, the Relative Expression Unit (REU) was introduced as a
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standard for reporting promoter measurements4,24. REUs report the promoter activity by
normalizing measurements to a constitutive promoter standard in a strain that is treated
identically and measured simultaneously. REU measurements have yielded reliable, reproducible
data when compared across labs, strains, and media, which is important for transcriptional
circuits that use promoters as inputs and outputs. In the future, this will facilitate the computer-
aided design of large circuits.
2-6. CONCLUSIONS
The first circuits were built by repurposing a small number of regulators and genetic parts
from other areas of genetic engineering. After early success"', these parts were put together in
different combinations to explore the range of circuit functions that could be performed in the
cell. We are now in a phase where there are >100 new regulators98 ,11 4,121-123,125,126,144,191225 that are
orthogonal and could theoretically be used to build synthetic regulatory networks at the scale of
247natural networks in bacteria
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Figure 2-9: Conceptual circuit for a therapeutic bacterium.
This therapeutic bacterium colonizes a niche in the human microbiome and delivers a drug. This circuit
demonstrates how the different classes of regulators and circuits described in this review could be
combined into a single system. The leftmost panel shows genetically modified bacteria that have colonized
the interior of a human gastrointestinal tract. The upper right panel focuses on the conceptual circuit that
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the bacteria use to regulate their growth and deliver drugs to the human patient. An analog circuit"4 (left)
and irreversible recombinases (right) are highlighted in the insets to emphasize the diverse biochemistries
used to build this circuit.
There are several key advances that have to happen before we can build and debug
genetic circuits this large. First, computational tools have to be developed to aid the design
process. These programs need to be able to simulate the dynamics of a circuit and convert the
designs into a linear assembly of genetic parts"' 24 2- 1 . Insulating DNA sequences will be critical
in future circuits because the majority of parts will be in new contexts 25 2'253. Second, new
approaches to whole cell omics measurements have to be integrated into the debugging cycle.
Currently, there is an over-reliance on fluorescent proteins as the output of circuits. However,
transcriptomics is now sufficiently inexpensive such that it could be used to infer polymerase
flux on many of the parts internal to a circuit2 '. Other single molecule approaches, such as
ribosome and RNAP mapping, will become powerful when the experiments become more
routine 55256. Third, new approaches need to be developed that can rapidly test circuits under
conditions that are difficult to control in the cell. Circuits are sensitive to parameters like the
number of ribosomes, RNAP, redox, temperature, and ATP all of which change in different cell
types and conditions. However, these are difficult to measure in the cell without broadly
impacting the host. To this end, the development of in vitro cell-free methods to debug circuits
will be valuable for designing circuits that are robust to these changes257,-26
New biochemistries, tuning knobs, and troubleshooting methods are now converging for
the sophisticated design and construction of genetic circuits. In these circuits, different classes of
regulators can be used in a single circuit to fulfill specialized functions. In this vision, each
regulator has found a niche within the larger circuit that exploits their strengths (Fig 2-9). For
example, digital circuits can be used to integrate sensors and respond to a particular set of
conditions, whereas analog circuitry can perform arithmetic function functions with a small
number of regulators'6. Integrases can store memory or cause an irreversible commitment.
CRISPRi can regulate essentially any gene in the genome. A vision of this marriage is shown in
Figure 6, which is an example of a commensal bacterium that has been engineered to produce a
pharmaceutical while colonizing the gut. In it, repressor-based logic gates respond dynamically
to environmental states and invertases record these observations. Analog circuits can be used to
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calculate a dosage rate and, if surpassed, CRISPRi knocks down specific host genes to arrest
growth and avoid overmedication. Collectively, these new circuits and the tools and knowledge
to connect and debug them will enable a new era of cellular programming and the applications
that come with this capability.
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Chapter 3: Antisense transcription as a tool to tune gene expression
A surprise that has emerged from transcriptomics is the prevalence of antisense
transcription, which occurs counter to gene orientation in genomes. While frequent, the roles of
antisense transcription in regulation are poorly understood. We built a synthetic system in
Escherichia coli to study how antisense transcription can change gene expression and tune the
response characteristics of a regulatory circuit. We developed a new genetic part that consists of
a unidirectional terminator followed by a constitutive antisense promoter and demonstrate that
antisense transcription represses gene expression and the magnitude of repression is proportional
to the antisense promoter strength. Chip-based oligo synthesis was applied to build a large
library of 5,668 terminator-promoter combinations. This library was used to control the
expression of three repressors (PhlF, SrpR, and TarA) in a simple genetic circuit (NOT gate).
Using the library, we demonstrate that antisense promoters can be used to tune the threshold of a
regulatory circuit without impacting other properties of its response function. We also
determined the relative contributions of antisense RNA and transcriptional interference to
repressing gene expression. Finally, we constructed a biophysical model of transcriptional
interference to capture the impact of RNA polymerase collisions on gene repression. This work
quantifies the role of antisense transcription in regulatory networks and introduces a new method
for controlling gene expression that has been previously overlooked in genetic engineering.
3-1. INTRODUCTION
Genetic engineers typically follow a simple scheme for controlling gene expression: a
promoter and terminator flank the gene and all parts are orientated in the same direction. Larger
designs consisting of multiple genes and promoters often are organized similarly, where
transcription is designed to proceed in one direction. This organization avoids potential
interference between promoters that can arise due to RNA polymerase (RNAP) collisions 267,
supercoiling2 ,269 , non-coding RNAs 270, and conflicts with the replication machinery 271 -273 .
Promoters that are oriented in the opposite direction of genes produce antisense transcription and
although this is generally regarded as a nuisance' 2 75 , it can be useful for reducing leaky
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expression of toxic proteins276-279 and generating genetic switches 2 o 282 . Here, we propose that
promoters oriented opposite to a gene can be used to reliably tune gene expression and control
the input threshold of genetic switches.
Increased use of transcriptomics has demonstrated that antisense transcription is
surprisingly common across all organisms, including archaea 28 3 , prokaryotes 2 4 2", and
eukaryotes 289-291 . For example, in E. coli ~30% of all transcription start sites were found to be
antisense and internal to, or just after, genes 29 2-294 . Similarly in H. pylori, about half the genes
have at least one antisense promoter274. Although some of this antisense transcription is the result
of inefficient termination by intrinsic and rho-dependent terminators295, it is often driven by
promoters with well-defined regulatory motifs, such as housekeeping sigma factor binding
sites 2 4,2 94 ,296. Depending on the organism, antisense transcription can be constitutive or regulated
under different environmental conditions 297298.
While prevalent, the role of most antisense transcription in regulation is unclear'".
Some have postulated that the majority of antisense transcription is non-functional and is
background due to pervasive transcription2 6. However, antisense transcription is known to be an
important component of the genetic switches that control bacterial competence2 and
virulence 30 1 , as well as Saccharomyces cereviseae's entry into meiosis 2 2 . Antisense transcription
also occurs frequently for genes that require tight expression control under defined conditions,
such as toxic or virulence proteins 279,302-304. One role of antisense transcription may be to impact
the threshold of a switch 305, defined as the amount of input signal required to reach half maximal
activity. As outlined in Chapter 2, the input thresholds of synthetic systems can be tuned by
mutating ribosome binding sites, adding small regulatory RNAs, or sequestering the proteins
using dummy operators or protein-protein interactions3-309. There is evidence that antisense
promoters can similarly change regulatory circuits by controlling expression of repressors,
activators, s factors and anti-s factors 31031
There are two classes of mechanisms for how antisense promoters regulate gene
expression. The first involves the antisense RNA (asRNA) that is generated, which can regulate
gene expression by binding to the mRNA to change its stability or translation, or act as a
transcriptional regulator 312 13 . The second is transcriptional interference, where the sense and
antisense promoters interact directly or via the RNAPs to cause the down regulation of a gene3 0 .
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There are four mechanisms by which transcriptional interference can occur267: 1. competition
(promoters overlap and only one RNAP can bind at a time), 2. sitting duck (an RNAP that is
slow to elongate is dislodged), 3. occlusion (one RNAP elongates over a promoter transiently
blocking the other), and 4. collision (two actively transcribing RNAPs collide)3 14-3 16. Of these,
modeling suggests that when promoters are >200 bp apart and oriented convergently, the
dominant mechanism of interference is collision 3 16. Regulation by asRNA and transcriptional
interference are not mutually exclusive. Examples have been described where regulation occurs
due to only one mechanism305310317 or they work in concert280 ,3 03 .
In this work, we harness antisense transcription as a reliable "tuning knob" for the
construction of genetic circuits. We introduce a new composite part to the 3'-end of the gene of
interest that consists of a unidirectional terminator followed by a reverse constitutive promoter.
We demonstrate that the antisense promoter represses gene expression in accordance with its
strength and that the antisense transcription can cause a change in the threshold of inducible
systems. A large library of promoter-terminator combinations was constructed via chip-based
oligo synthesis 318 and screened using flow-seq to identify terminators and promoters that can be
used to construct reliable antisense regulation 3 19,3 20. This approach has been used previously to
elucidate how translation rates affect mRNA stability 32 0 and codon bias influences RNA structure
and translation 3 2 1 . Finally, we determined the relative contributions of antisense RNA and
transcriptional interference to repressing gene expression and introduce a biophysical model to
parameterize RNA polymerase collisions. This work contributes to a larger effort to expand on
the classic concept of an "expression cassette" to include additional parts that utilize genetic
context to fine-tune expression levels 26 3 22 ,323.
3-2. RESULTS
3-2-1. Repression correlates with the strength of the antisense promoter
A simple system was designed to quantify the impact of an antisense promoter on gene
expression (Fig 3-1). The isopropyl b-D-1-thiogalactopyranoside (IPTG) inducible promoter P,.
was used as the forward promoter to drive the expression of red fluorescent protein (RFP).
Downstream of rfpi, there is a constitutive antisense promoter PR whose RNAPs will be fired
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toward Pa. Four constitutive promoters of different strength 26 ,3 20 were selected to serve as the
antisense promoters and the impact on RFP expression was quantified. The strengths of PR and
P, were determined using a separate plasmid system and normalized by a reference standard to
estimate promoter strengths as polymerase firing rates (Fig 3-2ab) (Methods). The full cassette
was placed on a plasmid containing the p15A origin.
IPTG-40 Lad
-10 -35
Ptac PR
Figure 3-1: A schematic showing the antisense transcription reporter system.
A constitutive promoter (red) at the 3'-end of rfp represses gene expression by firing polymerases at the
forward promoter Pt (black).
The addition of an antisense promoter changes the response curve for the IPTG induction
of RFP in three ways (Fig 3-2c). First, expression is reduced over the entire range of inducer
concentration. We defined a parameter 0 that captures the magnitude of repression,
0 = [RFP]O (3-1)
[RFP]+
where the subscripts +/0 represent the presence/absence of an antisense promoter. Plotting 0
versus inducer concentration shows that the impact of the antisense promoter is stronger when
Pa is less active (Fig 3-2d). This biased repression is consistent with previous findings that weak
promoters are more susceptible to repression via transcriptional interference and asRNAs than
strong promoters267,314,316. Second, the maximum repression increases with the strength of the
antisense promoter (Fig 3-2e, exponential regression; R2 = 0.99737). Notably, the strongest
promoter tested (apFAB96) is unable to completely repress expression. This promoter is among
the strongest from a large synthetic library 320 and of comparable strength to the E. coli rrn
promoters 32. Finally, the threshold for induction increases as a function of the strength of
antisense promoter (Fig 3-2e, linear regression; R2 = 0.9876).
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Figure 3-2: Impact of antisense transcription on gene expression
(A) Antisense transcription reporter plasmids used to quantify repression. Not1/Sbfl multiple cloning sites
were used to digest the plasmid and insert promoters (apFAB49, apFAB140, apFAB78, apFAB96) at the
3'end of rfp (B) Strengths of the forward and antisense promoters. The reference promoter (Pbla) used to
calculate promoter strength in units of RNA polymerase firings per second is shown in grey. Strengths of
the constitutive promoters used as PR (colors) and forward promoter (Ptac) at different inducer
concentrations (black). (C) Response functions for Pt with different antisense promoters located at the
3'end of RFP: no promoter, black; antisense promoters of different strength, colors as in (B). The inset is
the logo transform of the same data normalized by min and max. (D) The fold repression (Equation 3-1) is
shown as a function of the induction of the forward promoter. The colors correspond to antisense promoters
of different strength. (E) Maximum fold repression and threshold as a function of antisense promoter
strength. The induction threshold K was calculated by fitting Equation 2 to the data in part C. The lines are
linear and exponential fits to the threshold (R 2 = 0.9876) and repression (R2 = 0.99737) data, respectively.
In all panels, data represents the mean of three experiments performed on different days and the error bars
are the standard deviation of these replicates.
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Interestingly, the shape of the induction curve remains similar for the different antisense
promoters and the overall response to IPTG follows approximately the same dynamic range (Fig
3-2c, inset). The cooperativity (n = 1.7 0.12) is also unaffected by different antisense
promoters. Thresholds and Hill coefficients were calculated by fitting the response functions in
Fig 3-4a to the Hill Equation:
Y = Ymin + (Ymax - Ymin) Kn+xn (3-2)
where x is the concentration of IPTG, y is the activity of POT, n is the Hill coefficient, and K is
the threshold level of input where the output is half-maximal. E. coli growth rates were
unaffected by the addition of antisense promoters (data not shown). Fluorescence histograms of
bacteria harboring the antisense reporter plasmids are also very narrow (Fig 3-3). This indicates
very little variation between cells harboring the same genetic construct, therefore antisense
transcription is affecting gene expression in all cells nearly equally. Thus, altering gene
expression with constitutive antisense promoters does not cause a growth defect or alter RFP
expression profiles.
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3-2-2. Multiplexed characterization of antisense promoters
Experiments were designed to quantify the impact of an antisense promoter on the
function of a simple genetic circuit. We chose to characterize NOT gates, where an input
promoter drives the expression of a repressor that turns off an output promoter3 2 5. This creates a
response function that is inverted, as compared to an inducible system alone. Our design adds
antisense promoters to the 3'end of the repressor (Fig 3-4), which reflects natural motifs where
regulatory proteins are controlled by antisense promoters 326. The design also adds unidirectional
terminators between the 3'end of the repressor and the antisense promoter to demonstrate that
antisense promoters can alter gene expression when added to outside of complete expression
cassettes.
IPTG -10 NOT Gate
Repressr YFP4
PIN POUT
Antisense Unit
10362 Terminators 109 Promoters
0 10 20 30 40 50 10-0 50 100 Growlibrary Sorton Flr Barcode Measure Respon
Terminator # Promoter # +I00pM IPTG & Sequence Functions
Figure 3-4: Construction and characterization workflow of a library of terminator/antisense promoter
pairs.
Library construction and flow-seq screening used to measure the impact of terminator/antisense promoter
pairs on regulatory circuit performance. All combinations of 52 unidirectional terminators and 109
promoters were constructed to create a library of 5,668 transcriptional interference constructs. The
terminator and promoter strengths shown were measured previously 26,27320. The library was synthesized as
oligonucleotides then cloned into genetic NOT gates at the 3' end of the repressor gene (red box). Each
library was transformed into E. coli, grown with 100mM IPTG, and sorted into bins of varying YFP
fluorescence to find constructs with increased induction thresholds. Bacteria from each bin were plated on
solid media and individual colonies were selected to measure the full response function of sorted variants.
Plates were scraped to isolate plasmids from bacteria in each bin and plasmid DNA was barcoded and deep
sequenced (Methods).
0
Advances in chip-based DNA synthesis have made it possible to simultaneously
synthesize 10,000s of unique ~200 bp oligos3 27 . This length is appropriate to encode a terminator
and antisense promoter. A library was constructed based on 52 terminators 27 and 109 constitutive
promoters 26,320, paired combinatorially to produce 5,668 unique composite parts (Fig 3-4). All of
the promoters are synthetic and their strengths fall within a range of 0.0047 au to 21 au, with an
average of 3.6 au 320. All of the terminators are naturally occurring sequences from the E. coli
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K12 genome and were selected to encompass a wide range of terminator strengths. The majority
of these terminators are unidirectional and allow RNAPs fired from the antisense promoter to
proceed while blocking those from the forward promoter27 . The composite parts were
synthesized and cloned into three NOT gates made from TetR homologues (Fig 3-5a)
(Methods)3". The NOT gate repressors (PhlF, SrpR, TarA) were selected to represent different
response function shapes (Fig 3-5b).
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Figure 3-5: Response functions of NOT gates with antisense promoters.
(A) NOT gate plasmids used in this study. All NOT gate plasmids have Notl/Sbf 1 multiple cloning sites
used to insert terminator/antisense promoter oligonucleotide library. (B) Response functions of NOT gates
built with TetR homologs: PhlF (left), SrpR (center), TarA (right). Response functions are measured using
Pt activity as the input and YFP as the output. Fluorescence measurements are converted into REU with a
reference standard (methods). Vertical lines (red) demarcate P. activity with 100 tM IPTG, the inducer
concentration used to sort libraries. (C) Fluorescence histograms of the starting NOT gates and libraries
before sorting. Each NOT gate was grown with 0 sM (light grey) and 100 pM (dark grey) IPTG to set
upper and lower bounds for sorting, respectively. Libraries (green) were sorted into four bins, shown as
colored vertical bars and numbered by increasing fluorescence. (D) Response functions of randomly
selected clones from the sorted libraries. Response functions are colored by the bin in which the clones
were found: Bin 1: blue, Bin 2; green, Bin 3; yellow, Bin 4; red. The response functions of the NOT gates
lacking antisense promoters are shown in black.
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The NOT gate libraries were screened using flow-seq, a technique where fluorescence-
activated cell sorting (FACS) is used to sort the cells into bins, the contents of which are
determined using next-generation sequencing (Methods) 31 32 9. Here, we sorted the cells by NOT
gate threshold, i.e. the input promoter activity at which the output fluorescence is reduced to
half-maximum. To do this, each library was grown with 100[tM IPTG and sorted by
fluorescence into four log-spaced bins (Fig 3-5c). At 100 M IPTG, all of the gates lacking
antisense promoters are OFF (Fig 3-5b) and library members that are ON are likely to have
increased induction thresholds. NOT gates without antisense promoters were grown with 0 [M
and 100 [.M IPTG to set upper and lower bounds for sorting, respectively. 6.5%, 18.3%, and
4.9% of the cells from the PhlF, SrpR, and TarA libraries have increased fluorescence relative to
the gates without antisense promoters.
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Figure 3-6: Thresholds and Hill coefficients of sorted NOT gate constructs.
(a) Average thresholds K and (b) Hill coefficients n for NOT gates sorted into each bin of the PhIF (Left),
SrpR (Middle), and TarA (Right) libraries. Thresholds and Hill coefficients were calculated by fitting NOT
gate response functions to the repressor Hill Equation (Eq. 3). Error bars are the standard deviation between
the thresholds or Hill coefficients of the eight NOT gates characterized from each bin. Brackets indicate
two-sample Student t tests with P values <0.05 (*).
After sorting, cells were plated onto solid agar medium and eight colonies from each bin
were randomly selected and their full response functions were measured (Fig 3-5d). As expected,
the response functions cluster according to bins and the most fluorescent bins (bins 3 & 4)
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captured gates with the largest increase in threshold (Fig 3-5d, yellow & red). To quantify the
effects of the antisense promoter/terminator parts, each response function was fit to a repressor
Hill Function
Y = Ymin + (Ymax - Ymin) Kn+x '(33)
where x is the activity of PIN, y is the activity of P0uT, n is the Hill coefficient, and K is the
threshold level of input where the output is half-maximal. High fluorescence bins have increased
thresholds K relative to lower fluorescence bins, but the Hill coefficient n does not show a
consistent trend across bins (Fig 3-6). After individual colonies were analyzed, we pooled the
remaining cells from each bin (50,000 - 200,000 colonies) and measured their response
functions in aggregate. Analysis of pooled constructs shows that the ON and OFF states of all
library members are essentially constant and threshold differences between the bins are
statistically significant (Fig 3-7, one-way ANOVA).
A PhIF SrpR TarA
100-
80-
60- 
40-
20-
100 A
2 80-
0
.00
40
20
0 -L----
100-
60
20
100 10 102 103 10 F 1051r 101 102 10s 10 10 101 102 103 104 10,
Fluorescence (au)
B Tukey HSD Test Results
Library Bini 8Dn2 B3 BIn4
PhIF 100pM
Mean (au) 66.53 112.39 385.05 846.92
s.d. (au) 78.77 163.60 959.71 620.12
p-value -. 9--- 0.001
0.001
S 0.011
1- - 0.001
SrpR 1001sM 0.001Mean (au) 58.22 228.07 959.07 1.59.43
s.d. (au) 71.74 255.12 3805.81 1,284.53
p-value P-- 0.900- 4
0.001
P-- 0.052-
TarA 100pM -- 0.067--
Men (au) 15.77 141.09 523.55 587.32
s.d. (au) 30.72 139.58 1,277.83 601.34
p-value e-- 0.584-.
.- 0.001-
0.001
TerA 1mM -- 0.900--1
Men (au) 6.46 16.63 44.81 86.41
s.d. (au) 28.78 43.54 172.14 87.92
p-value 0.036 1
00.4I.- 0.194-
Figure 3-7: Fluorescence histograms and statistics of sorted bins.
(a) The fluorescence histogram of cells from the PhIF (Left), SrpR (Center), and TarA (Right) libraries.
Fluorescence was measured using flow cytometry in ON (0mM IPTG - top), threshold (100mM IPTG -
middle), and OFF (1000mM IPTG - bottom) conditions. Histograms are colored by bin: 1-purple, 2-green,
3-yellow, 4-orange. One hundred randomly selected individual cells from each data set were used as input
to one-way ANOVA tests. There were no statistically significant differences between group means for the
PhlF ON (F(3,396) = 1.06, p = 36.67) and OFF (F(3,396) = 1.54, p = 20.48) conditions, the SrpR ON
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(F(3,396) = 1.22, p = 30.04) and OFF (F(3,396) = 1.41, p = 23.87) conditions, or the TarA ON (F(3,396) =
1.25, p = 29.19) condition. There are significant differences between group means for the threshold
conditions: PhIF (F(3,396) = 34.67, p = 5.42E-18), SrpR (F(3,396) = 13.3, p = 2.65E-8), TarA (F(3,396) =
15.71, p = 1 .13E-9) and the TarA OFF condition (F(3,396) = 7.85, p =0.0042). (b) Post hoc comparisons
using the Tukey HSD test for the PhIF threshold, SrpR threshold, TarA threshold, and TarA OFF
conditions. Mean fluorescence values of the groups are shown in arbitrary units (au). Brackets indicate
Tukey HSD comparisons with P-values listed.
After sorting, the bins were sequenced to identify the promoter/terminator combinations
responsible for shifting gate thresholds. Briefly, plasmid DNA was isolated from bacteria in each
bin, the composite parts were amplified from the plasmids and barcoded for multiplexed
sequencing. Paired end reads were used to ensure complete sequencing of each
promoter/terminator pair (Methods). For the following analysis, we removed any sequencing
reads that did not perfectly match the designed promoter/terminator pairs. The percent of perfect
sequences from the pools was 32.38%, which is consistent with the error rate of chip-based oligo
synthesis (Table 3-1)7
Total Unpared Paked Notl/S-fl Notl/Sbf1 ( Perfect
Reads % Reads % Reds % Raids % Reads %
PhIF
Unsorted 2.187,634 258,535 11.82% L929,099 88.18% 79.033 4.10 .850.066 84.57% 607,711 32.85%
BN1 2,004,210 239,025 11.93% 1.765.185 88.07% 72,371 4.10% 1.692,814 84.46% 548,928 32A3%
WN2 167,601 12.946 7.72% 154,655 92.28% 5.204 3.38% 149,451 89.17% 46,927 31.40%
SN3 125,143 13,686 10.94% 111457 89.06% 4,628 4.15% 106,829 85.37% 34,268 32.03%
WN4 106.160 10,796 10,17% 95.362 69.83% 3.36 3.53% 9L993 8666% 35,642 36.74%
SrpR
Unsorted 1,663,731 198,112 11.91% .465,619 88.09% 75,217 5.13% 1,390402 83.57% 431.538 31.04%
IN1 1,872,39 225333 12.03% 1647056 87.97% 63961 3.88% 1583095 84.55% 497,718 31.44%
WN2 122,744 12,629 10.29% 110,115 89.71% 5,097 4.63% 105,018 85.56% 39,937 38.03%
WN3 153,442 13,967 9.12% 139,455 90.88% 4,774 3.42% 134,661 87.77% 37,026 27.49%
W__ 163,519 12.563 7.68% 150.956 92.32% 4,770 3.16% 146.136 89,40% 49.411 33.80%
TarA
Unsorted 2,171.123 198,140 9.13% 1.972,93 90.87% 76.631 3.8% 1.896.352 87.34% 622,713 32.84%
WNI 1,910,965 184,335 9.65% 1.726.650 90.35% 77,528 4.49% 1.649,122 86.30% 517,513 31.38%
WNZ 180,667 18.879 10.45% 16178 89.55% 6,060 3.75% 155,728 86.20% 57.696 37.05%
WN3 157,354 23,896 15.19% 133456 84.81% 6,502 4.87% 126,954 80.68% 5L839 40.83%
BWN4 143.926 17,630 12.25% 126,296 87.75% 4.831 3.83% 121465 84,39% 47.742 39,31%
Table 3-1: Illumina sequencing results.
3-2-3. The response threshold correlates with antisense promoter strength
Previously measured values of the promoter and terminator strengths were used to
analyze the parts identified in each bin during deep sequencing (Fig 3-4). In all three libraries,
antisense promoter strength increases as a function of bin fluorescence (Fig 3-8a, linear
regressions; R2 = 0.87421 - 0.96112). The high fluorescence bins (bins 3 & 4) contain constructs
with greater median antisense promoter strength than lower fluorescence bins (bins 1 & 2) (Fig
46
3-8b). In contrast, there is no consistent trend in the forward or antisense terminator strengths
across the sorted libraries (Fig 3-8ab).
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Figure 3-8: Correlations between bin fluorescence and part strength.
(A) Median strengths of the composite parts sorted into bins in the PhIF (left), SrpR (center), and TarA
(right) libraries as a function of median bin fluorescence. Antisense promoter strengths correlate positively
with bin fluorescence; PhlF R2 = 0.87421, SrpR R2 = 0.96061, TarA R2 = 0.96112 (logarithmic regression).
Forward and reverse terminator strengths do not show consistent trends across the libraries; PhlF FW R2 =
0.84079, PhlF RV R2 = 0.78599, SprR FW R2 = 0.8628, SrpR RV R2 = 0.16902, TarA FW R2 = 0.71405,
TarA RV R2 = 0.74852 (logarithmic regression). (B) Strengths of antisense promoters and terminators
sorted into each bin. Previously measured values (Fig 3-4) were used to calculate the strength of parts
sorted into each bin. Box plots display the median, with hinges indicating the first and third quartiles. The
unsorted library is marked "U."
The parts responsible for shifting gate thresholds were further explored by enrichment
analysis. Enrichment identifies the parts that are selected for, or against, in each bin during
sorting (Methods). Since high fluorescence bins (bins 3 & 4) have an increased threshold relative
to lower fluorescence bins (bins 1 & 2) (Fig 3-7), composite parts that are enriched in high
fluorescence bins are more likely to generate large shifts in gate thresholds than those enriched in
lower fluorescence bins. To visualize trends in the data, enrichment was used to assign each
composite part to the one bin (1-4) that best reflects its ability to shift gate thresholds (Fig 3-9).
Most composite parts with strong antisense promoters are maximally enriched in bins 3 and 4
(Fig 3-9, top). However when strong promoters are paired with bidirectional terminators that
47
~.10.
5
1-0 __ _]__ __ _
102
9101
lopl I [ r
102: .
U 1 2 3 4 U 1 2 3 4
Bin #
10
j8
6
i4
82
0
o_ 25
M20
115
10
(5
0U
LI!!
U 12 3
have significant antisense termination efficiencies (TS antisense > 10), the composite parts are
incapable of shifting circuit thresholds (Fig 3-9, left). In contrast, strong antisense promoters are
sorted into high fluorescence bins when paired with unidirectional terminators.
These terminators (Ts antisense <10) most likely facilitate greater shifts in gate thresholds
than bidirectional terminators by allowing more RNAPs fired from the antisense promoter to
interfere with gene expression. In addition, terminators that are predicted to destabilize mRNA or
contain cryptic antisense promoters also facilitate large shifts in gate thresholds (Fig 3-9, right).
Changes in mRNA stability can result in a large shift because the mRNA produces less protein
before it is degraded, thus more transcripts are required to produce the threshold amount of
repressor protein. Similarly, terminators with cryptic antisense promoters increase the gate
threshold by increasing the basal level of antisense transcription.
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Figure 3-9: Heat map of the bins in which terminator/promoter pairs were most enriched.
Promoters are rank ordered by their strength (Part A), with the strongest at the top. The terminators were
grouped based on known or predicted terminator features and sorted by the predicted strength of a cryptic
antisense promoter or impact on mRNA stability, if relevant (Methods). Unidirectional terminators were
sorted based on similarity in their profiles across the promoter set. Terminator/promoter combinations that
are not enriched in any of the bins are colored grey. Columns and rows >90% grey were removed from the
enrichment grid.
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I3-2-4. Characterization of terminator/promoter pairs as "parts"
One of our goals is to use antisense transcription to reliably change the expression level
of a gene or shift the threshold of a genetic circuit. Ideally, the impact of an antisense promoter
on these functions would be predictable and a set of promoters of different strengths could be
used to tune expression. When building multi-gene systems, it is desirable to use different
terminators to control each gene in order to avoid homologous recombination 33 0 . Therefore, we
sought to identify a set of strong terminators that could be used in conjunction with a set of
antisense promoters to reliably tune gene expression. Predictability would require that the
promoters impart their effect independent of the terminator to which they are paired.
Some terminators may have mechanisms that impact the effectiveness of the antisense
promoter. As such, we eliminated those with known features (cryptic promoters, bidirectional
termination, hairpins that impact mRNA stability) from the set (Fig 3-9). Then, terminators and
promoters were systematically removed until there remained a core set of both where the
promoters produced a reliable response when combined with any of the terminators. This set,
shown in Figure 3-10a, provides nine strong terminators that can be fused to different genes or
operons and twenty antisense promoters that can be added to control their expression (Fig 3-
10b). To confirm predictability, several terminator-promoter pairs were tested in the reporter
construct (Fig 3-10a). The repression produced by these pairs collapse onto a single curve,
independent of the identity of the terminator used (Fig 3-10c, exponential regression; R2
0.9275)(Table 3-2).
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Figure 3-10: Composability of unidirectional terminators and antisense promoters.
(A) The flow-seq data was used to identify a subset of promoters and terminators that could be combined to
obtain a reliable reduction of gene expression. (B) Each graph shows a terminator (name at top) and each
point is a promoter from the list in Part A. The x-axis (<Bin#>) is the average for the promoter across the
complete terminator set and the y-axis (Bin#) is the bin for the specific terminator. The Bin# is calculated
as described in Fig 2F. (C) Repression was explicitly measured for a subset of terminator/promoter pairs
selected from Part A. The pairs were cloned into the plasmid from (a) and fold-repression (Equation 1) was
measured as a function of the forward promoter activity (see Table 3-2 for terminator/promoter
combinations tested). Maximum fold repression is plotted against the previously measured promoter
activities 320 ; R2 = 0.9275. Composite parts are marked by terminator (ECK120035132, circle;
ECK120010831, square; ECK120034435, triangle; ECK120021270, diamond; ECK120010793, star;
ECK120030221, x; ECK120010815, +).
Terminator Promoter Maximum repression s.d.
ECK120035132 apFAB71 61.86 33.25
ECK120010831 apFAB71 36.60 12.32
ECK120021270 apFAB67 23.08 1.50
ECK120021270 apFAB61 17.94 2.29
ECK120010793 apFAB61 12.84 1.54
ECK120034435 apFAB341 7.05 0.63
ECK120030221 BbaJ23119 7.16 0.75
ECK120010815 apFAB345 1.49 0.02
ECK120010831 apFAB345 1.51 0.18
ECK120035132 BbaJ23102 1.44 0.06
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ECK120010793 apFAB69 1.26 0.03
ECK120034435 apFAB259 1.23 0.17
ECK120030221 apFAB259 0.98 0.04
ECK120010836-R BbaJ23109 0.87 0.03
Table 3-2: Terminator promoter pairs tested in Figure 3-10.
Maximum repression is the average of three replicates collected on different days.
3-2-5. Repression occurs due to a combination of asRNA activity and transcriptional
collisions
To determine the relative contributions of asRNA and transcriptional interference to
repression generated by antisense promoters, we built a set of plasmids to express asRNA
corresponding to the reporter gene (Fig 3-1 la). These plasmids each have one of the four
antisense promoters (apFAB49, apFAB140, apFAB78, or apFAB96) driving expression of the
reverse compliment of RFP followed by a strong bi-directional terminator (ECK120034435).
The cassette is placed on a plasmid containing the colEl origin, which is maintained at a copy
number approximately two times higher than p15A33 1.The asRNA plasmids were co-transformed
into E. coli along with the original RFP reporter plasmid (pJBTI241, Fig 3-2a).
Using these data, the fold-repression due to antisense RNA 0 asRNA is calculated as in
Equation 1, where the subscripts +/0 now represent the presence or absence of trans encoded
asRNA. OasRNA should be viewed as an upper bound on the contribution from asRNA to total fold
repression 0. This is because its expression in trans causes the asRNA to be longer (relative to
the asRNAs generated at the 3'-end by RNAP collisions) and expressed at a higher level (due to
absence of RNAP collisions and the higher copy number plasmid). Fold repression generated by
transcriptional interference 0 TI can then be determined by dividing the total fold repression q by
OasRNA Thus, OasRNA and 6 T, reflect the relative contributions of asRNA and transcriptional
interference to total repression generated by antisense transcription. Plotting 0, 6 asRNA, and 6TI
versus inducer concentration shows that asRNA and transcriptional interference generate
approximately equivalent contributions to repression (Fig 3-1 1b). When the forward promoter is
strongly induced, the predicted cis contribution declines, which is consistent with models of
transcriptional interference 316 (Fig 3-11 b).
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Figure 3-11: Repression generated by asRNA.
(A) Plasmids to measure repression generated by asRNA produced in trans. These plasmids were co-
transformed with pJBTI241 and RFP fluorescence was measured to test repression generated by asRNA in
trans. (B) Total fold-repression 0 generated by apFAB96 (a), apFAB78 (b), apFAB140 (c), apFAB49 (d)
antisense promoters are shown as a function of forward promoter activity using the characterization
system in Fig 4a (black line). This is compared to the repression observed when the same promoter is
used to drive the transcription of asRNA in trans from a separate plasmid (dashed red line). The
repression due to transcriptional interference 0T (solid red line) is inferred from the total and trans asRNA
repression data (see text for details).
It is noteworthy that strong repression cannot be achieved through either transcriptional
interference or asRNA alone. They each contribute equally in a multiplicative way to the total
repression that can be achieved using antisense promoters. The cis regulation is likely most
important for achieving maximal repression when the asRNA does not have specific regulatory
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A
qualities, such as RNA-RNA or RNA-DNA interaction hairpins" 33 3 , Hfq binding motifs3 3 4, or
RNase processing sites304-.
A differential equation model was developed to explore collision interference and
parameterize the repression that arises for different forward and antisense promoter firing rates
(F a R) and gene length N. The model and parameters are shown in Figure 3-12 and Table 3-
3. Polymerases that originate from the forward promoter PF transcribe a gene at a constant
velocity v unless they collide with polymerases from the interfering promoter PR on the opposing
strand of DNA. In the event of a collision, polymerases dissociate from the DNA.
Collision interference can be captured by two differential equations that track the steady-
state concentration of polymerases on the forward CF and reverse CR strands as a function of the
distance from the start site x (in bp):
dCF = -EFCFCR (3-4)
dx
dR= ER CF R (3-5)
Here, the EF and ER are parameters that reflect the possibility that RNAPs fired from the forward
and antisense promoters could have different propensities to encounter collisions and dissociate
from the DNA. Transcriptional bursting could prevent RNAPs from encountering head on
collisions by increasing the time between transcription events initiated at the opposing promoter.
In addition, RNAPs fired from the forward and antisense promoters could have different
propensities to dissociate from the DNA following collision. In vitro experiments show that
head-on RNAP collisions result in stalling and backtracking of the enzymes 336, which leaves
them vulnerable to clearance 33 73 38. However, co-translating ribosomes 339 and actively
transcribing RNAPs 340 1 have been shown to rescue stalled/backtracked complexes by realigning
the 3'termini of the RNA transcript with the enzyme's active site. In addition, there are active
mechanisms that favor the termination and release of RNAPs transcribing non-coding RNA342 .
Therefore the model was built to accommodate differences in dissociation for RNAPs fired from
forward and antisense promoters of different strengths.
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Figure 3-12: Schematic of the transcriptional interference model.
A forward PF and antisense R promoter are located on either side of a gene, N bases apart. The promoters
fire at rates F and R RNAP/second. Polymerases transcribe at a constant velocity v unless they collide
with polymerases fired from opposing promoter. Polymerases collide and dissociate from the DNA with a
probability E.
Parameter Meaning Values References
N Distance between transcription start points (bp) 841
v Speed of transcription (bp/s) 40 Sneppen et al, 2005
* Rate of RNAP production from PF (s-1) pBla: 0.031 Liang et al, 1999
pTac [1]: 0.001439 this study
pTac [5]: 0.001548 this study
pTac [10]: 0.002232 this study
pTac [20]: 0.003643 this study
pTac [50]: 0.006778 this study
pTac [70]: 0.025262 this study
pTac [100]: 0.03976 this study
pTac [200]: 0.18756 this study
pTac [500]: 0.35764 this study
pTac [1000]: 0.41141 this study
+R Rate of RNAP production from PR (s-1) apFAB49: 0.15345 this study
apFAB1 40: 0.64814 this study
apFAB78: 1.01410 this study
apFAB96: 1.23185 this study
EF Ejection factor for RNAP fired from PF 0.104 0.031 fitted
ER Ejection factor for RNAP fired from PR 0.494 0.027 fitted
Table 3-3: Parameters in the transcriptional interference model.
Boundary conditions are defined by the rates that polymerases are fired, i.e. begin
elongating, at the forward CF(x=O) = F/v and reverse CR(x=N) = PRIv promoters. The
polymerase velocity v = 40 bp/s is held constant3 16,343 . The equations are numerically solved for
each PF and R combination (Methods). We chose to model PF as Pa with ten different IPTG
concentrations and Pa as four different constitutive promoters: apFAB49, apFAB 140, apFAB78,
and apFAB96 (Fig 3-2). Simulated repression can be calculated as the ratio of full-length (x = N)
transcripts produced from PF with and without an antisense promoter
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PF #F #R PR
0 = CFIEF=O (3-6)
CFIEF>o
providing a prediction that can be compared with measurements (Equation 3-1). For each
combination of forward and antisense promoters, 0 is calculated and compared with that derived
from experiments.
Repression due to asRNA is not included in the model. Rather, our approach was to fit
the model predictions to the two bounds that we measured. First, results were fit to total
repression 0, which assumes there is no contribution from asRNA to the observed repression.
Next results were fit to 0.., which represents the minimum amount of repression attributable to
transcriptional interference. These bounds were then used to fit the underlying biophysical
parameters and provide a range of values that reflect the possible contribution of transcriptional
interference to gene repression.
We first simulated collision interference with EF = ER = 1, since previous models of
transcriptional interference assume that actively transcribing polymerases never survive head-on
collisions 2,281,316 (Fig 3-13a). However, assuming EF = ER = 1 predicts too much repression and
results in a poor fit to our experiments.
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Figure 3-13: Comparison of model predictions to experimental data.
Each data point shows experimentally measured repression (0 - white, 0T - grey) for each PF/PR pair
plotted against model predictions generated with the same promoter combinations. Repressions predicted
by the model were calculated using Equation 6 with (a) EF = ER = 1 or (b) optimal EF and ER. The optimal 8 F
and ER values simulate repression closest to the experimentally measured value (Methods).
To optimize EF and ER, the model was solved where these parameters are varied in the
range [0,1] in increments of 0.01 (Fig 3-14). This was repeated for each value of F and R in our
data set and the values of EF and ER that generate repression closest to the experimentally
56
measured 0.r were determined. This yielded a set of 88 optimal values of EF and ER,
corresponding to all of combinations of forward and antisense promoter activities (44 pairings)
fit to either 0 or 0 TI. The optimal values of EF and ER produced behavior that closely matches the
experimental data (Fig 3-13b, linear regression; m = 1, R2 = 0.84082). Values of E < 1 are
interpreted as cases where polymerases either avoid or survive collision and continue
transcribing. Importantly, the model does not assume that one RNAP must dissociate in order for
the RNAP on the opposing strand of DNA to survive collision. This assumption that polymerases
can bypass is supported by in vitro experiments done with viral 3" and yeast345 RNA polymerases.
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Figure 3-14: Model results when SF and ER are varied between 0 and 1 at increments of 0.01.
Graphs show density of polymerases fired from either the forward (F - blue) or interfering promoter (R -
red) along the DNA. Forty different forward/interfering promoter combinations were simulated, which
model PF as pTac + ten WIPG concentrations (1, 5, 10, 20, 50, 70, 100, 200, 500, 1000 stM; across) and PR
as apFAB49 (top row), apFAB 140 (second row), apFAB78 (third row), or apFAB96 (bottom row).
The optimum values of EF and ER are surprisingly constant across the dataset and are
independent of the identity of the antisense promoter or the firing rate of the forward promoter
(Fig 3-15a). E values fit using 0 represent the probabilities that polymerases collide and dissociate
when transcriptional interference is assumed to be the sole mechanism for gene repression. In
contrast E values fit using 0 1, reflect the smallest possible contribution of transcriptional
interference to gene repression. Thus we find a range of E values that reflect the potential
contributions of collision interference to gene repression. We find that the probability that a
polymerase dissociates due to a competing enzyme is significantly larger for RNAPs fired from
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the antisense promoter (<ER>= 43-54%) as compared to those from the forward promoter (<EF>
= 7-15%) (Fig 3-15b). In addition, the model predicts that fold repression due to transcriptional
interference increases exponentially as a function of the antisense promoter strength and distance
between the two promoters (Fig 3-16). To test repression as a function of distance between the
forward and antisense promoters, we modified our antisense reporter system and inserted yfp
between the 3'end of rfp and the antisense promoter (Fig 3-25b). This increases the distance
between the two promoters from 850bp to 1,500bp. Measuring repression of RFP and YFP using
this system shows that repression increases as the distance between the two promoters grows.
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Figure 3-15: Best fit values of e as a function of forward PF and antisense PR promoter strength.
Relationships between forward promoter strengths, kF and OR, and the probabilities that polymerases fall
off the DNA after collision, EF (blue circles) and ER (red squares). Graphs show the best EF and ER for each
promoter combination from the E parameter sweep and experimentally measured OF and R . EF and ER
were fit to experimental data of fold repression generated by transcriptional interference alone OTI (a) or by
maximum fold repression (b). The highest scoring EFS and ERS for each OF and 9R are averaged, y-error
bars show the s.d. between these values. x-error bars show the s.d. of three replicates collected on different
days. (C) Range of optimal E values that result from fitting the model to 0 or T1I. Box plot extends from the
median optimal EF and ER when the model is fit to OT1 (<EF> = 0.07, <ER> = 0.52) to median optimal EF and
ER when the model is fit to 0 (<EF> = 0.14, <ER> = 0.47). In all figure parts, the data represents the mean of
three experiments performed on different days and the error bars are the standard deviation of these
replicates. In all panels, fold repression 0 is the magnitude of gene expression produced by forward
promoter in the absence of an antisense promoter divided by the amount of gene expression produced in the
presence of an antisense promoter.
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Figure 3-16: Model predicts an exponential increase in repression.
The collision interference model was used to predict fold repression with wide range of antisense promoter
strength PR values and different distances between promoters. (a) Top: schematic showing the antisense
transcription reporter system. Bottom: model simulations where @R is varied from 0 to 2 at increments of
either 0.01 or 0.1 (/s). EF is set to the median value fit by 0 T1 (EF = 0.07, white circles) and 0 (EF = 0.14,
grey circles). For these simulations, ER was held constant at 0.515. Experimental results for 0 (black
squares) and OT1 (red squares) are also shown as a function of antisense promoter strength. Data from Fig 3-
19. (b) Top: Schematic showing the antisense transcription reporter system with longer distance between PF
and PR. A second fluorescent protein yfp was added between the 3'end of rfp and PR to increase the
distance between promoters from 841bp to 1,500 bp. Plasmid maps in Appendix Fig S8. Bottom: model
simulations where N is varied from 200 - 5,000bp in increments of 50, 100, or 1,000 bp. PR was simulated
as apFAB49, apFAB140, apFAB78 and apFAB96 by setting lR to values of 0.15345 RNAP/s (blue circles),
0.64814 RNAP/s (green circles), 1.014108 RNAP/s (purple circles), and 1.231852 RNAP/s (red circles),
respectively. For all simulations in this figure, $F was held constant at 0.03976 (to simulate Pa + 100 M
IPTG) and 8 F and CR were set at the median optimum values: 0.07 and 0.515, respectively. Experimental
results show RFP and YFP repression with four different antisense promoters: apFAB49 (blue squares),
apFAB140 (green squares), apFAB78 (purple squares), and apFAB96 (red squares). For all figure panels,
repression is measured when Ptac is induced with 100RM IPTG.
3-3. CONCLUSIONS
This work demonstrates that antisense promoters can be reliably used to tune gene
expression. The degree of repression is proportional to the strength of the antisense promoter
over a >30-fold range. This builds on the modern revisiting of the classical "expression cassette"
to incorporate additional non-canonical parts to tune expression, insulate against context, and
provide for rapid debugging via -omics techniques2 6,3". In this paradigm, there are alternative
means to control the expression level of a gene, such as by changing the forward promoter26, the
RBS347, small RNA 332 433 , and 3'-hairpins for mRNA stability349. While some of these
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approaches can achieve greater ranges of expression control, antisense promoters have some
unique features that are advantageous for some applications. Notably, they offer a means of
control external to the expression cassette. This is particularly valuable when the forward control
elements (promoter and RBS) have been engineered to integrate additional regulatory
information32 3 3 2 . In these cases, it is not simple to adjust the overall expression level without
interfering with how the signals are integrated. Exploiting antisense transcription allows for
control without changing the inputs to the system or the sequence of the forward transcript. The
flow-seq data demonstrate that the impact of the antisense promoter is largely context-
independent. From this, we derive a set of unidirectional terminators that can be combined with
the antisense promoter in a modular manner. Thus, implementing this control is simple and
modular and can be done with existing promoter libraries.
The performance of antisense transcription is derived from its unique synergy between its
impact on transcription from the forward promoter and post-transcriptional impact on protein
expression. For our system, we find that antisense RNA and collision between actively
transcribing RNA polymerases contribute roughly equally to repress gene expression. This
synergy is important because transcriptional interference implements its control at the
transcriptional level and would not be able to repress mRNAs made by RNAPs that avoid
collision. Antisense RNAs prohibit escaped mRNA transcripts from being translated. For
asRNAs with weak affinity for the target mRNA, cohesion between the two mechanisms may
facilitate greater repression of target genes than the asRNA alone.
The model predicts some mechanistic details about collision interference. Most
strikingly, polymerases transcribing translated mRNA survive or avoid ~85% of their head on
collisions, which may explain the inability to completely abolish gene expression with
transcriptional interference alone, despite the use of very strong interfering promoters.
Polymerase survival rates are not as high if the polymerase is fired from the antisense promoter
(-50% survival). This imbalance may be due to differences in the kinetic properties of the two
promoters, e.g. burstiness, or differential dissociation of the RNAPs. Single molecule
experiments that measure polymerase survival rates directly could be done to differentiate
between these two mechanisms. Additional experiments can also refine our understanding of
antisense transcription by parameterizing additional mechanisms. The model presented here is
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limited to collision interference as the mechanism of repression in cis, however several
additional factors, such as r-loop formation3 53 , changes in DNA topology2"', differences in local
asRNA concentration4, and occlusion interference3', could also be considered. Direct
measurement of asRNA activity in cis and trans, as well as measurement of RNA duplex
formation and degradation rates, r-loop formation, and other modes of transcriptional
interference would facilitate the construction of a more detailed mechanistic model of repression
mediated by antisense transcription.
Considering natural genomes, antisense promoters could be a simple evolutionary
mechanism to reduce gene expression. This is especially true of housekeeping sigma factors -
such as S7O - whose binding sites are relatively information poor, and mutagenesis is expected to
cause promoters to frequently arise spontaneously during evolution296 . The particular location of
the antisense promoter would not matter and it could even occur within the gene itself, as is often
observed25 292 294 30 ,35 . Constitutive promoters arise quickly and this would provide a simple
mechanism to reduce gene expression that could be rapidly discovered during an evolutionary
search. This is consistent with the lack of conservation of antisense promoters between
species21,297, where they may appear and disappear quickly in evolutionary time to fine tune
expression. This would be an easier solution to find than making mutations to the sense
promoter, which can be significantly constrained by needs of regulatory signal integration3-6
Thus, the total expression of a gene could be tuned without disturbing the integration of signals.
The rate of evolution around any individual promoters may not be high296 because there are many
similar solutions that can be found.
Here, we show how antisense transcription can be integrated into a simple NOT gate, that
has been a common motif in building larger synthetic genetic circuits. This provides a
mechanism where the switching threshold can be tuned without impacting other characteristics
of the gate, such as the cooperativity. More complex circuits could be built by exploiting
antisense transcription in both prokaryotic and eukaryotic systems, where antisense regulation is
known to occur202 2 2301 and additional tuning knobs can help improve performance of synthetic
systems3233573. The simple constitutive promoters we employ here could be exchanged for
dynamic promoters that respond to inducers or cellular/environmental conditions or implement
negative feedback. This motif occurs in natural regulatory networks, for example many of the
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antisense promoters in B. subtilis are regulated by alternative sigma factors that respond to
different environmental conditions2 97 . This gets more complex as the sigma factors themselves
are regulated by antisense transcription 3 2 6. Even more interesting architectures have been
observed in nature, for example there are many that involve overlapping 5'- and 3'-UTRs. The
overlap can include entire genes; for example, divergent operons have been observed where the
promoter for each occurs one gene into the other280 15,3. These motifs would enable mutually
exclusive switch-like changes between the sets of genes that are expressed3 o. Collectively, this
points to antisense transcription as something that should be routinely incorporated into
engineered systems, as opposed to being avoided.
3-4. MATERIALS AND METHODS
3-4-1. Strains and media.
E. coli strains NEB10 (A(ara-leu)7697 araD139 fhuA AlacX74 galK16 galE15 e14-
f8OdlacZAM15 recAl relAl endAl nupG rpsL (StrR) rph spoT1 A (mrr-hsdRMS-mcrBC)) and
DH1OB (F- D(ara-leu)7697 araD139 DlacX74 galE15 f8OdlacZDM15 recAI endAl nupG rpsL
mcrA D(mrr-hsdRMS-mcrBC) 1-) were used for all experiments. Cells were grown in either LB
Miller Broth (Becton Dickinson 244630) or M9 minimal medium supplemented with glucose
((6.8 g/L Na2HPO4, 3 g/L KH2PO4, 0.5 g/L NaCl, 1 g/L NH4Cl; Sigma M6030), 2mM MgSO4
(Affymetrix 18651), 100 mM CaCl2 (Sigma C1016), 0.4% glucose (Fisher scientific M10046),
0.2% casamino acids (Becton Dickinson 223050), 340 mg/mL thiamine (vitamin Bi) (Alfa
Aestar A19560). Carbenicillin (100 mg/mL) (Gold Bio C-103), kanamycin (50 mg/mL) (Gold
Bio K-120) and/or chloramphenicol (35 mg/mL) (USB Corporation 23660) were added to
growth media to maintain plasmids when appropriate. Isopropyl b-D-1-thiogalactopyranoside
(IPTG) (Gold Bio 1248 1C) was used as the inducer for all constructs.
3-4-2. Measurement of response functions.
E. coli strains were grown for 16 h in LB media containing antibiotics in 96-deep well blocks
(USA Scientific 1896-2000) at 370C and 250 r.p.m in an INFORS-HT Multitron Pro. After 16 h,
the cultures were diluted 1:200 into M9 medium with antibiotics and grown for 3 h with the
same shaking and temperature settings as the overnight growth. Next, the cultures were diluted
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1:700 into fresh M9 medium with antibiotics and different concentrations of isopropyl P-D-1-
thiogalactopyranoside (IPTG). These cultures were grown for 6 h then diluted 1:5 into phosphate
buffered saline (PBS) containing 2mg/mL kanamycin or 35[tg/mL chloramphenicol to arrest
protein production and fluorescence was measured using a flow cytometer.
3-4-3. Cytometry measurement and data analysis.
Cells were analyzed by flow cytometry using a BD Biosciences Fortessa flow cytometer with
blue (488 nm) and red (640 nm) lasers. An injection volume of 10 [tL and flow rate of 0.5 tL/s
were used. Cytometry data was analyzed using FlowJo (TreeStar Inc., Ashland, OR) and
populations were gated on forward and side scatter heights. The gated populations consisted of at
least 30,000 cells. The median fluorescence of the gated populations was used calculated using
FlowJo and used for all reporting. Auto-fluorescence of white cells (NEB10 without plasmids)
was subtracted from all fluorescence measurements.
3-4-4. Promoter strength calculations.
Promoter firing rates (RNAP/second) were estimated using NEB10P cells harboring one of the
following plasmids: pJBTI26, pJBTI264, pJBTI265, pJBTI266, pJBTI267, pJBT136 (Fig 2-17).
Fluorescence of each strain was measured as described above. Fluorescence produced by the
strain harboring plasmid pJBTI136 (<YFP> = 528 au) was used to define a promoter-firing rate
of 0.031 RNAP/second, which has been reported for promoter Psba59 . Fluorescence of strains
carrying the other plasmids were divided by fluorescence produced by the strain harboring
pJBTI136 and multiplied by 0.031 RNAP/second to obtain promoter firing rates. The
hammerhead ribozyme insulator RiboJ56 was used to standardize the 5'UTR of YFP mRNA so
that changes in fluorescence could be attributed solely to differences in polymerase firing. To
convert promoter-firing rates (RNAP/second) back to arbitrary units reported by the cytometer,
multiply the firing rates by 17,032.
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Pbla B0034
RiboJ YFP TrmB
pJBT1136: N_PbIa_S_RiboJYFP
pl 5A
Pconst Lad LuxR AmpR
apFAB140 B0034
RiboJ YFP TrmB
pJBTI266: N-apFAB140_SRiboJ_YFP
Pconst LacI LuxR AmpR
apFAB96 B0034
RiboJ YFP TrmB
pJBT1267: N_apFAB96_S_RiboJYFP
Pconst Lad LuxR AmpR
apFAB49 B0034
RiboJ YFP TrmB
pJBT1264: N apFAB49_S_RiboJYFP
Pconst Lal LuxR ApR
apFAB78 B0034
FT
RiboJ YFP TrmB
pJBT1265: N apFAB78_S_RiboJYFP
Pconst LacI LuxR AmpR
Ptac B0034
RiboJ YFP TrmB
pJBT126: NPtac_S_RiboJYFP
Pconst LacI LuxR AmpR
Figure 3-17: Plasmids to measure promoter firing rates (RNAP/second).
Promoter PbIa was used to define a polymerase firing rate of 0.031 s'. Notl/Sbfl multiple cloning sites were
used to digest the reference plasmid and insert other promoters (apFAB49, apFAB140, apFAB78,
apFAB96, Pt) for promoter strength measurement.
Relative expression units (REUs) were calculated using DH10B cells harboring one of the
following plasmids: ORFP2, pAN1717 (Fig 3-18a). Strains harboring ORFP2 and pAN1717 were
grown and measured in parallel with experimental strains. To convert raw RFP fluorescence
measurements into REU, RFP produced by experimental strains was divided by red fluorescence
produced by the strain harboring ORFP2. To convert our reported RFP measurements (REU)
back to arbitrary units, multiply the REU value by 2295. To convert raw YFP fluorescence
measurements into REU, YFP produced by experimental strains was divided by YFP produced
by pAN1717. To convert our reported YFP measurements (REU) back to arbitrary units,
multiply the REU value by 550. When measuring NOT gate response functions, input promoter
(Pta) activity was measured using plasmid pJBTI26 (Fig 3-18b) and converted into REUs as
described here.
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BBaJ23101 B0064 BBaJ23101 B0032
A 0 0
L3S3P21 RiboJ YFP L3S2P21 RiboJ RFP BBa_BOO10
pAN1717: YFP REU standard ORFP2: RFP REU standard
Pconst KanR TetR Lac KanR
B Ptac B0034
RiboJ YFP TrrnB
pJBT126: NPtac_S_RiboJYFP
Pconst Ladc LuxR AmpR
Figure 3-18: REU standard plasmids used in this study.
(a) Plasmids used to convert YFP (pAN1717) and RFP (ORFP2) fluorescence measurements into Relative
Expression Units (REUs). (b) Plasmid used to measure input (P,) promoter activity for NOT gate response
functions.
Promoter strength measurements reported throughout the paper as au are from the RNA-seq
experiments of Kosuri et. al, 2013r4. In these experiments, promoter strengths are calculated
using RNAseq read depth of mRNA produced by each promoter driving expression of green
fluorescent protein.
3-4-5. Classification of terminators.
Terminators that encode cryptic antisense promoters or destabilize mRNA when placed at the
3'end were identified by analyzing data from Chen et al.'s study of E. coli intrinsic terminators.
In this study, termination strength was measured by observing the changes in GFP and RFP
expression that occur when a terminator is placed between two fluorescent proteins (5' GFP and
3'RFP). Strong terminators resulted in a large drop in RFP fluorescence relative to a control
plasmid with no terminator (pGR). Chen et al. measured several terminators in both the forward
and reverse orientation, which allowed us to identify unidirectional terminators for this study.
We classified terminators as unidirectional if they have termination strength <10 in the reverse
orientation and >10 in the forward direction.
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Average levels of GFP and RFP fluorescence produced by plasmids carrying Chen et.
al's library of terminators were used to identify terminators that encode cryptic antisense
promoters or destabilize mRNA. Terminators that decreased GFP expression relative to the
average were assumed to destabilize mRNA. Similarly, terminators that increased RFP
expression when measured in the reverse direction, were assumed to encode cryptic antisense
promoters. We classified terminators that decreased GFP expression more than one standard
deviation below the mean as destabilizing mRNA and terminators that increased RFP expression
more than one standard deviation as encoding cryptic antisense promoters.
3-4-6. Library design and construction.
The terminator/antisense promoter library was built as described previously 320 . The library was
constructed based on 52 terminators 27 and 109 constitutive promoters 26,320, paired combinatorially
to produce 5,668 unique composite parts. We used 90 promoters from an existing library26 and
19 from the Anderson promoter library on the BioBricks Registry. The terminators are naturally
occurring sequences from the E. coli K12 genome that were previously characterized by Chen et
al. and selected to encompass a wide range of terminator strengths. The composite parts were
checked for restriction sites (NotI and Sbf1) and none were found. To generate the final library,
all sequences were flanked by restriction enzyme sites (Noti and Sbf 1) and PCR primer binding
sites: (1) ATATAGATGCCGTCCTAGCG and (2) AAGTATCTTTCCTGTGCCCA.
The oligonucleotide library was constructed by CustomArray, Inc. using their CMOS
semiconductor technology. The library was delivered as a 1 fM oligonucleotide pool and
amplified using specific PCR primers: ojl299 and ojl300 (Table 3-4). The PCR products were
then digested with Notl (New England Biolabs R3189) and Sbf 1 (New England Biolabs R3642)
restriction enzymes and cleaned with DNA Clean & Concentrator columns (Zymo Research
C1003). Plasmid backbones encoding repressor-protein based NOT gates (PhlF, SrpR, TarA;
maps in Fig 2-9) were amplified by PCR with primers to add Notl and Sbfl restriction sites to
the 3'end of the repressor gene. Plasmid backbones were then digested with the same restriction
enzymes and cleaned using DNA Clean & Concentrator columns. After digestion, the library
inserts and plasmid backbones were ligated using T4 DNA Ligase (New England Biolabs
M0208) and cloned into E. coli NEB1OP electrocompetent cells (New England Biolabs
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C3020K), resulting three libraries (PhIF, SrpR, and TarA) of ~160,000 clones each and >20 fold
coverage of the designed sequence space. Each library was scraped from solid media plates and
frozen at -800C in 200 [tL aliquots with 15% glycerol for subsequent analysis.
3-4-7. Library growth and fluorescence activated cell sorting (FACS).
To grow libraries for flow cytometry analysis or cell sorting, one aliquot of each library was
thawed and 10[tL of the sample were added to 3 mL of LB media supplemented with
carbenicillin in 15mL culture tubes (Fischer Scientific 352059). Once thawed, the remaining
library aliquot was discarded to avoid cell death from repeated freeze-thaw cycles. The
inoculated libraries were grown for 12 h at 300C and 250 r.p.m. in a New Brunswick Scientific
Innova 44. NEB I0P control strains, containing unmodified NOT-gate plasmids (Fig 3-2a) were
inoculated from single colonies into 3 mL of LB supplemented with carbenicillin and also grown
at 300C and 250 r.p.m. After 12 h, both library and control strain cultures were diluted 1:200 into
25 mL of M9 medium with carbenicillin in 250mL Erlenmeyer flasks (Corning 4450-250) and
grown at 370C and 250 r.p.m. for 3 h. Next, the cultures were diluted to 0.001 OD6 in 25 mL of
M9 medium with carbenicillin and either 0[tM or 100 tM IPTG. These cultures were grown for 6
h to obtain exponential phase growth. At the end of 6 h, cultures were diluted to OD6 ~0.05 into
PBS containing 35 tg/mL chloramphenicol to arrest cell growth and protein production until
sorting. Aliquots of each library were also frozen at -800C with 15% glycerol (VWR BDH1 172)
to serve as 'unsorted' controls.
Cell sorting was done on a BD Biosciences FACSAria II with a blue (488 nm) laser.
Each NOT gate library was sorted into four non-adjacent log-spaced bins based on YFP
fluorescence. Control strains grown with 0pM and 100tM IPTG defined the upper and lower
boundaries for bin placement, respectively. One million cells were sorted into the lowest
fluorescence bin (Bin 1; Fig 3-10, blue), which captured 9.8-13.9% of each library. 50,000 -
200,000 cells were sorted into all other bins, which captured 0.2-4.4% of the cells in each library.
After sorting, cells were plated on solid media to minimize the effect of growth rate differences
on library representation. Each bin was then scraped from the solid media plates and frozen at -
800C in 200 tL aliquots with 15% glycerol (VWR BDH 1172) for subsequent analysis.
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3-4-8. Sorted library sequencing.
Plasmids were isolated from cells in each bin using a miniprep kit (Qiagen 1018398) by thawing
one aliquot of each frozen sorted bin and using the entire sample as input to the kit. For deep
sequencing, 30ng of each miniprepped sample was amplified for thirty cycles of PCR with
Phusion High-Fidelity Polymerase Master Mix (New England Biolabs M0531). This PCR step
added barcodes to each sample using primers oj1302, 1334 - oj1348 (Table 3-4). Amplification
of samples was verified with gel electrophoresis and quantified using a NanoDrop
spectrophotometer (ND-1000). Unsorted control samples were identically processed and
sequenced. 13.1M constructs were sequenced in a single MiSeq 150 paired-end lane with the
sequencing primers oj1301, oj1303, and oj1356 (Table 3-4). To correct for the fact that fewer
cells are sorted into the later bins (BIN2-4), the samples were mixed such that the 'unsorted' and
'BINi' samples were present in equimolar ratios and made up 90% of the final sequenced
mixture. The 'BIN2', 'BIN3', and 'BIN4' samples, which were also mixed in equimolar ratios,
constituted the last 10% of the final sequenced mixture. This resulted in 1.7-2.2 million
sequencing reads from the each of the 'unsorted' and 'BINi' samples and 100,000 - 180,000
sequencing reads from each of the 'BIN2', 'BIN3', and 'BIN4' samples (Table 3-1).
Amplify oligonucleotides from chip synthesized pool:
oj1299 FW
ojl300 RV
Add deep sequencing barcodes:
oj 1302 FW amplification primer:
oj1334 RV PhIF BINI amplification primer
oj1335 RV PhIF BIN2 amplification primer
oj1336 RV PhlF BIN3 amplification primer
oji337
oj1338
RV PhiF BIN4 amplification primer
RV PhiF Unsorted amplification primer
oj1339 RV SrpR BINI amplification primer
oj1340 RV SrpR BIN2 amplification primer
oj1341 RV SrpR BIN3 amplification primer
ATATAGATGCCGTCCTAGCGGCG
TGGGCACAGGAAAGATACTTCCTG
AATGATACGGCGACCACCGAGATCTACACgtgacatT
AACTAGGGCGCGGCCGC
CAAGCAGAAGACGGCATACGAGATGTGTGTgcttctcg
ccaTGGGGGTATGGCCTGCAGG
CAAGCAGAAGACGGCATACGAGATAGGTGTgcttctc
gccaTGGGGGTATGGCCTGCAGG
CAAGCAGAAGACGGCATACGAGATTCGTGTgcttctcg
ccaTGGGGGTATGGCCTGCAGG
CAAGCAGAAGACGGCATACGAGATCAGTGTgcttctcg
ccaTGGGGGTATGGCCTGCAGG
CAAGCAGAAGACGGCATACGAGATGTAGGTgcttctc
gccaTGGGGGTATGGCCTGCAGG
CAAGCAGAAGACGGCATACGAGATGTGTTCgcttctcg
ccaTGGGGGTATGGCCTGCAGG
CAAGCAGAAGACGGCATACGAGATCATGACgcttctc
gccaTGGGGGTATGGCCTGCAGG
CAAGCAGAAGACGGCATACGAGATGTTCTCgcttctcg
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oj 1342 RV SrpR BIN4 amplification primer
oji 343 RV SrpR Unsorted amplification primer
oj1344 RV TarA BINI amplification primer
oj 1345 RV TarA BIN2 amplification primer
oj1346 RV TarA BIN3 amplification primer
oj1347 RV TarA BIN4 amplification primer
oji 348 RV TarA Unsorted amplification primer
Sequencing primers:
ojl301 FW seq primer:
oj1303 RV seq primer:
oj1356 Barcode read:
Table 3-4: Oligonucleotides used in this study.
ccaTGGGGGTATGGCCTGCAGG
CAAGCAGAAGACGGCATACGAGATAGTCTCgcttctcg
ccaTGGGGGTATGGCCTGCAGG
CAAGCAGAAGACGGCATACGAGATTCTCTCgcttctcg
ccaTGGGGGTATGGCCTGCAGG
CAAGCAGAAGACGGCATACGAGATTGCAGAgcttctc
gccaTGGGGGTATGGCCTGCAGG
CAAGCAGAAGACGGCATACGAGATGTATCAgcttctcg
ccaTGGGGGTATGGCCTGCAGG
CAAGCAGAAGACGGCATACGAGATTCTCCAgcttctcg
ccaTGGGGGTATGGCCTGCAGG
CAAGCAGAAGACGGCATACGAGATCATCCAgcttctcg
ccaTGGGGGTATGGCCTGCAGG
CAAGCAGAAGACGGCATACGAGATGTCACAgcttctc
gccaTGGGGGTATGGCCTGCAGG
gtgacatTAACTAGGGCGCGGCCGC
gcttctcgccaTGGGGGTATGGCCTGCAGG
CCTGCAGGCCATACCCCCAtggcgagaagc
3-4-9. Deep sequencing analysis.
Custom software ('IlluminaSeqAnalysis.m') was written to combine paired end reads and
identify composite parts with perfect sequence identity to designed constructs. Each set of paired
150bp reads was aligned and merged into a contig based on overlapping sequence. Notl and
Sbfl restriction enzyme sites were identified and all sequences (including adapter and constant
primer sequence) outside the restriction sites were trimmed from both ends of the contig. Reads
that did not pair or did not have both restriction sites were discarded since all composite parts
were under 200bp, thus paired reads should have overlapping sequence and yield contgis with
both restriction sites. Of the 13.1M constructs sequenced, 11.2M (85.30%) yielded paired reads
with overlapping sequence and both restriction sites. Once paired, all remaining contigs with
mismatches (insertions, deletions, or substitutions) to designed constructs were discarded. Of the
11.2M contigs, 3.6M (32.28%) are perfect matches to the designed library. This is consistent
with the error rate of chip-based oligo synthesis 327.
Analysis of the perfect sequences shows that 70.0 - 77.5% of the composite parts appear
at least once in each of the unsorted libraries (Fig 3-19, Table 3-1). When we select for library
members that alter the NOT gate response functions, coverage of the library decreases to 50.2 -
74.8% in Bin 1, 38.5 - 50.0% in Bin 2, 25.0 - 26.1% in Bin 3 and 15.8 - 25.3% in Bin 4 (Fig 3-
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19). This is expected since a limited subset of the constructs will be capable of shifting the gate
thresholds. Indeed, >50% of the composite parts encode promoters weaker than apFAB49, which
generated less than a two-fold change in RFP expression in our original experiments (Fig 3-4).
Unsorted Bin 1 Bin 2 Bin 3 Bin 4
0
E
0
0
Terminator #
log 1o(count) 0 1 2 3 4
Figure 3-19: Composite part frequencies in each library by bin.
Sequencing read counts for each composite part in the PhIF (top), SrpR (middle), and TarA (bottom)
libraries. Only reads that are perfect matches to the designed sequences are shown. Promoter and terminator
ordering is the same for all heatmaps. Promoters are ordered by strength from 1 (weakest) to 109
(strongest). Reference spreadsheet is Table 3-5.
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Terminator number Terminator Name Promoter number Promoter Name
1 ECK120010843-R 1 apFAB46
2 ECK120010802 2 apFAB1O1
3 ECK120010813-R 3 apFAB96
4 ECK120010780 4 apFAB47
5 ECK120029530-R 5 apFAB42
6 ECK120015446-R 6 apFAB95
7 BBa B0051 7 apFAB36
8 ECK120030672 8 apFAB68
9 ECK120035132 9 apFAB31
10 ECK120015439-R 10 apFAB93
11 ECK120026315-R 11 apFAB54
12 ECK120010831 12 apFAB92
13 ECK120010841-R 13 apFAB52
14 ECK120020528 14 apFAB81
15 ECK120010796 15 apFAB71
16 ECK120010874 16 apFAB67
17 ECK120020622 17 apFAB70
18 ECK120010857 18 apFAB79
19 ECK120030802 19 apFAB100
20 ECK120021270 20 apFAB45
21 ECK120011170-R 21 apFAB61
22 ECK120010852 22 apFAB341
23 ECK120020525 23 apFAB80
24 ECK120010832-R 24 apFAB29
25 ECK120010833 25 apFAB32
26 ECK120010812-R 26 apFAB40
27 ECK120010836-R 27 apFAB30
28 ECK120010871 28 apFAB56
29 ECK120010806 29 j23119
30 ECK120030221 30 apFAB50
31 ECK120010825 31 apFAB85
32 ECK120015457-R 32 apFAB53
33 ECK120010840 33 apFAB318
34 ECK120010781 34 apFAB44
35 ECK120010864 35 apFAB76
36 ECK120010793 36 apFAB65
37 ECK120010856 37 apFAB 140
38 ECK120010867 38 apFAB66
39 ECK120010815 39 apFAB75
40 ECK120010863 40 apFAB345
41 ECK120010782 41 apFAB103
42 ECK120016882 42 apFAB347
43 ECK120023928 43 apFAB39
44 tonB/P14 44 apFAB94
45 ECK120035133 45 apFAB323
46 ECK120010855 46 apFAB97
47 ECK120017009 47 apFAB78
48 ECK120015170 48 apFAB57
49 ECK120026481-R 49 apFAB72
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50 BBaB0062 50 apFAB62
51 ECK120010858-R 51 apFAB48
52 ECK120034435 52 apFAB55
53 j23100
54 apFAB77
55 j23104
56 apFAB33
57 apFAB339
58 apFAB321
59 apFAB115
60 apFAB 125
61 apFAB82
62 j23102
63 apFAB346
64 apFAB317
65 apFAB63
66 apFAB64
67 apFAB322
68 apFAB150
69 apFAB69
70 j23101
71 apFAB104
72 apFAB89
73 apFAB306
74 apFAB338
75 apFAB58
76 apFAB302
77 apFAB73
78 j23118
79 apFAB342
80 apFAB87
81 j23106
82 apFAB49
83 apFAB38
84 apFAB130
85 apFAB98
86 apFAB312
87 apFAB 129
88 apFAB311
89 j23107
90 j23105
91 apFAB277
92 apFAB300
93 j23110
94 j23116
95 j23114
96 j23108
97 apFAB259
98 j23115
99 j23109
100 apFAB139
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101 j23113
102 j23112
103 apFAB134
104 j23103
105 apFAB 114
106 j23117
107 apFAB109
108 apFAB149
109 apFAB 124
Table 3-5: Promoter and Terminator ordering for Figure 3-28.
3-4-10. Sorted-parts strength analysis.
Custom software ('IlluminaPerfSeqAnalysis.m') was written to analyze the perfect
oligonucleotides, i.e. sequences that are perfect matches to the designed library, sorted into each
bin. Analysis relied on previously measured terminator2 7 and promoter 26320 strengths, therefore
all sequences with mutations were disregarded because they could change a part's activity and
convolute the analysis. Occurrences of each promoter and terminator were counted per bin and
used to calculate the median promoter, forward and reverse terminator strengths for each bin.
3-4-11. Enrichment calculation.
To calculate enrichment for each composite part, we normalized the counts of each composite
part in a bin to the total number of perfect sequences in that bin. We defined the frequency of a
composite partfi in a bin as
ciix
where cy is the number of occurrences of composite part i in bin j for library x, where x = PhlF,
SrpR or TarA. Then we defined enrichment E, as the ratio of the frequencies of a composite part
i in a sorted bin j to the frequency of that composite part in the unsorted pool (f.).
Eijx = fjfiux
If a composite part did not appear in the unsorted library at least once (f. = 0), c,x was set to
one, indicating one count of the part in the unsorted library. This correction was used to ensure
that none of the enrichments were infinite. Enrichment Ei1x for each composite part was then
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averaged by bin across all three libraries. We defined the average enrichment Eij for a composite
part as
Ei 
_ x Ej xN
where N = 3, the total number of libraries. To ensure that composite part behavior is consistent
across all three libraries, any composite parts that did not appear in all three libraries for a given
bin were assigned an enrichment of zero for that bin, i.e. if Ei1X = 0 for any x, F11 = 0.
Next each composite part was assigned to the bin where its average enrichment was
highest. Maximum average enrichment Emax for each composite part i was calculated as
Emaxi = max (Eij)
Then the composite part i is assigned to the bin j where E11 = Emaxi. If the maximum enrichment
is less than one, the composite part is depleted in the sorted library and is not assigned to a bin
(Fig 3-16, grey). Depletion of a composite part in all of the sorted bins relative to the unsorted
pool may be the result of biases in cell recovery after sorting or in amplification of the DNA for
deep sequencing. The matrix of bin assignments was generated using custom software
('IlluminaEnrichmentGrid.m') and used to create Fig 3-16.
3-4-12. Measurement of growth curves.
E. coli strains were grown for 16 h in LB media containing antibiotics, when appropriate, in 96-
deep well blocks (USA Scientific 1896-2000) at 370C and 250 r.p.m in an INFORS-HT
Multitron Pro. After 16 h, the cultures were diluted 1:200 into M9 medium with antibiotics and
grown for 3 h with the same shaking and temperature settings as the overnight growth. Next, the
cultures were diluted to OD6. = 0.001 into fresh M9 medium with antibiotics and 100 tM IPTG.
150 [tL of these cultures were grown in black 96-well optical bottom plates (Thermo scientific
165305) at 370C and 1mm orbital shaking in a BioTek Synergy HI plate reader. Optical density
measurements at 600nm wavelength (OD6.) were made every 20 minutes for 12 h.
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3-4-13. Construction and testing of the transcriptional interference model.
Custom MATLAB software was written to solve the model ODEs (Equations 3-7 & 3-8) with
mixed boundary conditions. Initial mesh for the MATLAB boundary solver bvp4c were formed
using MATLAB function bvpinit with general solutions for the model ODEs derived in Wolfram
Alpha's Mathematica:
CF (x) = ER (3-7)ER+ C2 eCix
CR (x) = 3-( 8)
Integration constants were approximated using boundary conditions CF(x=O) = qF/ and CR(x=N)
= #R/V- EF and ER were input directly into the model for EF = ER = 1 or parameter sweep
experiments. Model results were reported as polymerase concentrations CF(x) and CR(x). Full-
length transcript production is assumed to be proportional to CF IEF=O' which should be a measure
of polymerases fired from PF that successfully transcribe the entire stretch of DNA between
promoters. Fold repression 0 is calculated using Eq. 3-6, which compares CF in the absence of
interference (CF IeF=) to CF with an interfering promoter (CF EF>o). Model results for each
forward/interfering promoter pair were scored by simple comparison to experimental data:
s = [abs(OTI-m - OTIp)]- (3-9)
where s is the score for a specific promoter pairing, 6 TI-m and and 6 TIp are measured and
predicted repression, respectively, for that pair. The best EF and ER values were calculated for
each forward/interfering promoter pair using a weighted average, were each E was weighted by
its score.
3-4-15. Data availability
Brophy, JAN, Voigt, CA (2015). Antisense library. NCBI Sequence Read Archive SRP065456
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Chapter 4: Stable Engineering of Undomesticated Bacteria using a
Miniaturized Integrative Conjugative Element (ICE)
Engineering probiotics to optimize human or plant health will require robust bacteria that
are capable of surviving in harsh, competitive environments. Here, we present an Integrative
Conjugative Element from Bacillus subtilis (ICEBs]) as a tool to deliver synthetic programs to
diverse collections of undomesticated bacteria isolated from valuable microbiomes. We
demonstrate that ICEBs1 can be used to deliver synthetic programs to >X species of Gram-
positive bacteria isolated from the human gut and soil microbiomes (e.g., Bacillus sp.,
Enterococcus sp., Staphylococcus sp.). We develop a miniature ICE, which irreversibly
integrates DNA into recipient bacteria's genomes, to deliver therapeutically relevant biosynthetic
pathways (e.g., nitrogen fixation, indole-3-acetic acid production) to the bacteria. We measure
the performance of these pathways across species and demonstrate that species variation can be
used to optimize the desired phenotypes. This work produces an easy to use tool for stably
engineering diverse species of undomesticated bacteria.
4-1. INTRODUCTION
Advancements in microbiome analysis techniques have revealed the importance of
microbial communities for human, plant, and animal health 360 . The bacteria that inhabit these
ecosystems help maintain fitness by producing molecules that eliminate pathogens 12 ,13 ,34 , function
as nutrients35 or hormones36-38, or educate the immune system 361 . Importantly, the strains of
bacteria that have essential roles in human, plant, and animal health produce their effect while
competing with tens to thousands of other bacterial species. Deep sequencing studies find that
the human gut, oral, and skin microflora are composed of 500 - 25,000 species worldwide3 62 .
Similarly, a gram of soil may contain 2,000 - 8.3M microorganisms representing 5,000 - 20,000
different operational taxonomic units (OTU) 3 63 . In addition to being diverse, bacteria in these
environments are highly variable. The most prevalent bacteria vary significantly from sample to
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sample, indicating a great flexibility in the combinations of species that make up a functional
microbiome3"6 .
Bacteria's ability to alter human, plant, and animal health has inspired researchers to
create designer probiotics that leverage genetic engineering to optimize the fitness of these
systems. These efforts have largely been focused on moving simple phenotypes, such as
therapeutic protein secretion, into a few well-established probiotic strains (e.g., Lactococus lacis
and Escherichia coli Nissle 1917 (EcN)) 36 6 . These strains, though effective for specific
applications, such as secreting interleukin 10 (IL-10) to treat irritable bowl disease (IBD) 367, have
limited potential in applications that require different colonization patterns, immune interactions,
or other innate behaviors. Consequently, researchers are developing toolkits for new strains that
368are well adapted for specific applications, such as long-term human gut colonization .
However, broadly applicable tools that can be used to engineer multiple species are
lacking. These tools could be used to accelerate probiotic development by eliminating the need
to generate specific toolsets for each new organism of interest. They could also impact industrial
bio-production by allowing metabolic engineers to work with bacteria that have advantageous
features, such as solvent tolerance, leading to increased yields3 69 or streamlined manufacturing 370.
Unfortunately, even the basic tools required for genetic engineering, such as transformation
methods, growth medias, and functional plasmids, are underdeveloped or unknown for the vast
majority of bacterial species worldwide. Transformation is especially difficult for Gram-positive
bacteria, which are often electroporated despite poor performance303 7 1 . Electroporation creates
stable tears in the peptidoglycan wall of Gram-positive bacteria, which leads to cell death and
transformation efficiencies at least four orders of magnitude worse than commercially available
Gram-negative cloning strains 37 3 73 . These low transformation efficiencies (102 - 106
transformants/tg DNA) prohibit library construction and deter high throughput engineering in
Gram-positive bacteria. Vectors for introducing new DNA to bacteria, such as plasmids, are also
unknown for most bacterial species. Plasmids often have narrow host ranges3 4 and can vary in
copy number/stability3 7 5, which make them difficult to use without extensive species-specific
characterization. Additionally, plasmids are prone to horizontal gene transfer and often require
constant selection for maintenance3 76 , which make them inappropriate for in vivo applications
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where a synthetic program can be unintentionally lost or spread to other bacteria in the target
environment" 7 .
Integrative conjugative elements (ICEs) have great potential as tools for engineering
diverse bacteria. ICEs are unique mobile genetic elements (MGE) that reside in bacterial
genomes and encode all of the proteins needed to excise from the chromosome, replicate,
conjugate into a neighboring cell, and integrate into the recipient's genome (Fig 4-1). ICEs are
found across the bacterial domain and a single element can often transfer into a diverse range of
recipient species 378. Tn916, an ICE first identified in Enterococcus faecalis, appears in
tetracycline resistant clinical isolates, as well as unrelated species of soil and skin bacteria3 79.
Similarly, ICEBsJ, an ICE from the Gram-positive model organism Bacillus subtilis, was shown
to conjugate into four different bacterial species in a laboratory setting (B. subtilis, B. anthracis,
B. licheniformis, and L. monocytogenes)38o. The success of these elements across species and
their ability to integrate into the host genome make them attractive candidate tools for
introducing DNA to a broad range of bacterial species for advanced engineering applications.
oReplicate
Excise Conjugate Circularize F integrate
Donor Recipient
t Re-integrate I
Figure 4-1: Typical Integrative Conjugative Element (ICE) life cycle.
ICEs reside in bacterial chromosomes bound by specific sequences on the right (attR) and left (attL) ends.
When stimulated, ICEs will excise from the chromosome to form a covalently closed circle. Circularized
ICE will then be nicked by a relaxase protein and will replicate via a rolling circle mechanism. If an ICE-
cell is in contact with the donor, a single strand of ICE DNA will be transferred to the recipient during
replication. Once in the recipient, the ICE will circularize and the complementary strand will be
synthesized to regenerate double-stranded ICE. This circularized form will then integrate into the host
chromosome via a recombination event between attP (in the ICE) and attB (in the chromosome).
Natural ICEs (natty ICEs) carry a wide range of useful phenotypes between species.
Several natty ICEs facilitate bacteria survival by moving antibiotic38" and heavy metal resistance
cassettes 38 into new species. Other natty ICEs carry more complex traits, such as the ability to
colonize a eukaryotic host383 or promote virulence and biofilm formation4. ICEMlSymR7Ais one
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notable example that encodes 0.5 Mb of pathways sufficient for transferring plant symbiosis,
including root nodule formation and nitrogen fixation, between cells83.
ICEBs], the integrative conjugative element from Bacillus subtilis, is unusual because it
conjugates at an extremely high efficiency (-0.2 Bacillus subtilis transconjugates/donor)
compared to other Gram-positive conjugation systems (e.g., ~10-5 transconjugates/donor
(Tn916), 10- - 10-8 transconjugates/donor (pRK212)385) (Fig 4-2). During growth, ICEBs1-
encoded repressor protein ImmR prohibits transcription of the ICE conjugation proteins.
However, when ICE+ B. subtilis encounter DNA damage or a high density of ICE- cells, anti-
repressor protein ImmA cleaves ImmR and stimulates expression of the ICE conjugation and
excision proteins 38K. Excision is mediated by tyrosine recombinase Int and directionality factor
Xis 387 . After excision, ICE circularizes and the relaxase protein NicK nicks ICEBs1 DNA at the
origin of transfer oriT3 18. This is followed by rolling circle replication, facilitated by the ICEBs1-
encoded helicase HelP389. During replication, the relaxase associates with the coupling protein
(putatively ConQ) and a single strand of ICEBs1 DNA is conjugated into a neighboring cell. The
structure of the conjugation apparatus is unsolved, however ATPase ConE,
peptidase/muramidase CwlT, and putative transmembrane proteins ConB, ConC, ConD and
ConG are known to be essential for conjugation390. Once in the recipient cell, ICE re-circularizes,
its second strand of DNA is synthesized by host factors from a single stranded origin (sso) 391. In
the recipient, Int and ImmR are expressed to integrate ICE into the recipient chromosome and
repress further conjugation/superinfection. Benefical phenotypes encoded in ICEBs1 are
currently unknown, however the high conjugation efficiency, potentially broad host range, and
integrative phenotype make it an attractive tool to deliver DNA to diverse bacterial species.
int immA| xis4Q helP conQ InicKI T A 8 C D conE yddF conG cwfT Irapl | yddM
attL immR ydc oriT sso ydc y ydd p r MR
i 22 kb I
Figure 4-2: Schematic of wild type ICEBsJ.
Proteins are color coded by function: regulatory proteins, red; integration/excision proteins, beige;
conjugation proteins, blue; unknown, white.
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Here, we develop ICEBs] as a tool for engineering a diverse range of undomesticated
bacteria. First, we demonstrate control over ICEBsJ conjugation by creating a miniature element
that is incapable of self-transfer. Second, we broaden the known host range of ICEBsJ by
compiling a collection of 82 strains of Gram-positive bacteria isolated from several important
environments (e.g., human gut, human skin, organic fertilizer, crop rhizospheres). Using the
collection, we show that a miniature ICE can be used to introduce heterologous DNA into 16
different bacterial species from 5 different genera. Finally, we utilize miniature ICE to deliver a
functional heterologous nitrogen fixation pathway to the soil-dwelling species. These engineered
soil bacteria should promote plant growth by delivering bioavailable nitrogen to plant roots. This
work contributes to a larger effort to facilitate engineering of real-world applicable organisms for
the transition of genetically modified probiotics from lab concepts to useable and effective
products.
4-2. RESULTS
4-2-1. Engineering control over ICEBsJ conjugation: small molecule inducers
Controlling ICEBsI conjugation will make it easier to use ICEs as an engineering tools
by allowing researchers to dictate the conditions under which DNA is delivered to recipient
species. ICEBsJ conjugation is stimulated by high concentrations of ICE- B. subtilis cells and
DNA damage380 . Over expression of the quorum sensing protein RapI using a heterologous
380inducible promoter can also cause ICEBs] excision and conjugation . We carefully tested
several different RapI induction cassettes to identify the inducible promoter that gave us low
uninduced and high induced conjugation rates. For these experiments, we used a ArapIphrI
ICEBsJ and over expressed RapI using inducible promoters integrated at amyE (Fig 4-3).
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amyE::Pind_rap1
spwcR R Pind rapt
tRNA'e::ICEBs1 (rapIphrl::kanR)
Int ~ ~ ~ L mA|xsQhP n nK|L _ CD nEyF conG cwfT I J K rapt yddM
affL 1MmR ydc orTSSOyd yd ydd P rl attR
Figure 4-3: Schematic for inducible ICEBsJ strains.
Quorum sensing proteins RapI and PhrI are removed from wild type ICEBsJ. RapI induction cassettes are
integrated at amyE in the B. subtilis chromosome with a spectinomycin cassette. Here R and Pa, are generic
repressor and inducible promoter and the dark circle represents the B. subtilis chromosome with lines
pointing to approximate locations of ICEBs1 and amyE.
First, we expressed RapI using isopropyl s-D-1-thiogalactopyranoside (IPTG)-inducible
promoters Pa a and Pshy> (Fig 4-4a). IPTG is a non-hydrolyzable molecular mimic of
allolactose that is used to induce expression of genes under control of lac repressor (LacI). The
Pspak(hy) promoter is ~10 fold stronger than PPaa in B. subtilis (Fig 4-4a). Full induction of PsPa.
and Psp(hy) with 1mM IPTG lead to high levels of conjugation (~0.2 transconjugates/donor) (Fig
4-4c). However, uninduced (0mM IPTG) conjugation frequencies were at least 50 fold higher
than the ArapI control.
A -3s _ 1-
Pspank TTTTGCAAAAGTTG*MTTATCTACAAGGTGTGGM
Pspank(hy) TTTTGCAAAAGTTGIAMOcTTTATCTACAAGGTGTG C 3
PJ3 CATCATTTCCTTCCGAAAAAACGGitGA&NTTAAATCTTACATATGTtIASRtTTCAA A
PJ3M CATCATTTCCTTCCGAAAAAACGGTTGACATTAAATCTTACATATGTThIAATTTCAA A
PJ4 A ATCATTTCCTTCCGAAAAAACGGTrfORcATTAAATCTTACATATGTPAUTTTCA
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Figure 4-4: Inducible B. subtilis promoters for RapI expression/conjugation.
(A) Promoter sequences. Lac operators shown in blue (wt) or pink (synthetic inverted repeats), xylose
operator in green, -10 and -35 recognition sequences in orange. Transcription start site (+1) indicated with
an arrow. (B) PsPak and Pspank(hy) transfer functions measured using GFPmut2. (C) Conjugation efficiencies
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M
+/- 1mM IPTG for Pspank(hy) (JMA168) and Pspank (JAB221) and +/- 2% xylose for PY (JAB785). Control
strain is ArapI (JMA8). (D) New IPTG-inducible promoter transfer functions measured using GFPmut2.
To reduce leaky expression of RapI, we attempted to build new IPTG-inducible
promoters by replacing the wild type lac operators with perfect inverted repeats (lacOsyn) (Fig 4-
4a, pJ3, pJ3m, pJ4). These synthetic lac operators have been shown to produce tighter OFF states
in Escherichia coli (data not shown). We added these lac operators to a strong constitutive
promoter from Bacillus licheniformis Pe392 . Unfortunately, our best inducible promoters did not
provide substantial improvement in leaky expression when compared to the Pspank promoter (Fig
4-4d).
Next, we tried using xylose inducible promoter PxY1 to express RapI. PxY1 is a modified
version of the xylA promoter from Bacillus subtilis subsp. spizizenii W23 (Fig 4-4a)393. This
promoter is catabolite repressed in rich media, which reduces leaky expression393 . Unfortunately,
catabolite repression can also inhibit full induction. We quantified xylose-inducible conjugation
in rich media (LB) using a P,,1 rapI cassette and found ~4,500 fold induction of conjugation (Fig
4-4b). PxY1 results in a much tighter OFF state than the IPTG-inducible promoters (>10 fold less
leaky than Pspank) with only ~3.5 fold reduction in transconjugates/donor when fully induced.
Thus we chose to use PxY1 to drive expression of RapI and control ICEBsJ conjugation.
4-2-2. Engineering control over ICEBsJ conjugation: miniature elements
We gained further control over conjugation by building miniature ICEs (mICEs) that are
incapable of self-transfer. These ICEs are designed to conjugate once (from B. subtilis donor into
neighboring recipient) and then become stuck in the recipient cell's genome. mICEs can be when
used for stabling engineering target strains and should reduce the unintended spread of synthetic
DNA through microbial populations. mICEs do not encode all of the proteins necessary to excise
and conjugate themselves into neighboring cells. Instead, the proteins that mediate ICEBsJ
excision and conjugation are expressed ectopically from the threonine synthase locus thrC (Fig
4-5a). These genes, collectively referred to as locked-in ICEBsJ (liICE), complement the missing
components of mICE in the B. subtilis donor strain388 . Consequently, mICE can conjugate from a
B. subtilis strain containing liICE into any recipient cell, but cannot conjugate further.
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We built two different mICE/liICE systems. In the first system (1.0) (Fig 4-5a), liICE
encodes all of the essential conjugation proteins except the relaxase NicK. The nicK gene was
not included in IiICE 1.0 because its coding region includes the origin of transfer oriT. During a
normal ICE life cycle (Fig 4-1), the relaxase nicks the ICE DNA at oriT after it excises from the
chromosome to initiate replication and transfer. However, when oriT is suck in the genome,
nicking leads to single-stranded breaks and donor cell death (data not shown). Thus, NicK and
oriT were encoded in mICE 1.0 instead of liICE (Fig 4-5a). All genes upstream of nicK in wild
type ICEBsJ were kept in mICE 1.0 to maintain the original context for expression of NicK. In
total, mICE 1.0 is 8.7 kb (reduced from 22 kb of wild type ICEBsJ) and its conjugation
efficiency of is -50 fold less than wild type ICEBsJ under identical conditions (Fig 4-5b). This
drop in efficiency is probably due to the elimination of secondary transfer, which is known to
occur for wild type ICEBsJ in chains of B. subtilis cells3 9, and not a deficiency expression of
ICE conjugation proteins.
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Figure 4-5: Miniature ICE schematics and conjugation efficiencies.
(A) Schematic for mICE and liICE versions 1.0 and 2.0 Here the dark circle represents the B. subtilis
chromosome with lines pointing to approximate locations of the liICE/mICE. (C) Conjugation efficiencies
for mICE 1.0, 2.0, and wild type ICEBsJ.
In the second system (2.0) (Fig 4-5a), iICE includes a recoded version of nicK that does
not contain oriT. mICE 2.0 is reduced to 2.4 kb and only encodes ImmR, to silence Pi., in the
recipient, and parts that are essential for transfer: oriT for recognition by the relaxase, Int for
integration in the recipient cell, and kanR for selection of transconjugates. This tiny ICE is
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approximately 3.5 orders of magnitude less efficient than wild type ICEBsI (Fig 4-5b). The
severe drop in efficiency is likely attributable to the lack of ICE components that enable
replication in the recipient, such as NicK, the sso, and HelP. ICE DNA can get lost during cell
division if it is unable to replicate, thereby reducing the conjugation efficiency. Truncations of
important, yet ill defined, sequences such as attL, attR, or oriT, may also contribute to the poor
conjugation efficiency of mICE 2.0. Int and Xis may recognize more than the 60 bp att sites in
mICE 2.0 to catalyze excision, circularization, or integration of ICEBs]. Similarly, the 100 bp
fragment of nicK that we used as oriT may be insufficient for NicK recognition/cleavage.
Additional mICE variants will need to be constructed to test these hypotheses and identify the
minimum number of components needed for efficient conjugation.
4-2-3. High throughput mating conditions
One goal of this project is to find conjugation conditions that enable efficient DNA
delivery. ICEBs] conjugations are typically performed using cells grown in large volume flasks
that are concentrated onto analytical filters and incubated for 3 hours on agar plates (Fig 4-6a,
filters). These mating conditions simulate biofilms and increase cell-cell contact for maximal
mating efficiency. However, the protocol is not ideal for high throughput screening. Several
steps in the mating protocol, including incubation time, media, temperature and donor/recipient
growth phases, could be tuned to increase throughput and alter mating efficiencies. We
compared conjugation efficiencies using different medias for the solid agar support in filter
matings, e.g., Spizizen minimal media salts395, TSS salts3 1, +/- magnesium chloride (MgCl 2 )-
Then we used the best medias to compare conjugation techniques, e.g., liquid, spots, filters, with
different potentials for high-throughput adaptation (Fig 4-6a).
While screening medias, we confirmed previous results that MgCl 2 increases conjugation
efficiency (Fig 4-6b)3 97. We compared TSS + MgCl 2 to Spiz + MgCl 2 and found similar
conjugation efficiencies with the two salt solutions (Fig 4-6b). Although the previous study
hypothesized that MgCl 2 increases ICEBsJ conjugation efficiency by affecting the activity of cell
surface components involved in conjugation or stabilizing mating pairs, it is possible that MgCl 2
increases conjugation efficiency by neutralizing unfavorable interactions between the DNA
(negatively charged) and charged portions of macromolecules on the bacteria's outer surface.
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This is the mechanism by which another multivalent cations (calcium) increase transformation
efficiency". Thus, we tested a conjugation null (AconG) strain to make sure that the MgCl 2
mediated increase in conjugation efficiency was not the result of increased donor cell lysis and
natural competency. Based on our results, MgCl 2 specifically increases conjugation efficiency
and does not facilitate recipient acquisition of ICEBs] DNA via donor cell lysis and natural
competency (Fig 4-6b).
To streamline ICEBsJ conjugation, we sought to eliminate filters and reduce the volume
of cell culture needed for matings by conjugating in spot or liquid conditions. Spot matings are
commonly for Gram-negative conjugations and, like filter matings, spots increase donor-
recipient contacts by concentrating a large number of cells into a small area. Spot matings were
performed by concentrating 150 [tL each of donor and recipient cell culture ten-fold and spotting
the dense cell mixture onto agar plates. Spots were allowed to dry before incubation. Liquid
matings were performed by mixing 150 [tL of donor and recipient cell culture. The cells were
either allowed to conjugate in LB, or were harvested and resuspended in an equivalent volume of
Spiz + MgCl 2. For all comparisons, matings were incubated for 3 h at 37'C.
Spot matings were just as efficient as filter matings, whereas liquid matings were >1,000
fold less efficient than filter matings (Fig 4-6c). These findings are unsurprising since matings
require direct contact between donor and recipient cells. Spots, like filters, concentrate cells into
a small area and yield high conjugation efficiencies by increasing cell-cell contact. In liquid,
cells are too disperse for donor strains to encounter as many recipients. To fix this 'large volume'
problem, Enterococcus faecalis conjugative plasmid pCF10 encodes a surface protein called
aggregation substance (PrgB) during conjugation that increases cell stickiness and helps donors
bind to recipient cells to increase conjugation efficiency 39. As far as we know, ICEBs] does not
encode a similar surface protein, therefore liquid matings, which likely decrease cell-cell
contacts are less efficient than spot or filter matings. Although spot matings were only X fold
less efficient than filter matings, the hit in conjugation efficiency means that low frequency
conjugation events (such as those between B. subtilis and unrelated recipient strains) may be
missed. Thus we will use filter matings to define a baseline for conjugation into diverse recipient
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species. Once conjugation is established, we can use spot matings for more economical
engineering.
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Figure 4-6: High throughput conjugation methods optimization.
(A) Schematics for each conjugation method. (B) The effects of different salt solutions (Spiz or TSS +/-
125 mM MgCl2) in the solid agar support were compared using filter matings. (C) Conjugation method
variations. Liquid and spot matings were compared to filter matings with LB or Spiz + 125 mM MgCl 2. For
all assays, donor strain is JAB785 and recipient is JAB299.
4-2-4. D-alanine auxotrophy as a counter selection to streamline transconjugate isolation
Isolating transconjugates requires a unique selectable marker in the recipient bacterium
that is used to kill donor cells after mating (Fig 4-7a). Typically researchers rely on identifying a
unique naturally-occurring antibiotic resistance in the recipient to select for transconjugates. If
no suitable antibiotic resistance can be found, resistance to spectinomycin can be generated by
plating a large number of cells on spectinomycin selective plates. Specinomycin resistance
frequently arises via mutations in the 16S rRNA and resistant strains can often be isolated
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Figure 4-7: Transconjugate isolation using a D-alanine auxotrophic donor.
(A) Typical mating selection scheme. Donor is D-alanine auxotroph (Aalr), recipient is wild type, ICE
carries a tetracycline resistance marker (tet(M)). After mating, cells are plated on rich media with
tetracycline. Only the recipients that received ICE (transconjugates) survive. (B) Alanine racemase
schematic. Air is the alanine racemase in B. subtilis. (C) Conjugation efficiencies are the same for wildtype
(JMA168) and Aalr (JABXX) donor strains. Error bars are the s.d. of three replicates collected on different
days.
Each selection method requires a significant amount of recipient strain characterization
and often yields mediocre results. Innate resistance phenotypes can be unreliable, making it
difficult to select for transconjugates using dual antibiotic selections. Generating spectinomycin
resistance becomes more difficult as the number of rRNA operons increases. Plus, 16S rRNA
mutants can are often much less robust than their spectinomycin sensitive parents. Crafting new
growth medias to isolate specific strains is tedious and may lower the observed conjugation
efficiency if it is difficult for the recipient strain to survive in the selective media. Ideally, one
would be able to isolate transconjugates using rich media and a single antibiotic to select for
acquisition of the conjugated element.
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We introduced a D-alanine auxotrophy to our B. subtilis donor strain to streamline
transconjugate isolation. D-alanine is an essential cell wall component that is either taken
directly from the environment or made by isomerizing L-alanine using a dedicated racemase 4
0 2 4 0 3
(Fig 4-7b). Alanine racemases have been used previously for cloning plasmids into auxotrophic
strains44. Here, we knocked out the B. subtilis D-alanine racemase encoded by alr to generate
donor strains that require D-alanine to grow. These strains do not grow in any of the rich medias
tested (luria broth (LB), nutrient broth (NB), tryptic soy broth (TSB), brain heart infusion (BHI),
or deMan, Rogosa and Sharpe media (MRS)) without 100 tg/mL D-alanine. This auxotrophy
simplifies transconjugate isolation by allowing us to select for transconjugates on rich media
with a single antibiotic. Aalr donor strains conjugate with the same efficiency as alr+ strains
(Fig 4-7c).
4-2-5. Compilation and characterization of recipient bacteria collection
Bacteria were isolated from several different environments to test the ICEBs1 host range.
In total, 82 strains were collected from >6 different sources, including the American Type
Culture Collection (ATCC), Bacillus Genetic Stock Center (BGSC), research groups at MIT and
the Broad Institute, and Epsoma soil products (Table 4-1). All potential recipient strains are
Gram-positive aerobic (or facultatively aerobic) bacteria. We focused on collecting commensal
strains from humans and agricultural soils. These organisms are of particular interest for
generating human probiotics (human isolates) and modulating plant growth (soil isolates).
Several of the strains in our collection have been well characterized as plant growth promoting
bacteria (e.g., Paenibacillus macerans, Bacillus amyloliquefaciens subsp. plantarium FZB42),
human probiotics (e.g., Bacillus coagulans GBI-30, Bacillus clausii domuvar, Lactococcus
lactis), insecticide producers (e.g., Bacillus thuringensis), or living concrete additives (Bacillus
cohnii) (Table 4-1). Others were added to the collection because they are known colonizers of
interesting microbiomes (e.g., Lactobacillus reuteri - human gut, Staphylococcus epidermis -
human skin, Bacillus megaterium - soil). Finally, some bacteria were simply isolated from the
target environments (e.g., commercially available organic fertilizer), though their rolls and
persistence in these settings are unknown. Table 4-1 lists some notable features of the recipient
strains. 16S rRNA sequencing was used to identify bacterial strains isolated from commercial
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products during this study (strain names with BT# or CP#, Table 4-1). A phylogenetic map of the
recipient collection was also generated using the 16S rRNA sequences (Fig 4-8). Altogether, the
collection spans 56 distinct species from 15 different genera.
Strain Source Isolation Known Functions Ref
1 Enterococcus mundtiiMOI-7_JAB432 Alm Feces -
2 Lactobacillussp.CD12 JAB487 Alm Feces -
3 Lactobacillussp.DLS1_JAB488 Alm Feces -
4 PediococcuspentosaceusJAB482 Alm Feces -
5 Bacillus cereus_55000 JAB564 ATCC Soybean Biological control R. solani
Corynebacteriumammoniagenes_6871_ ATCC Feces Industrial chemical production 405,4066 JAB511
7 Enterococcuscaccae_BAA-1240_JAB509 ATCC Feces -
8 Enterococcus durans_6056_JAB518 ATCC Feces -
9 Enterococcus faecalis 19433 JAB510 ATCC Feces Gut commensal, probiotic
10 Lactobacillusbrevis_14869_JAB513 ATCC Feces ucer mensal, Biological control 409
11 Lactobacillusgasseri_33323_JAB514 ATCC Feces Gut commensal, Immunostimulant
12 Lactobacillusparacasei 27092JAB515 ATCC Feces Be erge prod ction
13 Lactobacillus reuteri_23272_JAB512 ATCC Feces Modulate cytokine responses
Streptococcusinfantariuscoli 
_BAA- ATCC Feces 
- 41414 103_JAB517
StreptococcusinfantariusinfantariusBAA- ATCC Feces -414
15 102_JAB516
16 LactobacillusplanariumBAA-793_JAB480 ATCC Saliva Gut commensal, probiotic
PaenibacillusrhizohabitansBAA-94 ATCC Maize soil Nitrogen fixation
17 JAB560 416
18 PaenibacillustropicalisBAA-414 JAB559 ATCC Maize soil -
19 Bacillussp_53935 JAB563 ATCC Maize soil Biological control of root rot
20 Paenibacillus brasilensis BAA-413 JAB558 ATCC Maize soil Nitrogen fixation
21 PaenibacillusgraminisBAA-95 JAB561 ATCC Maize soil -
22 Paenibacilluspolymyxa 39564 JAB562 ATCC Potato roots Biological control of Verticillium sp.
23 Lactococcus lactisJAB481 ATCC Probiotic Food fermentation
24 Paenibacillus macerans 8244TJAB801 ATCC Soil Nitrogen fixation
25 Paenibacilluspolymyxa 842_JAB508 ATCC Soil Nitrogen fixation
26 Bacillusamyloliquefaciens BAA-390_JAB557 ATCC Wheat soil Biological control of blight/tan spot
27 Paenibacillus durus_35681_JAB802 ATCC Wheat roots Nitrogen fixation 4/_4,42
28 Bacillus circulans 16A1_JAB252 BGSC - Industrial ab production
29 Bacillus megaterium_7A16 JAB768 BGSC Soil Industrial enzyme production
30 Bacillus thuringiensis alesti 4C1_JAB240 BGSC - Agricultural insecticide
31 Bacillusthuringiensis andalousiensis_4AW1 BGSC - Agricultural insecticideJAB767
32 Bacillus thuringiensis finitimus 4B1 JAB239 BGSC - Agricultural insecticide
33 Bacillusthuringiensis israelensis_4Q1_ BGSC - Agricultural insecticideJAB550
34 Bacillusthuringiensissubspkurstaki_4D1_ BGSC - Agricultural insecticideJAB549
35 Bacillusthuringiensis mexicanensis_4AC2 BGSC - Agricultural insecticideJAB551
36 Bacillusthuringiensis-thuringiensis_4Bl_ BGSC - Agricultural insecticideIJAB239 * ' I III __
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37 Bacillus-subtilisBSn5_3A35_JAB547 BGSC Plant tissue Biological control of Erwinia sp. 4Z
38 Bacillussubtilis_inaquasorum_3A28T_ BGSC Desert soil - 430JAB766
Douglas fir Enhances vegetable growth,39 BacillussubtilisGB033A37JAB548 BGSC f photosynthesis, iron uptake, dieasefoliage reitne431
1 resistance
40 Brevibacillus-laterosporus_40A4 JAB556 BGSC Maize soil Biological control corn rootworm
41 Bacillus amyloliquefaciens plantarium_10A6 BGSC Maize roots Auxin production 433,434
JAB552 -BC _e_ s xnpdtn34
42 BacilluspumilusBiosubtyl_8A1_JAB171 BGSC Probiotic 43unost5,ant '436
________________________________ _______ ____________diarrhea treatment
43 Bacillusmethylotrophicus 10A23_JAB553 BGSC Rice soil ACC deaminase production
44 Bacillusglycinifermentans 51A1 JAB770 BGSC Soil -
45 Bacillus lentus 60A1_JAB771 BGSC Soil -
46 Bacillus-licheniformis_5A2 JAB242 BGSC Soil Glutamic acid production
47 Bacillus licheniformis_5A24_JAB249 BGSC Soil Biological control of Sclerotinia sp.
48 Bacillus megaterium 7A1 JAB170 BGSC Soil -
49 Bacillus subtilisNm-i_3A25_JAB546 BGSC Soil Oozone resistance in Brassica sp.
50 Lysinibacillusspaericus_13A1 JAB253 BGSC Soil Mosquito larvae toxin
51 Paenibacillus macerans 22A1 JAB174 BGSC Soil -
52 Paenibacillus vorticalis_31A1_JAB555 BGSC Soil Pattern formation
53 Rummeliibacilluspycnus_24AlJAB769 BGSC Soil -
54 Bacillus shakletonii_102A1_JAB772 BGSC Volcanic soil Thermophile
55 BacillusclausiiDomuvar _17A1_JAB554 BGSC Probiotic Antidiarrehal, 43447B vitamin production
56 Arthrobacter creatinolyticusBT9 JAB452 Biotone Soil -
57 BacillusamyloliquefaciensBT3_JAB397 Biotone Soil -
58 Bacillusamyloliquefaciens BT16 JAB570 Biotone Soil -
59 BacilluscereusBT1_JAB395 Biotone Soil -
60 Bacillus-flexisBT7 JAB409 Biotone Soil -
61 BacilluslicheniformisBT2_JAB396 Biotone Soil -
62 Bacillusmegaterium BT12_JAB566 Biotone Soil -
63 Brevibacillus-laterosporusBT8_JAB451 Biotone Soil -
64 Oceanobacillus sojaeBT6_JAB400 Biotone Soil -
65 RummeliibacillusstabekisiiBT20_JAB574 Biotone Soil -
66 Sporosarcina-spBT19 JAB573 Biotone Soil -
67 Compost-bacteriumBT10_JAB453 Biotone Soil -
68 Bacillus anthracis UM44-1C9 Grossman Lab strain Non-virulent
69 Bacillus subtilis AG174 Grossman Lab strain
70 Bacillus subtilis PY79 Grossman Lab strain -
71 BacilluscoagulansGBI-30_JAB565 DA Probiotic ifunc ordulatoy, 451
72 Enterococcus faecalis_(JMJ28)_JAB790 Vlamakis Feces -
73 Enterococcus faecalis_(JMJ29)JAB791 Vlamakis Feces -
74 Enterococcus faecium_(JMJ27)JAB789 Vlamakis Feces -
75 Pediococcus-acidlactici_(JMJ36)jAB798 Vlamakis Feces -
76 Streptomyces laendulae_(JMJ39)JAB800 Vlamakis Feces -
77 Streptococcussalivarius_(JMJ33)JAB795 Vlamakis Mouth -
78 Streptococcus vestibularis (JMJ34)JAB796 Vlamakis Mouth -
79 Staphylococcus-captitis_(JMJ32)JAB794 Vlamakis Skin -
80 Staphylococcusepidermis_(JMJ31)_JAB793 Vlamakis Skin -
81 Streptococcusdyscalactiae_(JMJ30)JAB792 Vlamakis Skin -
82 Escherichia coliMG1655_JAB410 Voigt Lab strain Cloning
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Table 4-1: Complete list of potential recipient bacteria.
Strains source abbreviations: American Type Culture Collection (ATCC), Bacillus Genetic Stock Center
(BGSC), MIT/Broad labs: Alm, Grossman, Vlamakis, Voigt. Biotone is an organic fertilizer produced by
Epsoma. Digestive Advantage (DA) is a probiotic pill made by Schiff. All 'Mouth,' 'Skin,' and 'Feces'
strains were isolated from humans.
We began characterizing the recipient collection by measuring their growth rates in
different commercially available medias. We chose four medias (LB, TSB, BHI, and MRS) and
two temperatures (30'C or 37'C) for the growth experiments. The human isolates were grown in
BHI and MRS at 37*C, whereas the soil strains, which are typically more tolerant to diverse
culture conditions, were grown in both LB and TSB at 30*C and 37*C to find conditions that
maximize growth rate. Doubling times were measured using a plate reader and calculated as the
slope of the natural log of OD60 vs. time (Tables 4-2 & 4-3). From the growth experiments, we
found that Bacillus soil strains grew fastest and to the highest optical density (OD6.) of all
strains. Unsurprisingly, MRS, which contains sodium acetate to suppress the growth of non-
Lactobacilli, was the least hospitable growth medium for all strains tested except Lactobacillus
sp. and Pediococcus sp. A few strains (JAB453, JAB514, JAB796) grew very poorly in all
conditions tested and were not analyzed further.
Next, the strains were tested for natural resistance to tetracycline, chloramphenicol, and
spectinomycin (Tables 4-2 & 4-3). Tetracycline and chloramphenicol resistance cassettes, tet(M)
and cat, were integrated into wild type ICEBs] to create a dual-marker element for screening
conjugation into the recipient collection. Tet(M) and cat were cloned from broad host range
vectors Tn916 and pC194, respectively. These cassettes were chosen because they have been
identified during deep sequencing studies or used for cloning in several different Gram-positive
genera (e.g., Bacillus, Enterococcus, Staphylococcus, Clostridium, Lactobacilus)-AM. Since
isolating transconjugates requires recipients to become resistant to an antibiotic upon receiving
ICEBs1, it is nearly impossible to differentiate between strains that have not received ICE and
those that received the element, but were unable to utilize the antibiotic resistance marker. Thus,
we chose to use two antibiotic resistance markers to enhance our ability to successfully screen
for transconjugates. Spectinomycin was used to enumerate donors after conjugation. Each strain
was tested for antibiotic resistance by plating serial dilutions of recipient cultures onto selective
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media plates. Strains were deemed resistant when bacteria formed colonies on the ten-fold
dilution.
Doubling time (m) Antibiotic resistanceHuman Isolates BHI MRS Spec Tet Cam
1 Enterococcus mundtiiMOI-7_JAB432 27.20 S S S
2 Enterococcus-faecium_(JMJ27)JAB789 30.45 ND S ND
3 Enterococcus durans_6056_JAB518 38.26 R S S
4 Enterococcus caccaeBAA-1240_JAB509 63.70 S S S
5 Enterococcus faecalis_19433_JAB510 31.48 R S S
6 Enterococcus-faecalis_(JMJ28)JAB790 41.54 ND R ND
7 Enterococcus-faecalis_(JMJ29)JAB791 37.97 ND R ND
8 Corynebacteriumammoniagenes 6871_JABS11 62.53 S S R
9 Escherichia coli MG1655_JAB410 24.62 S S R
10 Lactococcus lactisJAB481 31.29 43.01 S S S
11 Streptococcus salivarius_(JMJ33)JAB79S 23.39 ND S ND
12 Streptococcus vestibularis (JMJ34)JAB796 ND ND ND
13 Streptococcus infantarius _infantariusBAA-102_JAB516 26.75 R S S
14 Streptococcus infantarius coliBAA-103_JAB517 44.37 R S S
15 Streptococcusdyscalactiae_(JMJ30)_JAB792 36.34 ND S ND
16 Lactobacillusgasseri_33323_JAB514 ND ND ND
17 Lactobacillusparacaseiparacasei 27092 JAB515 87.99 S S S
18 Lactobacillus brevis_14869 JAB513 35.17 R R S
19 Pediococcus pentosaceusJAB482 33.54 33.60 R S S
20 Pediococcus acidlactici_(JMJ36)_JAB798 93.30 33.12 ND S ND
21 Streptomyces_laendulae_(JMJ39)JAB800 64.32 ND ND ND
22 Lactobacillus reuteri 23272_JAB512 60.61 ND ND ND
23 BacillusclausiiDomuvar_17A1_JAB554 S S ND
24 Bacilluscoagulans GBI-30_JAB565 61.78 S S S
25 Staphylococcuscaptitis_(JMJ32)_JAB794 46.99 61.38 ND S ND
26 Staphylococcusepidermis_(JMJ31)_JAB793 46.28 ND S ND
27 Lactobacillussp.CD12 JAB487 33.46 R S S
28 Lactobacillusplanarium BAA-793 JAB480 32.39 53.74 R S S
29 Lactobacillus sp.DLS1 JAB488 33.91 34.67 R S S
30 Bacillus subtilisPY79 22.12 S S S
Table 4-2: Doubling times and antibiotic resistance of human isolates.
Antibiotic concentrations are 100 tg/mL spectinomycin (spec), 10tg/mL tetracycline (tet), and 10 stg/mL
chloramphenicol (cam).
Doubling time (m)
Soil & Other Isolates LB TSB Antibiotic resistance
370C 30*C 37*C 300C Spec Tet Cam
Arthrobacter-creatinolyticusBT9_JAB452 56.44 7.09 58.96 S
2 Paenibacillus-brasilensisBAA-413_JAB558 56.16 83.11 R R S
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3 Paenibacillus polymyxa_842 JAB508 36.52 35.89 43.98 47.67 S S ND
4 Paenibacillus polymyxa 39564 JAB562 44.86 49.29 45.62 46.74 R S S
5 PaenibacillusgraminisBAA-95 JABS61 57.09 42.93 59.00 51.57 R S S
6 Paenibacillus tropicalis BAA-414 JAB559 58.61 43.98 34.91 ND R R S
7 Paenibacillus rhizohabitans BAA-94 JAB560 59.24 S S S
8 Paenibacillus durans 35681 JAB802 ND ND ND ND
9 Paenibacillus vorticalis 31A1 JAB555 46.27 62.55 51.20 32.64 S R ND
10 Paenibacillus macerans BKM-B-51 JAB174 16.66 37.84 22.71 41.28 S S S
11 Paenibacillus macerans 8244T JAB8O1 55.84 ND 33.24 ND ND ND ND
12 Brevibacillus aterosporus BT8 JAB4S1 24.78 ND S S S
13 Brevibacillus laterosporus 53694 JAB556 26.85 ND S S ND
14 Sporosarcina spBT19JAB573 67.22 ND 59.64 ND R S S
15 Lysinibacillus spaericus_13A1 JAB253 25.27 36.61 29.81 36.11 ND ND ND
16 Rummeliibacillus stabekisil BT2O JAB574 29.10 ND 27.21 ND S S S
17 Rummeiibacilluspycnus24Al JAB769 32.83 ND 32.67 ND ND ND ND
18 Compost bacterium BT10 JAB4S3 ND ND ND
19 OceanobacillussojaeBT6 JAB400 46.77 64.80 51.95 66.60 R S S
20 Bacillus circulans 16A1 JAB2S2 33.54 49.31 32.03 57.96 ND ND ND
21 Bacillus shakietoni 102A1 JAB772 30.16 ND 32.66 ND ND ND ND
22 Bacillus thuringensis subspkurstakiJAB549 23.16 33.38 23.31 35.73 R S ND
23 Bacillus-lentus-60Al-JAB771 25.15 ND 27.86 ND ND ND ND
24 Bacillus thuringensis mexicanensis JAB551 22.34 31.36 25.01 37.45 R S ND
25 Bacillus thuringensis israelensis JAB55O 24.19 32.76 25.21 36.03 s s ND
26 Bacillus thuringensis andalousiensis JAB767 22.92 ND 23.46 ND ND ND ND
27 Bacillus cereus BT1 JAB395 21.13 30.32 31.92 53.41 R S R
28 Bacillus anthracis UM44-1C9 26.50 39.88 30.06 44.96 S S S
29 Bacillus-thuringensis subspfinitimusJAB239 17.06 24.44 20.92 31.89 R S S
30 Bacillus thuringensis thuringensisiAB237 20.93 28.03 24.04 37.73 R S S
31 Bacillus cereus 55000 JABS64 22.08 29.99 22.94 30.73 S S ND
32 Bacillus thuringensis alesti JAB240 26.78 30.93 26.52 35.14 R S S
33 Bacillus flexis BT7 JAB49 21.90 32.69 19.01 31.09 R S S
34 Bacillus-megaterium 899 JAB170 20.76 20.79 20.81 30.73 ND ND ND
35 Bacillus megaterium BT12 JAB566 24.40 29.00 25.25 34.06 S S S
36 Bacillus megaterium 7A16 JAB768 22.91 ND 24.59 ND ND ND ND
37 Bacillus pumilusBiosubtyl JAB171 29.92 45.47 28.83 45.44 s s s
38 Bacilus licheniformis 5A2 JAB242 25.92 40.73 22.42 26.87 ND ND ND
39 Bacillus-licheniformis BT2 JAB396 27.15 23.49 26.52 26.59 S S R
40 Bacillus-licheniformis BGSC-5A24 JAB249 20.50 29.02 8.56 27.09 ND ND ND
41 Bacillus subtilissubspinaquasorumJAB766 21.14 ND 14.80 ND ND ND ND
42 Bacillus subtilis PY79 21.72 35.79 22.58 34.25 s s s
43 Bacillus subtilis BSnS JAB547 21.78 36.23 18.93 21.96 ND ND ND
44 Bacillus methylotrophicus JAB553 19.91 30.91 28.96 54.53 s R ND
45 Bacillus sp_53935 JAB563 23.81 32.51 23.38 37.09 S S S
46 Bacillus glycinifermentans SlAl JAB77O 26.50 ND 28.44 ND ND ND ND
47 Bacillus amyloliquefaciens JAB570 21.37 1 19.80 83.36 S R ND
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48 Bacillus subtilis _Nm-1_3A25_JAB546 25.05 33 77 18.20 32.91 S S ND
49 Bacillusamyloliquefaciens BT3 JAB397 20.42 28.15 22.74 26.73 S S S
50 BacillusmsubtilisGB03_JAB548 21.34 29.87 22.60 27.48 S S ND
51 Bacillus_amyloliquefaciensBAA-390 JAB557 25.97 33.64 21.53 16.66 S S N
52 Bacillusamyloliquefaciens 10A6_JAB552 22.29 35.04 64.16 24.45 S S ND
Table 4-3: Doubling times and antibiotic resistance of soil and other isolates.
Antibiotic concentrations are 100 stg/mL spectinomycin (spec), 10 g/mL tetracycline (tet), and 10 [tg/mL
chloramphenicol (cam).
Using data from the antibiotic and growth screens, we loosely grouped the recipients into
three different growth categories: fast (doubling times <30 min), medium (doubling times 30-50
min), and slow (doubling times >50 min). These groupings were used to divide strains into
manageable units for the conjugation assays (see next section).
4-2-6. Conjugation of wild type and miniature ICEBs] into diverse bacterial species
ICEBsJ conjugation has been tested in 44 of the 82 recipient strains (53%) (Fig 4-9b). Of
those tested, 20 yielded transconjugates (45%), which were verified by re-streaking on the
appropriate antibiotics and colony PCR using ICE-specific primers (Fig 4-9a). Interestingly,
there is little correlation between species' 16S rRNA phylogenetic distance and successful
conjugation. Several strains that are closely related to our B. subtilis donor (e.g., Bacillus
amyloliquefaciens FZB42, Bacillus subtilis GB03) did not receive ICEBs] during the conjugation
assays. However, all of the Enterococci strains, which are the most distantly related strains in our
collection, did receive ICEBsJ. Similarly, distinct strains of the same species have different
mating abilities. ICEBs] conjugates into Bacillus thuringensis subsp. fimintus and subsp.
kurstaki strains, however we did not detect transconjugates when attempting to mate ICEBs1 into
the mexicanensis, israelensis, thuringensis, and alesti subspecies strains.
In addition, some of the recipient strains showed mixed colony morphologies after
conjugation (Fig 4-9, starred). We presume that ICEBs] integrates randomly into the genome of
these strains and occasionally disrupts genes that are necessary for robust growth leading to
diverse colony sizes. In B. subtilis, ICEBsJ recognizes a specific 60-bp direct repeat sequence
(attB) for integration5 5 . When attB is missing, ICEBs1 will integrate randomly into the B.
subtilis chromosome. The ICEBs1 attB is in a leucine tRNA (tRNA 1U 2 ) and although tRNAs are
highly conserved across species, it may be missing from many of the recipient bacteria, causing
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Figure 4-8: Phylogenetic tree and conjugation proficiencies for recipient bacteria collection.
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Tree was constructed using 16S rRNA sequences. Bacteria that successfully receive ICEBs] are shown in
green. Unsuccessful conjugation in black. Untested in grey. Bacillus subtilis donor strain (AG174) in blue.
ICEBsJ to integrate randomly. Although genome sequences are unavailable for the vast majority
of our recipient strains, BLAST was used to identify species with potential att sites. BLAST
results show that 30 of the 56 recipient species (53.5%) contain sequences with at least some
sequence identity to the ICEBsJ attachment site (Fig 4-9). Thus ICEBsJ is likely integrating
randomly in the majority of recipient species.
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CTAGGTTGAGGGCCTAGTGGGT-GAATAACCCGTGGAGGTTCAAGTCCTCTCGGCCGCATC
------------ CCTAGTGGGTGAAT-ATCCGGATGAGGT---------------------
------------------------- TAACCCGGTGGAAGTTCAAATCTTCTTGGCCGCA--
-------------------------------- GTGGAGGTTCGAACCCTCTTGGCCGCATC
------------------------------- CGTGGGGGTTCAAGTCCCTTCACCCGCAT-
------------------------------- CGTGGGGGTTCAAGTCCCTTCATCCGCAT-
------------------------------- CGTGGGGGTTCAAGTCC--------------
--------------------------------- TGGAGTTTCAAGTTCTCTC---------
------------------------------ CCGTGGAGGGTCA------------------
------------------------------------------ AAGTCCTCTCGGACGC---
----- TTGAGGGGGTAGTGG-GCGTACG-CCCGTGGAGGTTCGAGTCCTCTCGACCGCAT-
----- TTGAGGGGGTAGTGG-GTGTATA-CCCGTGGAGGTTCGAGTCCTCTCTACCGCAT-
--- GGTTCAGGTCCG-TGTGGGCTAACCCCCCGTGGAGGTTCGAGTCCTCTCGACCGCATC
CTAGGTTGAGGGCCTAGTGGG--GGAAACCCCGTGGAGGTTCAAGTCCTCTCGGCCGCATC
CTAGGTTGAGGGCCTAGTGGG--GGAAACCCCGTGGAGGTTCAAGTCCTCTCGGCCGCATC
CTAGGTTGAGGGCCTAGTGGG--GGAAACCCCGTGGAGGTTCAAGTCCTCTCGGCCGCATC
CTAGGTTGAGGGCCTAGTGGGA-GTTAATCCCGTGGAGGTTCAAGTCCTCTCGGCCGCA--
CTAGGTTGAGGGCCTAGTGGGA-GTTAATCCCGTGGAGGTTCAAGTCCTCTCGGCCGCA--
CTAGGTTGAGGGCCTAGTGGGG-GTTAACCCCGTGGAGGTTCAAGTCCTCTTTACCGCA--
CTAGGTTGAGGGCCTAGTCGGG-GCA-ACTCGGTGGAGGTTCAAGTCCTCTCGATCGCA--
------------------------ AATAACCCGTGG-------------------------
CTAGGTTGAGGGCCTAGTGGGG-GCA-ACCCCGTGGAGGTTCAAGTCCTCTCGGCCGCA--
CTAGGTTGAGGGCCTAGTGGG--GGCG&CCCCGTGGAGGTTCAAGTCCTCTCGGCCGCA--
CTAGGTTGAGGGCCTAGTGGGAGTTAAATCCCGTGGAGGTTCAAGTCCTCTCGGCCGCAT-
CTAGGTTGAGGGCCTAGTGGGT-GAATAACCCGTGGAGGTTCAAGTCCTCTCGGCCGCATC
CTAGGTTGAGGGCCTAGTGGGT-GAATA&CCCGTGGAGGTTCAAGTCCTCTCGGCCGCATC
CTAGGTTGAGGGCCTAGTGGGT-GAATAACCCGTGGAGGTTCAAGTCCTCTCGGCCGCATC
CTAGGTTGAGGGCCTAGTGGGT-GAATAACCCGTGGAGGTTCAAGTCCTCTCGGCCGCATC
CTAGGTTGAGGGCCTAGTGGGT-GAATAACCCGTGGAGGTTCAAGTCCTCTCGGCCGCATC
------------------------------ CCGTGGAGGTTCAAGTCCTCTCGGCCGCA--
---------------------------------- GGAGGTTCAAGTCCTC-----------
Figure 4-9: ICEBsJ attB site in recipient bacterial species.
Sequences closely related to the ICEBsJ att site were identified through BLAST and aligned using Clustal
Omega.
After confirming ICEBsJ conjugation into several recipient species, we began using
mICE to deliver exogenous DNA to the bacteria. First, we added a PspankGFPmut2 cassette to
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mICE 1.0 and delivered it to the recipient bacteria that received wild type ICEBs] (Fig 4-10a).
We measured the response function of this cassette across species. Incredibly, the cassette is
functional in all strains tested thus far. All of the bacteria express GFP in an IPTG-dependent
manner, however the background fluorescence (Fig 4-10b, blue lines) and fold change in GFP
expression +/- IPTG varies significantly across species. The variation in fold change across
species is attributable to differences in both leaky expression of GFP and maximum
fluorescence.
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Figure 4-10: P,,,,.GFPmut2 response functions in diverse bacterial species.
(A) Schematic of B. subtilis donor strain (JAB402) used to deliver mICE carrying P,,,kGFPmut2 to
diverse bacterial species. (B) Recipient species engineered with mICE carrying PP,._GFPmut2 and the
IPTG-response functions. Engineered strains in red, unmodified recipient bacteria in blue. Error bars are
the s.d. of three separate transconjugates from the same conjugation experiment.
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4-2-7. Delivery of a functional nif clusters to soil dwelling bacteria
The most famous plant growth promoting bacteria are nitrogen fixers that turn
atmospheric nitrogen into a form that plants can easily use. These bacteria are typically
endophytes that invade plant roots and, through a complex interaction with plant cells, form
oxygen poor nodules in which the bacteria fix nitrogen in return for sugars45. Nitrogen-fixing
bacteria can improve crop yields and reduce the application of nitrogen fertilizers, which are bad
for the environment. However, nodule-forming nitrogen-fixing bacteria can only interact with
specific plant species (i.e., legumes). Thus, fertilizers must be used to produce many of the most
prevalent food crops worldwide (i.e., wheat, rice, maize). Fortunately, non-nodule forming
nitrogen-fixing bacteria (diazotrophs) can also improve plant growth in nitrogen-limited
environments 45748. Thus there is immense interest in identifying diazatrophic bacteria that can be
used to improve growth of non-legume food crops.
Here, we use mICE to introduce nitrogen fixation capabilities to diverse soil bacteria and
generate new diazatrophs. Most microbial nitrogen fixation is catalyzed by a molybdenum-
dependent nitrogenase enzyme that converts N2 into ammonia. The structural subunits of this
enzyme are typically encoded in complex nitrogen fixation nif gene clusters along with proteins
for co-factor biosynthesis and electron transport459. However, a simple single-operon nif cluster
was recently discovered in Paenibacillus sp. WLY784 0 . This nif cluster successfully conferred
nitrogen-fixing capabilities to Escherichia coli when over expressed in laboratory conditions. We
cloned the 10 kb nif cluster into mICE in B. sutbilis AG174 under the control of three different
promoters: Pan (the native Paenibacillus promoter), Pspaa, and PT7 (a promoter recognized by
bacteriophage promoter T7 RNA polymerase (T7RNAP)) (Fig 4-1 la). Minimal ICEBsJ with the
nif gene cluster will be referred to as nICE. Then nitrogenase enzyme production was measured
using an acetylene reduction assay (methods). Of the three promoters, Ps, produced the most
active nitrogenase (Fig 4-11 b). In the P,_nfWLY78 strain, T7RNAP is expressed from a non-
ICE locus (amyE). However, this configuration is not useful for engineering nitrogen fixation
into other bacterial species. Thus, we added T7RNAP to nICE. The cluster is only functional
when transcription of all of the genes (niJWLY78, T7RNAP, and lacd) is co-directional. The first
iteration of T7RNAP-nICE that we built had Pspank oriented convergently with PT7 (Fig 4-11 c).
However, this nICE produced significantly less functional nitrogenase than the original
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P,7_nifWLY78 strain (Fig 4-11d). I speculate that this architecture leads to repression via
antisense transcription and, although no experiments were done to prove this hypothesis
conclusively, flipping the PspankT7RNAP cassette so that the promoters are no longer oriented
convergently restores nitrogenase production.
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Figure 4-11: Activity of nitrogen fixation pathway nifWLY78 across species.
(A) Schematics for mICE with nifWLY78 driven by native promoter Pan (top), viral polymerase P-r
(middle), or IPTG-inducible promoter Pspank (bottom). B. subtilis strain with PT-7-driven nif cluster has IPTG
inducible T7RNAP cassette at amyE. (B) Activity of the nif clusters from (A) in Bacillus subtilis PY79. (C)
Schematics for mICE with nifWLY78 and Pspa,,T7RNAP oriented convergently (nICE1, top) or co-
directionally (nICE2, bottom). (D) Activity of the nif clusters from (C) in Bacillus subtilis PY79. (E)
Activity of nICE2 (panel (C), bottom) and Pspank-driven nifWLY78 (panel (A), bottom) across soil bacterial
species. In all panels, ImM IPTG was added to induce expression of nif cluster genes. Error bars are the
s.d. of three different transconjugates.
Once we had a functional T7RNAP-nICE donor, we conjugated the T7RNAP-driven nif
cluster into several of the soil bacteria species and measured nitrogen fixation (Fig 4-1le). X out
of X bacteria tested were able to fix nitrogen. Importantly, none of the strains fix nitrogen in the
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absence of IPTG, therefore the diazatrophic phenotype is due to expression of the genes carried
on nICE. We also tested the Ppank-niWLY7 8 nICE in the other bacterial species and found that
although some of the Bacillus licheniformis strains are able to fix nitrogen using Pspank-nICE,
addition of the orthogonal viral polymerase improves the nitrogen fixation phenotype.
4-3. DisCUSSION
Here, we present ICEBs] as a tool for engineering diverse bacterial species. We created a
miniature version of ICEBs1 that is incapable of self transfer and demonstrate that it can be used
to introduce foreign DNA to at least twenty different strains spanning sixteen bacterial species
and five genera (Bacillus, Enterococcus, Paenibacillus, Streptococcus, Staphylococcus). We use
this minimal ICE to test an inducible promoter system across species and demonstrate that a
single cassette is functional across all strains tested. Since our interest in developing this tool is
to enable the construction of sophisticated probiotics, we demonstrate that mICE can be used to
transform non-nitrogen fixing soil bacterium into diazatrophs with potential for improving plant
growth. We use mICE to deliver a minimal rnf cluster to six different soil bacteria and show that
the best nitrogen fixation results are achieved when a viral polymerase (T7RNAP) is used to
drive expression of the cluster. Future work will focus on testing the remainder of the recipient
bacteria collection and modifying mICE 1.0 to improve reliability of the tool and potentially
expand host range further.
Although our current data shows ICEBs1 conjugation >45% of the bacterial species
tested, there are several modifications that could be made to the element that may expand its host
range. There are several potential points of failure that may be easily addressed by modifying the
mICE (or full length ICE) delivered to the recipient bacteria. Each modification should be
preceded by simple assays to elucidate the point(s) of failure in the recipient. The first point of
failure may be degradation of ICE DNA in the recipient bacteria by an incompatible restriction
modification system. If the ICE DNA is digested by restriction enzymes in the recipient, it will
be immediately lost before transconjugates can form. There are several ways to circumvent
restriction modification (R/M) systems, however a straightforward method used by other mobile
genetic elements is expression of antirestriction proteins. One (or more) of these antirestriction
proteins could be added to ICEBs] to prevent digestion of the delivered DNA by recipient R/M
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systems. Alternatively, the element could be recoded to remove all known restriction enzyme
recognition sequences or the B. subtilis donor strain could be engineered to express more DNA
modification enzymes to methylate tDNA before it is transferred to the recipient cell.
A second point of failure could be integration of the ICEBsJ DNA into the recipient
bacteria's genome. Failure to integrate is most likely due to insufficient expression of the Int
protein in the recipient (since we know the protein itself is capable of integrating ICE DNA in
the absence of attB)455 . Promoter and RBS engineering could potentially be used to boost
expression of the integrase in the recipient cell. Synthetic biologists have recently published
mixed feedback control loops and software tools for developing 'universal' RBSs that may help
drive expression of Int in organisms with distant transcription/translation machinery41 . Failure to
integrate may also be due to insufficient second strand synthesis in the recipient. tDNA needs to
be double stranded in order for host RNAP to transcribe the int gene and for the Int protein to
catalyze recombination. To ensure second strand synthesis in the recipient, additional single
strand origins (sso) could be added to ICEBsJ. Ssos from broad host range rolling circle plasmids
may increase the amount of double stranded DNA in the recipient and facilitate integration4 2 .
Failure to maintain ICEBsJ may be due to disregulation of int and xis in the recipient
species. If too much excisionase is expressed, ICEBsJ will continually excise and eventually get
lost. This can be fixed by eliminating xis from the transferred DNA so that once ICE has
integrated into the recipient's genome it cannot excise and become lost. Integration of ICE DNA
into essential genes may lower the observed conjugation efficiency. Random integration of
ICEBsJ could be prevented by swapping the native integrase for one with a known recognition
sequence in the target strain63 . Unfortunately, this requires genome sequence information in the
target, which may be difficult to aquire. CRISPR/Cas systems could also be used to target
integration of ICE DNA to specific locations in the host chromosome4, though this would also
require knowledge of genome sequences and expression of more genes in the target strain.
Several additional strains, including anaerobics, thermophiles, and isolates from other
important microbiomes (e.g., aquatic bacteria, animal commensals), could be tested as ICEBsJ
recipients in future studies. B. subtilis is capable of anaerobic growth and can withstand very
high temperatures (it can still grow at 65*C). Thus, it may be amenable to conjugation
experiments in more extreme environments. Being able to engineer anaerobic strains would be
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especially useful for manipulating gut microbes. Several of the most important gut bacterial
species, including Bifidobacterium and Clostridia are obligate anaerobes with very few tools
available for genetic modification.
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Figure 4-12: Methods for engineering bacteria with ICE.
ICEs could be used to genetically modify bacteria either in vitro (A) or in situ (B). Bacteria can be
extracted from the target environment, modified, and reintroduced (A). Or a donor strain of bacteria can be
introduced to the target environment to modify bacteria in situ (B).
Most excitingly, ICE could be used in the future to modify recipient bacteria in situ.
During this project, we brought bacteria out of their environments and into the lab in order to
modify them (Fig 4-12a). However taking bacteria out of their environment(s) and into lab is not
necessary if the synthetic DNA is delivered to bacteria via conjugation. Horizontal gene transfer
via conjugation is known to occur in almost all environments4 5 . Thus, instead of bringing
bacteria into the lab, donor strains of B. subtilis could introduced to the environment to spread
target synthetic programs to the bacteria already living in these environments (Fig 4-12b). This
would eliminate the need to find culture conditions for target bacterial species or clear out
bacteria from specific niches to prevent colonization competition. In situ engineering may
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instigate a new paradigm for treating disease in which donor bacteria are consumed or
distributed, like probiotics to deliver 'smart' therapeutic pathways, instead of bioactive
molecules, to the native cells.
4-4. MATERIALS AND METHODS
4-4-1. Media and growth conditions.
Escherichia coli strains were grown at 370 C in Luria Broth (LB) (Becton Dickinson 244630).
Saccharomyces cerevisiae strains were grown at 30*C in yeast extract peptone dextrose (YPD)
or uracil dropout synthetic defined media (SD-URA). Bacillus subtilis donor strains were grown
at 37*C in LB medium. Media and growth conditions for all other strains are listed in Table X.
Starter cultures were generated for all assays by streaking out the appropriate strains from freezer
stocks onto solid media and incubating overnight. In the morning, one colony was inoculated
into 2mL of medium in 15mL culture tubes (Fischer Scientific 352059) and incubated for 2h at
30*C or 370 C and 250 r.p.m. in a New Brunswick Scientific Innova 44.
Antibiotics and other chemicals were used at the following concentrations: carbenicillin
(E. coli - 100 tg/mL) (Gold Bio C-103), kanamycin (E. coli - 50 tg/mL, B. subtilis - 5 [tg/mL)
(Gold Bio K-120), tetracycline (B. subtilis - 10 tg/mL), spectinomycin (B. subtilis - 100 ptg/mL),
erythromycin (B. subtilis - 0.5 [tg/mL), lincomycin (B. subtilis - 12.5 tg/mL), chloramphenicol
(B. subtilis - 5 tg/mL), isopropyl -D-1-thiogalactopyranoside (IPTG) (1mM) (Gold Bio
12481C), xylose (2% wt/vol), D-alanine (100 [tM) (Sigma A7377). For the nitrogenase activity
assay, all strains were incubated in modified BB medium (20 g sucrose, 0.25 g MgSO4*7H20, I
g NaCl, 0.1 g CaCl2*2H20, 2.9 mg FeCl3, 0.25 mg NaMoO4*2H20, 2.5 g Na2HPO4, 0.3 g
KH2PO4, 1.5 mL 10% serine; per liter).
4-4-2. Strains.
Escherichia coli strain NEB1sOP (A(ara-leu)7697 araD139 fhuA AlacX74 galK16 galE15 e14-
f8OdlacZAM15 recAl relAl endAl nupG rpsL (StrR) rph spoTI A(mrr-hsdRMS-mcrBC)),
Escherichia coli strain XL1OGold (endA1 glnV44 recAl thi-1 gyrA96 relA1 lac Hte
A(mcrA)183 A(mcrCB-hsdSMR-mrr)173 tetR F'[proAB lacIqZAM15 TnlO(TetR Amy
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CmR)])(Agilent Technologies 200314), and Saccharomyces cerevisiae were used for all plasmid
constructions. Bacillus subtilis subsp. subtilis strain JH642 was used as the base strain for all
donors. All recipient strains in this study are listed in Table 4-1.
4-4-3. 16S rRNA sequencing.
Colony PCR was performed to amplify and sequence 16S rRNA. To perform colony PCR, single
colonies were inoculated into 35 tL of Bio-Rad InstaGene Matrix (Bio-Rad 7326030) and
incubated at X for X min, then boiled at X for X min. InstaGene Matrix beads were removed via
centrifugation and 1 tL of supernatant was added to a PCR reaction using Integrated DNA
Technologies ReadyMade Primers for 16S rRNA amplification (IDT 51-01-19-06 and 51-01-19-
07).
4-4-4. Growth rate measurement.
Strains are struck out on the appropriate solid media and incubated at 25'C, 30*C, or 37'C
overnight. The next day, colonies are picked into 200 tL of the appropriate media in 96-deep
well blocks (USA Scientific 1896-2000) and incubated for 3 h at 250 C, 300C, or 37*C and 250
r.p.m. in an INFORS-HT Multitron Pro. After 3 h, the cells are diluted 1:500 into 150 [tL of
fresh media in black 96-well optical bottom plates (Thermo Scientific 165305) and incubated at
the same growth temperature with 1 mm orbital shaking in a BioTek Synergy H 1 plate reader.
Optical density measurements at 600-nm wavelength (OD6 O) were made every 20 min for 12 h.
To calculate growth rates, a standard curve was made to correlate plate reader
measurements with OD6. measurements from the BioRad XX spectrophotometer used for all
other assays. Briefly, OD6. of B. subtilis PY79 cultures (in the same media as the test strains)
were measured using the BioRad XX spectrophotometer. These cultures were serially diluted
(ODWO = 1.6, 0.8, 0.4, 0.2, 0.1, 0.05, 0.025, 0) into fresh media with 50 tg/mL chloramphenicol
to prohibit growth. 150 tL of each were added to the 96-well optical bottom plates and measured
concurrently with test strains. Growth rates (min/doubling) were calculated using the slope of the
linear portion of the exponential agrowth curves.
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4-4-5. Conjugation assays.
Conjugation assays were performed on filters as previously described. Briefly, starter cultures
are diluted to OD6. 0.025 in 20mL of medium in 250 mL Erlenmeyer flasks (Corning 4450-250)
and grown at the same temperature and speed as starter cultures. After 1 h, 2% xylose (wt/vol) is
added to the donor culture to induce expression of RapI and the cells are grown for an additional
hour. Next, 2.5mL of donors and recipients at OD6. 0.9 are mixed, collected on a mating filter
(Thermo Scientific 145-0020) by vacuum, and placed on a solid mating support consisting of
1.5% agar with Spiz+MgCl 2 (0.2 g NH4SO4, 1.4 g K2HPO4, 37.5 mg KH2PO4, 0.1 g
Na3citrate-2H20, 20 mg MgSO4-7H20 per liter + 125mM MgCl2) for 3 h at 37*C. Cells were
then rinsed off the filter, diluted, and spread on plates with selective antibiotics and/or D-alanine
to determine the numbers of transconjugates, donors, and recipients. For all conjugation assays,
donor starter cultures and O/N plates contain antibiotics to prevent ICEBs1 excision/loss.
Slight modifications to the filter mating protocol were made for spot and liquid matings.
For spot and liquid matings, starter cultures are diluted into 2 mL of medium in 15 mL culture
tubes. 150 tL of donor and recipients at OD6. 0.9 are mixed and either incubated at 37'C for 3 h
(liquid mating) or centrifuged at 12,000 r.p.m. for I min, resuspended in 15 tL of media, and
spotted onto agar plates.
4-4-6. Nitrogenase activity assay.
Nitrogenase activity was determined by acetylene reduction as previously described. Starter
cultures are diluted to OD600 0.025 in 2mL of medium in 24-deep well blocks and grown for 2.5
h at 250 r.p.m in an INFORS-HT Multitron Pro. The cells were then collected by centrifugation
(1 min, 12000 r.p.m.) and resuspended in 2mL BB minimal media in lOmL glass vials with
PTFE-silicone septa screw caps. Headspace in the bottles was repeatedly evacuated and flushed
with argon gas using a vacuum manifold equipped with a copper catalyst 02 trap. Acetylene gas
was freshly generated from CaC2 in a Burris bottle and ImL was injected into each bottle to start
the reaction. Cultures were incubated at 30'C, 250 r.p.m. for 22 h. Ethylene production was
analyzed by gas chromatography on an Agilent 7890A GC system (Agilent Technologies, Inc.)
equipped with a PAL headspace autosampler and flame ionization detector as follows. 250mL
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headspace preincubated to 35*C was sampled and separated on a GS-CarbonPLOT column (0.32
mm x 30 m, 3 micron; Agilent) at 60'C and a He flow rate of 1.8 mL/min. Detection occurred in
a FID head heated to 300*C with a gas flow of 35 mL/min H2 and 400 mL/min air. Under these
conditions, acetylene eluted at 3.0 min after injection and ethylene at 3.65 min. Ethylene
production was quantified by integrating the 3.65 min peak using Agilent GC/MSD ChemStation
Software.
4-4-7. Fluorescence measurement.
Starter cultures are diluted to OD600 0.025 in 2mL of medium in 15 mL culture tubes and grown
for 2.5 h at the same temperature and speed. After 2.5 h, the cells are diluted 1:200 into 200 !.L
media with different concentrations of IPTG (0, 1, 5, 10, 20, 50, 70, 100, 200, 500, 1000 [tM).
These cultures are grown for 3 h, then diluted 1:15 into phosphate buffered saline and measured
using a BD Biosciences Fortessa flow cytometer with blue (488 nm) and red (640 nm) lasers. An
injection volume of 10 tL and flow rate of 0.5 tL/s were used. Cytometry data was analyzed
using FlowJo (TreeStar Inc., Ashland, OR) and populations were gated on forward and side
scatter heights. The gated populations consisted of at least 30,000 cells. The median fluorescence
of the gated populations was used calculated using FlowJo and used for all reporting.
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Chapter 5: Conclusions
5-1: UTILITY OF SUBTLE REGULATORY METHODS FOR CONTROLLING GENE EXPRESSION
In natural systems, gene expression is regulated by an astounding number of variables,
many of which are ignored by synthetic biologists. This is because a few specific regulatory
sequences, e.g., RBSs, promoters, terminators, can drastically change gene expression and
synthetic biologists have primarily focused on maximizing changes in gene expression.
However, as synthetic genetic systems become more intricate, genetic engineers will need to
make more nuanced adjustments to transcription/translation. To achieve a finer level of control,
additional regulatory mechanisms must be considered. Just as natural genetic systems use
multiple mechanisms to precisely control gene expression, genetic engineers could layer
regulatory methods to build synthetic genetic programs. Layering subtle regulatory mechanisms
may allow genetic engineers to move away from extreme overexpression of protein and/or RNA
regulators, e.g., repressor proteins, activator proteins, RNA IN/OUT, CRISPR/dCas9, to create
more robust genetic circuits. If genetically engineered bacteria are ever approved for commercial
release, they need to be able to survive in the target environment and closely mimicking natural
regulation may be the best way to reduce the metabolic burden placed on cells by synthetic
programs. This should help genetically modified bacteria compete with wild type organisms.
Thus, it will become important to characterize more natural forms of gene expression control so
that they can be incorporated into synthetic designs.
One example of a biological variable that affects gene expression is DNA topology46.
DNA can change from negatively to positively supercoiled or flip from B-form to Z-form 7.
Each form of DNA differentially affects transcription initiation and protein binding to
DNA 46'468'469. However, topology is largely ignored when genetic engineers design DNA. This is
surprising because DNA topology can be changed using transcription, protein binding, and DNA
looping470 , which are all processes dictated by DNA sequence. Therefore, genetic engineers
could design DNA sequences that convert between topologies and use DNA structure to tune
gene expression. Another biological variable that is largely ignored by genetic engineers is tRNA
modification. tRNA modifications can affect the rate and fidelity of translation by altering
ribosome-binding affinity and reducing misreads/frame shifts. tRNA modifications can be
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induced by cell stress or growth rate and can change the translation rate of specific codons471.
Therefore, when synthetic biologists 'recode' genes, they may be able to use codons recognized
by differentially modified tRNAs to promote translation under specific conditions. Antisense
transcription (discussed in Chapter 3) is another form of regulation that could be layered on top
of existing modes of regulation to fine tune gene expression. Now that we have started to
quantify the affect of antisense promoters on gene expression, we expect that antisense
promoters can be used in creative ways to tune gene expression. For example, operon
arrangement could now be used as a design parameter. Engineers could design constructs with
convergent operons to create antisense transcription and coordinate expression of the two
operons 30. Alternatively, inducible antisense promoters could be embedded in the coding regions
of genes to predictably differentially regulate expression. The advantage of these alternative
methods for tuning gene expression is the ability to layer regulation. Antisense transcription,
DNA topology, and codon usage can all be considered when designing constructs that use
characterized promoters, RBSs, and terminators. As the desire to precisely tune gene expression
increases, I believe that features such as DNA topology and tRNA modification rates will
become more important.
5-2: ADDITIONAL FACTORS THAT AFFECT ANTISENSE TRANSCRIPTION
As discussed in Chapter 3, promoter strength can affect the amount of repression
generated by antisense transcription. However, additional factors, such as RBS strength and
promoter firing kinetics, may also affect antisense transcription-mediated repression. The ODE
model developed in Chapter 3 predicts that polymerases fired from the forward promoter, i.e.,
the promoter driving expression of the protein of interest, are more likely to survive collisions
than those fired from the antisense promoter. We interpret this result to mean that ribosomes
translating the forward mRNA prevent RNAPs fired from the forward promoter from
backsliding/stalling and increase the number of RNAPs that survive collision. Therefore, we
hypothesize that changes in the RBS alter the amount of repression. Weaker RBSs should
increase repression by increasing susceptibility to collisions. Weaker RBSs could also increase
fold repression by reducing the number of ribosomes present on the mRNA, thereby leaving
more mRNA available for binding by the antisense RNA (asRNA). Preliminary experiments
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with different RBSs show that RBS strength is inversely correlated with fold repression (Fig 5-
1). However, additional experiments will be needed to identify the mechanism behind RBS-
mediated changes in repression. These experiments may include single molecule techniques to
measure the frequency of RNAP ejection following collision or additional gene expression
experiments in which both the forward and antisense promoters drive expression of translated
mRNAs.
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Figure 5-1: Impact of RBS sense on antisense transcription
(A) Antisense transcription reporter plasmids used to quantify repression. Plasmids are the same as in Fig
3-2, except RBS is varied. (B) Fold repression (Equation 3-1) is shown as a function of the induction of the
forward promoter. The colors correspond to RBSs of different strength. (C) Maximum fold repression as a
function of RBS strength. In all panels, data represents the mean of three experiments performed on
different days and the error bars are the standard deviation of these replicates.
Promoter kinetics may also influence repression mediated by antisense transcription.
Promoter kinetics can vary widely based on the ability of RNAP to bind, isomerize, and initiate
productive transcription at a given DNA sequence3 16 . Promoters that fire RNAPs in bursts may
be less susceptible to antisense transcription than those that fire deterministically, i.e., at regular
intervals. To visualize why this it true, consider two promoters that both produce the same
amount of mRNA in a given period of time (as measured by the amount of fluorescent protein
produced in that period of time). One promoter is deterministic and one fires RNAPs in bursts.
At the bursty promoter, several RNAPs will initiate transcription in quick succession472 . This
group of polymerases will transcribe the gene of interest and then fall off the DNA. Eventually
the bursty promoter will fire again and another group of RNAPs will traverse the DNA. When
compared to a deterministic promoter, the bursty promoter will create longer stretches of time
during which no RNAPs are fired and the template strand of DNA is free of RNAP. During this
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time, RNAPs fired from the antisense promoter will not cause collisions. Thus, for a given
antisense promoter, genes expressed with bursty promoters will be less susceptible to repression
via antisense transcription. Additionally, trailing RNAPs, i.e., those closely following another
actively transcribing RNAP, may also help prevent backsliding/stalling of the leading RNAP.
Thus, promoter dynamics may affect the quantitative effect of antisense transcription.
5-3: MODIFICATIONS THAT MAY EXPAND THE HOST RANGE & CONJUGATION FREQUENCY OF
ICEBsJ
There may be several ways to expand the host range of ICEBsI. We have been able to
conjugate ICEBsJ into half of the bacterial recipients tested so far (see Chapter 4). However, it
would be better if we could use ICEBsJ to engineer more of the recipient strains. Ideally, we
would be able to conjugate ICEBs] into any Gram-positive bacteria. We believe that the host
range of ICEBsJ is limited, in some cases, by mechanisms that can be circumvented with some
simple engineering. For example, restriction modification systems may be preventing ICEBs]
DNA from persisting in recipient cells. Restriction modification systems degrade foreign DNA
and bacteria these systems to prevent 'infection' by selfish DNA elements 4 73 474 . Conjugative
plasmids and other broad host range DNA elements often carry use antirestriction modification
proteins to avoid degradation by host enzymes 475. Wild type ICEBs] does not encode any
antirestriction modification proteins, however one could easily add antirestriction modification
proteins, such as Orf 18 from Tn916, to the element47 6. This may increase the recipient host range
by preventing DNA degradation.
Insufficient expression of the integrase Int, may be preventing integration of the ICEBs]
element into some of the recipient bacterias' genomes. If ICEBsI does not integrate, it must rely
on its ability to replicate like a plasmid to persist in the recipient bacteria. Unfortunately, the
plasmid form of ICEBsJ is not as stable as the integrated form and it may be lost during recipient
cell division. To increase expression of Int in the recipient, the integrase gene int could be placed
under a broad host range promoter, such as Pint from Tn916. A synthetic system designed to
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kick start transcription in any bacteria could also be used to express int6'. Low integration
efficiency may also be due to a dearth of integration sites in the recipient. The ICEBsJ integrase
prefers to integrate at a specific DNA sequence (attB). When this sequence is missing in the
recipient, ICEBsJ will integrate randomly in the bacteria's chromosome45 5 . ICEBsJ's random
integration is much less efficient than site specific integration. Thus, poor conjugation efficiency
may be due to poor integration efficiency caused by a lack of good integration sites in the
recipient strain. To circumvent this, we could replace the integrase in ICEBsJ with a more
promiscuous integrase or with a protein that targets a different sequence.
Second strand synthesis may also prevent successful expression of the ICEBs] integrase.
When ICEBs] conjugates, it enters the recipient cell as single stranded DNA. The second strand
of DNA is made by the host DNA polymerase, which recognizes a second strand origin (sso) on
ICEBs]. Since double stranded DNA is required for transcription and recombination with the
host genome, it is essential for integration. Unfortunately, ssos can have a very narrow host range
and we do not know how well the ICEBs] sso will function in all recipient bacteria4 2 . Additional
ssos can be added to ICEBs] to increase second strand synthesis in diverse bacterial species.
Finally, the antibiotic resistance cassettes that we are using to isolate transconjugates
could be altered to potentially increase the known host range of ICEBs]. As discussed in Chapter
4, we selected tet(M) and cat as the antibiotic resistance markers to use for our ICEBs]
conjugation experiments because they are from broad host range elements Tn916 and pC194.
However, it is possible that these resistance cassettes are not functional in the some of the
recipient bacteria. If the resistance proteins are poorly expressed or nonfunctional in a recipient
bacteria, we would not be able to isolate transconjugates, even if ICEBs] was successfully
conjugated and integrated, giving us a false positive result. Other antibiotic resistance markers or
selection methods could be used to test ICEBs] conjugation to potentially broaden it's known
host range.
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Before modifying ICEBs] to increase host range, it is necessary to identify the
mechanism(s) preventing ICEBsI acquisition by potential recipient strains. If ICEBs] is getting
digested by a recipient's restriction modification system, then a new sso will not improve
conjugation efficiency. It will be straightforward to test several hypotheses for inefficient
ICEBs] conjugation and these experiments should be done before building new ICE varients so
that one does not waste time building solutions to the wrong problems.
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